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The immune system is comprised of numerous cell types, molecules and pathways 
whose primary purpose is to regulate tissue homeostasis and protect an individual from 
disease. Researchers have tried to identify and characterise components of the immune 
system and their interactions as modulating aspects of this system is a major goal of the 
pharmaceutical industry. This work has described the significant heterogeneity of 
immune cell types which are defined by their microenvironment, extending from their 
lineage commitment in specialised tissues, e.g. bone marrow and thymus, to their 
activation states in disease. A facet of this heterogeneity are tissues-resident immune 
cells (TRICs) which have tissue specific homeostatic functions, and differ from their 
tissue naïve counterparts at the transcriptomic and epigenetic level. Furthermore, these 
cells display unique activation states in disease, making them a target for tissue-specific 
therapies. Hence, in this thesis, I have sought to expand on the current knowledge of 
TRICs in health and disease, investigating their heterogeneity and how to define them 
using various computational approaches.  
Initially in chapter two a single well defined TRIC population, microglia, the tissue-
resident macrophage of the brain is investigated. Microglia are the dominant immune cell 
type of the brain and are strongly implicated in neurodegenerative disease. These cells 
exhibit great heterogeneity depending on the brain region they reside in, also influencing 
their activation states. Fifteen studies had previously sought to define the functional 
profile of microglia in humans and mice, but these ‘gene signatures’ showed poor 
agreement overall. To address this issue a core human microglia signature conserved 
across brain regions was derived. Accordingly, data derived from intact brain tissue and 
pooled cells derived transcriptomic data from various brain regions was collated. This 
included nine datasets across three resources, the Genotype-Tissue Expression (GTEx) 
project, the Allen Brain Atlas (ABA) and a study of central nervous system (CNS) cells 
from Zhang et al. From each dataset, a microglial signature was derived using gene 
coexpression network (GCN) analysis to capture genes sharing a common expression 
profile across samples and which likely represented the same biology. The final human 
microglia signature comprised of 249 genes which were present in three or more of the 
dataset-derived microglial signatures. This gene set was validated using various sources 
of evidence. The average expression of signature genes correlated with microglial 
numbers and was significantly higher in myeloid populations relative to other immune 
and CNS cell types. Furthermore, the proteins encoded by signature genes positively 
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stained for microglia in different brain regions. The signature provides a means to 
understand the homeostatic state of these cells and a baseline against which their 
divergence in disease may be measured. Accordingly, the signature was used to analyse 
microglia in a transcriptomic dataset generated from post-mortem brain tissue of 
individuals of different ages and from Alzheimer’s patients in four regions of human brain. 
This helped untangle the qualitative (activation states) and quantitative (cell proportions) 
differences in microglia between conditions and brain regions. Microglial cell numbers 
correlated with neuroinflammation and tau pathology in a region-dependent manner. The 
activation state of these cells was characterised by the downregulation of homeostatic 
genes (CX3CR1 and P2RY12) and upregulation of TREM2-TYROBP pathway genes 
which have been implicated in Alzheimer’s disease through genome-wide association 
studies (GWAS). 
In chapter three, the analysis of TRICs was expanded upon from microglia to other TRIC 
populations. Currently, several immune cell types have been defined by selected 
markers and cytokine/chemokine profiles in the context of different diseases and tissues. 
However, a comprehensive unbiased analysis of these phenotypes in the context of 
other immune cells is required to appreciate the breadth of cellular heterogeneity, 
revealing commonalities and further subdivisions of known cell types. Given the 
availability of transcriptomic atlases of immune- and tissue-derived cells, there is a 
considerable scope for further analyses of TRIC biology. Hence, publicly available 
transcriptomic datasets from mouse including that derived from pooled-cells of marker-
defined cell types and that from unbiased single cell RNA-Seq (scRNA-Seq) were 
considered. The former was taken from the Immunological genome project (ImmGen) 
resource, which comprised of 128 combinations of marker-defined cell types from 26 
tissues. The relationship between these cells was studied, as were the gene signatures 
associated with them. Comparing cell types based on their transcriptome showed the 
relative similarity between lymphoid cell types relative to the heterogeneous myeloid cell 
populations. Using GCN analysis, 157 gene modules associated with either cell lineages, 
cell types, cell subsets or TRICs were identified. Interestingly, it was difficult to distinguish 
certain marker-defined cell types from others, either suggesting that cell types could be 
defined by a few genes or current markers may encompass overlapping cell populations. 
As a complimentary unbiased approach, we also analysed immune subsets defined by 
the Tabula Muris Atlas, which included scRNA-Seq data derived from twelve tissues. 
Forty-three cell clusters were identified which were associated with forty-four gene 
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clusters. The analyses highlighted gene clusters associated with the different cell 
lineages, cell types and TRICs, many of which significantly overlapped with those from 
the ImmGen GCN analysis. Some gene signatures were unique to TRICs or common 
across them, indicative of a tissue-dependent/independent biology. As expected, the 
greatest number, eleven signatures were associated with macrophages, eight of which 
agreed with cell types identified in the literature based on certain associated genes. To 
aid these analyses, novel approaches including annotating cells from a reference set of 
known cell types based on their transcriptomic profile; and capturing gene coexpression 
patterns using GCNs were developed, both of which are ongoing challenges unique to 
scRNA-Seq due to particular technical and biological variations. 
Building upon the work described in chapter three, chapter four involved extending 
similar deconvolution analyses to human TRIC gene signatures from bulk tissue 
transcriptomic data taken from the GTEx resource. First, a set of reference immune 
signatures (RIS) was derived from a downsampled collection of all the 28 tissues of the 
GTEx, thus representing nine classifications of immune cell types. In the case of 
macrophages, monocytes and dendritic cells, combined gene signatures were identified, 
thus highlighting the resolution of bulk-transcriptomics for signature derivation. Finally, 
the RIS aided in deriving TRIC signatures individually from the 21 tissues of the GTEx 
considered for downstream analyses. As expected, signatures of macrophages-
monocyte-dendritic cells were found in every tissue and across tissues 1,012 genes were 
associated with these cells, the highest number relative to other cell classifications. 
Interestingly, genes that were most commonly associated with a given cell type across 
tissues included many known markers for them, as found for macrophage-monocyte-
dendritic cells, neutrophils, T cells, NK cells and B cells. Subsequently, each TRIC 
signature was compared with those derived from mouse in chapter three. Thirty-nine 
gene clusters overlapped between species and were associated with 12 TRICs. Seven 
TRIC populations and their associated genes were supported through literature.  
In conclusion, this work has sought to examine the heterogeneity of TRICs, the 
transcriptomic signatures associated with them and the computational approaches to 
best derive them from tissue and cell level data.  The work also shows the potential of 
using these TRIC signatures to explore disease states and the associated response of 








Humans possess a defence system called the immune system which helps in protecting 
them from disease. This system comprises of specialised cell types which are spread 
across different tissues of our body. These cells are constantly sensing for signs of 
infection or injury and respond accordingly to counteract them. Indeed, cells of the 
immune system are associated with the pathology of almost all diseases, from cancers 
to the infection of COVID-19.  Understanding and modulating the immune system is a 
cornerstone of the biomedical research and a major target of pharmaceuticals.  Modern 
research has studied this natural defence system and uses it to treat various diseases. 
Hence, there has been a great interest in understanding the different parts of the immune 
system. In order to respond appropriately to the numerous challenges associated with 
the spectrum of disease, the immune system consists of a diverse set of cell types each 
with unique characteristics. Though communicating with one another they can launch an 
array of responses. In addition to the commonly known “white blood cells” which are 
measured in blood tests, immune cell types display a great diversity as they also reside 
in various tissues. Within the tissues they help maintain proper functioning of the tissues 
and have unique responses to counteract infections or injuries. One of the ways we can 
understand these cells is to see which genes they utilise or express. Genes encode the 
instructions to make specific proteins, and when expressed by a cell allow it to carry out 
specialised functions associated with these proteins. Each cell type expresses a different 
combination of genes which define their identity and activity. In many cases, a group of 
genes work together to carry out a particular function and we try identifying those that 
are expressed by a particular cell type. In this thesis GCN analysis was used to identify 
these genes. The method constructs a network of genes, where genes related to the 
same biology, sharing a similar expression across samples are highly connected and 
hence can be captured. Using this approach this thesis examines the diversity of immune 
cells across tissues and the genes that are associated with them. 
In chapter 2, we begin exploring these immune cells in the context of tissues by 
examining the major immune cell type of the brain, known as the microglia. These cells 
are implicated in various diseases such as Alzheimer’s disease, Parkinson’s and multiple 
sclerosis, all of which are associated with dying neurons, and together are termed as 
neurodegenerative diseases. Microglia are the most abundant immune cell type of the 
brain responsible for its proper function, e.g. redefining connections between neurons. 
These cells differ depending on the region of the brain, hence we tried to find a group of 
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genes or a gene signature that defines microglia across brain regions by using GCNs. 
To identify these genes nine publicly available datasets of gene expression data derived 
from the human brain were considered. From each dataset we used GCN analysis to 
identify a group of genes that represented microglia, and genes that were found in three 
or more of these networks were considered to represent the final core human microglia. 
249 such genes were identified. Knowing this signature of genes in healthy brains we 
could then observe how these genes changed in disease. By examining the expression 
of these genes together, the number of microglial cells that changed in young, ageing 
and individual with Alzheimer’s disease was examined. In ageing, the proportion of 
microglia increased the most in the hippocampus, a region of the brain known to be 
significantly affected by age and which is associated with learning and enforcing 
memories. In Alzheimer’s, microglial numbers were higher in brain regions with 
inflammation and those known to have a greater accumulation of the protein tau, 
associated with Alzheimer’s. Furthermore, changes were also observed within microglia 
as they reduced the expression of genes associated with their identity in healthy 
individuals and began to express genes with known associations to Alzheimer’s. 
In chapter 3, the analysis from microglia was expanded upon to the various immune cell 
types across different tissues in the mouse. This study examined how these cell types 
are currently defined, i.e. by a set of genes or markers which can uniquely separate them 
from other cell types based on their expression. For this, a public resource called the 
ImmGen was used which is an international effort to understand the biology of the 
immune system. This resource included data from cells isolated from 26 different tissues 
and using 128 combinations of markers, each representing a unique cell type. Similar to 
how we studied the similarity between genes using GCN, from this data we were able to 
find the relationships between these cell types. Cell types of similar origin were found 
connected to one another while other heterogeneous cells formed separate groups e.g. 
macrophages, a versatile immune cell type ubiquitously present across tissues. 
Subsequently, the Tabula Muris dataset was analysed, which has the gene expression 
from single cells also called scRNA-Seq from 12 tissues; however, in this case, we did 
not know the cell types. This enabled the exploration of these cell types unbiased by 
predefined markers. From the data, 44 signatures for cell types were identified either 
specific to a tissue or those found in multiple tissues. These signatures overlapped 
between the analyses from both resources. In the process, methods to identify cell types 
based on known cell types were developed. Additionally, a method to identify genes with 
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a similar expression in scRNA-Seq data was also developed, which has been 
challenging in this research area due to the immense variation found in this data. 
In chapter 4, the analysis was extended to humans and the results were compared with 
the analysis in mouse. This comparison is essential as several drugs are based on 
studies in mouse but are found to be ineffective in human. For this the GTEx resource 
was considered, which provides gene expression data from 33 tissues. From each 
tissue, genes signatures were derived for the different immune cell types present using 
GCNs. Certain genes were repeatedly found to be associated with a particular immune 
cell type across tissues. Interestingly several of these genes included known markers 
which defined the immune cell type. Macrophages had the most number of genes in its 
signature and was identified in every tissues thus supporting its diversity. Lastly, the 
signatures were compared with those from mouse. Literature supported the signatures 
for seven immune cell types that overlapped across species. Still, the overlap across 
mouse and human immune signatures was minimal likely because when we examine 
the mixture of cells within a tissue it is difficult to find genes expressed by a certain cell 
type as they may be shared across several cell types. These findings highlighted the 
power of studying individual cells rather than a mixture of them like in tissues. 
In summary, this thesis examines 1) how the number and states of microglia differed in 
ageing and Alzheimer’s depending on the brain region; 2) The association between 128 
immune cell types (as defined by markers) from 26 different tissues. Here, cell types, 
were similar to those of the same origin based on their gene expression,  although 
heterogenous cell types like macrophages were very  different, evident from them 
forming different groups within the sample network; 3) An unbiased derivation of 44 
immune signatures across 12 tissues using scRNA-Seq data, revealing the diversity of 
immune cells and how much of it is dependent on tissue; 4) A methodology to identify 
the types of cell in scRNA-Seq data based on the gene expression of known cell types; 
5) developing and comparing different methods to construct GCN from scRNA-Seq data; 
6) human immune signatures from bulk RNA-Seq data spanning 21 tissues; and 7) A 
comparison of the immune signatures from human (bulk tissue) and mouse (cells), 
highlighting the lack of resolution in bulk RNA-Seq to identify tissue-specific genes of 
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1. Chapter 1: Introduction 
1.1 Components of the immune system 
1.1.1 The innate and adaptive immune system 
The immune system is responsible for an individual’s defence response to pathogens 
and in maintaining tissue homeostasis. It consists of specialised cell types and molecules 
which orchestrate different responses. By convention they are classified into the innate 
and adaptive immune response. These responses are characterised based on the type 
of cells, humoral components, receptors, response times and their capacity to memorise 
previously encountered antigens. The innate immune system is considered the first line 
of defence and is defined by its quick response to infection/injury. One of the primary 
components of innate immunity are the physical (mucosal layers and ciliated epithelial 
layers of the lung which facilitate pathogen clearance) and chemical (anti-microbial 
peptides like defensins and ribonuclease) barriers which prevent pathogens from 
entering the body (Turvey and Broide, 2010). Part of the humoral innate immunity are 
molecules like LPS-binding proteins, C-reactive protein and complement proteins which 
possess antimicrobial activity and facilitate innate immune responses, e.g. the 
complement system disrupts a pathogen’s cell membrane via a membrane attack 
complex and opsonizes them for subsequent phagocytosis (Dunkelberger and Song, 
2010). The immediate response of the innate immune system is attributed to the germline 
encoded pathogen recognition receptors (PRR) which recognise large groups of 
pathogens based on evolutionarily conserved pathogen-associated molecular patterns 
(PAMPs). In addition, they also recognise damage-associated molecular patterns 
(DAMPs) of molecules introduced as a result of infection. To account for these different 
patterns PRRs comprise of several subfamilies including, C-type lectin receptors (CLR), 
nucleotide-binding oligomerization domain leucin rich repeats containing receptors 
(NLR), retinoic acid-inducible gene 1-like receptors (RLR) and Toll-like receptors (TLR) 
(Takeuchi and Akira, 2010). Depending on the type of receptor they are localised to 
different cellular compartments and recognise different molecular patterns. For example, 
TLR3, TLR7, TLR8 and TLR9 that reside in the endosomal compartment are specific to 
DNA and RNA molecules found intracellularly (Kawasaki and Kawai, 2014). 
Furthermore, some of these interactions can result in different signalling cascades such 
as TLR3 which uses a TRIF-dependant pathway as opposed to the MyD88-dependent 
pathway used by the majority of the other TLRs. On recognising pathogens, innate 
immune cells can mediate various types of responses based on their specialised 
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functions. For example, macrophages, dendritic cells (DCs) and neutrophils are 
considered professional phagocytes which can phagocytose pathogens and debris at 
the sight of infection or injury. Innate immune cells such as granulocytes and NK cells 
release cytotoxic compounds on activation. Furthermore, in combination with cells of the 
adaptive immune system, innate immune cells secrete cytokines and chemokines to 
steer the inflammatory response and recruit further immune cells, e.g. a conventional 
proinflammatory response termed as type 1 is defined by cytokines like IL2, IL12 and 
IFNg, while that for a type 2 anti-inflammatory/wound healing response is characterised 
by IL4, IL5 and IL13, both of which are associated with cell types with corresponding 
activation states (Gause et al., 2013).  
Following activation of an innate immune response, the adaptive immune response is 
initiated. This system is characterised by different cell types and organs which unlike the 
innate immune system generate antigen-specific molecules through gene 
rearrangement and somatic hypermutations (Chaplin, 2010). Cells of the adaptive 
immune system, e.g. T cells are triggered by engaging antigens via the T cell receptor 
(TCR) through antigen presentation cells (APCs) such as DCs which capture and 
process antigens for presentation. Subsequently some of these cells exhibit effector T 
cells functions (e.g. secretion of cytotoxic compounds) while other helper T cells (Th) 
facilitate B cell maturation. B cells are lymphocytes specialised for producing vast 
amounts of antibodies on activation through a series of phases ultimately resulting in a 
stable interaction between B and T cells. Much like the mediators of the innate immune 
system, antibodies also facilitate the recognition of pathogens thereby facilitating 
immune responses, however, these antibodies are dynamic and epitope specific. 
Furthermore, depending on the context of activation, some cells of the adaptive immune 
system can convert to memory cells, which retain receptors specific to the PAMP from 
an earlier infection. These T and B memory cells are therefore able to initiate an 
immediate response on reencountering the same antigen. Thus, the innate and adaptive 
immune system present two arms of the immune system carrying out different functions 
with the ultimate goal of pathogen clearance.  
During an infection or injury immune cells migrate to the affected site as part of the 
immune response. There are also various tissues which are associated with the immune 
system where lymphocytes reside, develop and undergo activation. Lymphoid organs 
are categorised into primary, secondary and tertiary lymphoid organs. Primary lymphoid 
organs include the thymus and bone marrow. These tissues are involved in lymphocyte 
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production and development. The bone marrow is where both lymphoid and myeloid 
cells originate through the process of haematopoiesis. Subsequently, T cells are 
‘educated’ by engaging MHC and antigen complexes in the thymus through various 
checkpoints filtering out self-reactive T cells. Secondary lymphoid organs such as lymph 
nodes, Peyer’s patch, and spleen, have an assortment of cell types from both the innate 
and adaptive immune system and are involved in immune cell activation and pathogen 
clearance. For example, in the spleen APCs migrate to activate cells of the adaptive 
immune response, additionally phagocytic cells, such as macrophages await antibody 
bound pathogens. Whilst similar in function, tertiary lymphoid organs develop in tissues 
during adulthood in response to inflammation as observed in cancers, autoimmune 
diseases and infections (Buettner and Lochner, 2016).  
There is an increasing interest in immune cell types that reside in non-lymphoid tissues 
and the homeostatic functions they carry out. For example, adipose macrophages have 
increased b-oxidation which aids in lipid catabolism thereby minimising lipotoxicity. This 
alternatively activated phenotype is maintained by IL4 and IL13 released by tissue 
resident Th2 cells, ILC2s and iNKT cells (Odegaard and Chawla, 2015, Zhang et al., 
2019). Such cells or tissue-resident immune cells (TRIC) contribute significantly to 
immune cell diversity. Differences between TRICs and their tissue-naïve counterparts 
can be observed at the proteomic, transcriptomic and epigenetic level. One of the earliest 
exhaustive studies in the field described the transcriptomic profile of seven tissue-
resident macrophage populations, as well as the transcription factors and enhancers that 
define them (Lavin et al., 2014a). Distinctions are also observed in TRIC ontogeny and 
how they are sustained through adulthood, e.g. microglia, the tissue macrophages of the 
nervous system, originate from primitive haematopoiesis in the yolk sac (Mass, 2018), 
in contrast to majority of the other macrophage populations which are derived from 
definitive haematopoiesis in the bone marrow. Furthermore, microglia are sustained by 
a local pool of cells in the brain (Ajami et al., 2007). In summary, the immune system has 
numerous components from molecules to complex systems of cells, all which work in 
concert to protect and maintain homeostasis. 
1.1.2 Production of immune cell types from haematopoiesis 
The immune system consists of cell types originating from two lineages, the myeloid and 
lymphoid lineage. Whilst, innate immune cell types are derived from both lineages, those 
of the adaptive immune system originate from only the lymphoid lineage. Both lineages 
originate from a common multipotent cell, the hematopoietic stem cell (HSC). Cell 
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production and differentiation in the immune system is referred to as haematopoiesis 
and in adult life this process primarily takes place in the bone marrow. The factors 
regulating the differentiation towards lymphoid or myeloid commitment are still under 
investigation, e.g. aged HCSs have shown a preference towards committing to the 
myeloid lineage, suggesting a correlation between lineage commitment and the age of 
progenitors as defined by the number of cell divisions (Young et al., 2016). Alternately, 
certain mediators like TGFβ1 can direct HSC differentiation to myeloid cell types (Challen 
et al., 2010). Recent studies also suggest a precommitment towards cellular states, as 
cells which clonally expand from the same progenitor tend to share the same lineage 
(Naik et al., 2013). Supporting this, cells in the bone marrow were found to be 
predominately precommitted and unipotent (Notta et al., 2016). In contrast, HSCs 
presenting multi-lineage gene expression profiles have been identified suggesting a 
plastic phenotype (Olsson et al., 2016). These results could be indicative of the plasticity 
of HSCs and their ability to precommit to certain states. The question then remains, what 
factors determine cell type commitment.  
Definitive hemopoieses define many of the immune cell types in human, beginning from 
HSCs which sequentially differentiate through various states to become multi-potential 
progenitors (MPP) (Figure 1.1). These cells then diverge giving rise to lymphoid and 
myeloid lineages by differentiating into the common lymphoid progenitor (CLP) and 
common myeloid progenitor (CMP), respectively. CMPs can differentiate into either 
megakaryocyte–erythroid progenitor (MEP) which give rise to erythrocyte and 
megakaryocytes (platelets), or granulocyte-monocyte progenitors (GMP) which generate 
granulocytes (basophils, neutrophils, eosinophils and mast cells), monocytes, 
macrophages and DCs. CLPs differentiate into cell of the lymphoid lineage including B 
cell, T cells, NK cells, ILCs, NKT and DCs with certain cell types being developed in the 




Figure 1.1. Human haematopoiesis. 
Taken from (Antoniani et al., 2017). The simplified schematic of human haematopoiesis from 
multipotent HSC (top) to unipotent cell types (bottom). HSC: hematopoietic stem cells, MPP: 
Multipotent progenitors, CMP: Common myeloid progenitor, MLP:  multipotent lymphoid 
progenitor, MEP: megakaryocyte–erythroid progenitor, GMP: granulocyte-monocyte 
progenitors, CLP: Common lymphoid progenitor, Ery: Erythrocyte, Mk/Pla: 
Megakaryocyte/Platelet, Neutr: Neutrophils, Baso: Basophils, Eos:  Eosinophils, MC: Mast 
cells, M/M: Macrophage/monocyte, DC: Dendritic cell, B: B cells, T: T cells, NK: Natural killer 
cells. 
 
1.2 Disease as a disorder of the immune system 
1.2.1 Types of diseases and therapies 
The innate immune system facilitates an immediate response to infection or injury, 
inhibiting pathogen spread and recruiting neighbouring cells including those of the 
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adaptive immune system. A complex set of interactions allows the immune system to 
display a range of response types. Alternatively, disorders of the immune system can 
lead to: 1) inflammatory diseases where inflammation is induced by either infection or 
injury continues without resolution resulting in adverse effects such as the 
permeabilization of the blood-brain barrier during neuroinflammation (Erickson et al., 
2012); 2) allergies, where the immune system produces an inappropriate response to 
molecules, e.g. asthmatic patients exposed to aeroallergens like pollen and dust mite 
trigger a type 2 immune response (Caminati et al., 2018); 3) autoimmune diseases, 
where the immune system is unable to distinguish self from non-self, e.g. rheumatoid 
arthritis where antibodies are generated towards molecules like fibrin and collagen 
resulting in inflammation of the synovial joints (Guo et al., 2018); and 4) cancers, where 
the immune system produces an inefficient response towards abnormal and highly 
proliferative cells. Therefore, to develop therapies for such diseases it is important to 
understand the components of the immune system and their role, e.g. immune-
checkpoint blockade therapy targets key regulators which mediate the immune response 
of which anti-PD1 therapy has been found effective in treating various cancers and a 
recent scRNA-Seq study attributes it to a subset of tissue-resident memory T cells and 
classical monocytes (Krieg et al., 2018). Various types of immunotherapies have been 
developed based on our understanding of the immune system, including vaccines, 
cytokine therapies, antibody/ligand-based therapies, and engineering T cells which can 
e.g. regulate immune checkpoints (Figure 1.2) (Naran et al., 2018).  
Further studies in TRIC biology have led to a great interest in tissue-specific 
immunotherapies which are largely focused on treating cancers as TRICs attain alternate 
activation states relative to their tissue naïve counterparts under pathological conditions. 
For example, tumour-associated macrophages (TAMs) are pro-tumorigenic (mediate 
angiogenesis and metastasis) with clinical studies showing the significance in depleting 
these cells (through mAb induced apoptosis or inhibiting their CCL2 mediated 
recruitment) and modulation of their phenotype, e.g. reprograming macrophages from 
M2 to M1 state (Li et al., 2019). Other TRIC based immunotherapies unrelated to cancer 
include microglia-based therapies being developed for neurological diseases. Microglia 
are implicated in several neurological diseases and as a result numerous in vitro and in 
vivo models have been generated to describe their activation states (Masuda et al., 
2020). In health, these cells phagocytose apoptotic cells, neuronal synapsis and 
unfolded proteins such as amyloid beta (Ab). However, in Alzheimer’s disease (AD), a 
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neurodegenerative disease characterised by aggerates of Ab plaques, microglia exhibit 
certain pro-inflammatory features but can become anti-inflammatory on using metformin 
(Wang and Colonna, 2019). Hence, given the essential role of TRICs in tissue 
homeostasis it is crucial to understand these cell types and their activation states in 
disease. 
Figure 1.2. Types of immunotherapies. 
The figure is taken from (Naran et al., 2018). Shown are the different types of immunotherapies 
for cancers and infectious diseases. A) Drugs like denileukin diftitox target receptors of 
immunosuppressing Tregs to initiate apoptosis thereby skewing the immune response towards 
proinflammation. B) Depending on the response required different cytokines or associated 
antibodies are used to propagate either an inflammatory response, like IL2 mediated T cell 
activation or anti-inflammatory/inflammation suppression e.g. mAbs for blocking IL2R. C) mAbs 
can also block immune checkpoints which are essential steps in immune response, e.g. T cell 
activation activated by tumour cells can be inhibited by engaging PD1 and CTLA4, however 
these receptors can be blocked using mAbs. D) Recombinant receptors comprising of scFv 
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can redirect the specificity of T cells by mediating MHC-independent activation. Such T cells 
are called chimeric antigen receptors (CAR) T cells. Shown are the four generations of CAR-T 
cells which attempt to strengthen signalling (co-stimulatory receptors CD28 and CD137), while 
the fourth generation also introduces separate constitutive/inducible expression of coreceptors 
and cytokines. E) Certain antibodies, like bispecific T cell engagers (BiTE) can induce T cell 
activation which is MHC independent as the antibody brings T cells proximal to tumours cells 
due to their specific to both via CD3 and TAA, respectively. F) Vaccines introduce non-
pathogenic antigens which can be presented by APC such as DCs, thus initiating a T cell 
response which subsequently result in memory immune cells. mAb: monoclonal antibody, TAA: 
tumour associated antigen, BiTE: bispecific T cell engagers, CTL: cytotoxic T cell, APC: antigen 
presentation cell. 
 
1.2.2 A challenge in drug development: modelling the human immune 
system from mouse 
One of the challenges in drug development is the lack of translation from animal models 
to human. Currently, the chances of a drug successfully clearing all clinical trial phases 
is less than 10% (Dowden and Munro, 2019). Several factors determine the success of 
a drug including its efficacy, toxicity and risks. Furthermore, one of the requirements is 
to conduct trials in mouse. Unfortunately, this is also one of the factors that can mislead 
drug development. Indeed, mouse models have advanced our understanding of 
diseases as they allow testing which would be unethical/impossible to conduct in human, 
e.g. engrafting tumours subcutaneously for testing drug treatments (Tentler et al., 2012), 
and making genetically engineered mouse models to replicate human disease 
pathologies. A recent success story for drug development using mouse models is for 
sickle cell disease, where a gene therapy developed in mouse successfully translated to 
humans (Hoban et al., 2016). Conversely, few drugs have been approved for 
neurodegenerative diseases due to a lack of translation (Mehta et al., 2017).  
Whilst there are similarities between the mouse and human immune system such as the 
structure and function of immune tissues like the thymus, lymph node and spleen (Haley, 
2003), there are also many differences which could explain the lack of translation. There 
is different gene usage between similar cell types across species, e.g. a study found two 
thirds of genes are differently expressed across species amongst similar neuronal cell 
types (Hodge et al., 2019). Certain genes like APP (a precursor to Ab), where mutations 
of the gene in humans are associated with early onset AD, in mouse the protein is less 
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likely to aggregate as it differs in three residues (Xu et al., 2015). Pathways/signalling 
also vary between species, e.g. whilst, IFN and LPS induce iNOS production in mouse 
macrophages through the arginine metabolism pathway (Arg1, Gch1 and Ass1) the 
response and signalling is not observed in human macrophages, which express low 
levels of ARG1 and ARG2 (Young et al., 2018). The diversity of immune cells can also 
vary, as microglia in humans are more diverse relative to mouse strains and highly 
express genes enriched in AD-associated genes and ferroptosis also linked with AD 
(Geirsdottir et al., 2019, Li et al., 2020). The distribution of immune cells across certain 
tissues are also different, e.g. in humans there are a larger proportion of neutrophils in 
blood (30-50% lymphocyte and 50-70% neutrophils) in contrast to the mouse (75-90% 
lymphocytes and 10-25% neutrophils) (Doeing et al., 2003). Lastly, mouse models may 
not perfectly replicate all symptoms of the disease observed in humans, even the use of 
stable mouse strain has been questioned due to their lack of genetic diversity or 
exposure to the environment (Beura et al., 2016). 
1.3 Myeloid immune cell heterogeneity 
Immune cell types have been described in context of their ontogeny, the phenotypes 
they develop in disease or following stimulation, and the tissues they reside in. Only in 
the past decade has research on tissue-resident immune cells (TRICs) been expanded 
upon. This is likely due to initial studies being limited to cell cultures as the complexities 
of reconstructing the tissue environment are still being explored today, e.g. through 
organoids and tissue culture techniques (Pampaloni et al., 2007, Walsh et al., 2005).  
1.3.1 Monocytes 
Monocytes primarily reside in blood and are a direct product of haematopoiesis. Three 
states have been characterised in human monocytes, the classical (CD14+ CD16-), non-
classical (CD14+ CD16+) and intermediate (CD14int CD16int). The corresponding states 
in mouse include the Ly6C+ classical monocytes and Ly6C- non-classical monocytes. 
Additionally, a recent study examining the transcriptomic profile of monocytes at the 
single cell level has proposed two other subsets (Villani et al., 2017). As part of the innate 
response and as first responders to tissue injury, these cells secrete proinflammatory 
mediators, instigate the adaptive immune response by differentiating into DCs and 
macrophages which present antigen while also regulating wound healing. For GMPs to 
become monocytes, they first differentiate into common monocyte progenitor (cMoP) 
after which they require a combination of signals including the activation of certain 
transcription factors, PU.1, IRF8 and KLF4, as well as the inhibition of GATA1, GATA2 
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and CEBPα. The molecules determining the commitment towards the different monocyte 
subsets are still being determined. At least for non-classical Ly6C- monocytes it is known 
that one of the routes is through classical Ly6C+ monocytes on activation of CEBPβ and 
Nr4a1 (Mildner et al., 2017).  
Classical monocytes are scavenger cells. They comprise 80-95% of circulating 
monocytes and are highly phagocytic. These cells are considered more proinflammatory, 
as they secret the highest amounts of TNFα, IL6, and IL1β in response to TLR agonists 
(Boyette et al., 2017). Non-classical monocytes represent 2-11% of circulating 
monocytes and are characterise by pathways involving the complement system, Fc 
gamma-mediated phagocytosis and wound healing. These cells express higher levels of 
CX3CR1 which enables them to migrate towards damaged tissues more than other 
subsets (Ancuta et al., 2003). Intermediate monocytes are defined by their antigen 
presentation capability, expressing genes like CD74, HLA-DR, IFI30 and CTSB (Gren et 
al., 2015). Of the two recent monocyte subsets identified through single cell sequencing, 
Mono-3 displayed a high expression of genes (MXD1, CXCR1, CXCR2 and VNN2) 
thought to influence cell cycle differentiation and trafficking, while Mono-4 possessed a 
cytotoxic signature (PRF1, GNLY and CTSW) (Villani et al., 2017). Upon external 
inflammatory signals, classical monocytes can differentiate into macrophages and DCs, 
while also being one of the sources for tissues resident myeloid cells (Bain et al., 2013). 
For example, listeria infection of monocytes showed a subset of 
FcγRIII+CD209a−MHCII−Ly6C+ (non-classical) monocytes preferentially differentiated 
into iNOS+ inflammatory macrophage (Menezes et al., 2016). 
1.3.2 Macrophages 
It is well known in the field of immunology that macrophages represent one of the most 
diverse and heterogeneous cell types as supported by their ubiquitous presence across 
tissues. These cells are highly phagocytic and as part of the innate immune response 
are responsible for removing cellular debris, apoptotic cells and pathogens. Once they 
ingest microbes, they process associated proteins or antigens and present them to Th 
cells which carry out the adaptive immune response. Studies are continuing to explore 
the plasticity of macrophages to find novel subsets. Accordingly, macrophages have 
traditionally been categorised into eight classifications, M1, the four subsets of M2 (M2a, 
M2b, M2c, and M2d), tumour associated macrophages (TAM), TCR+ macrophage and 
CD169+ macrophage. However, several studies have challenged these classifications 
and rather proposed a spectrum of states for macrophages, e.g. on activating monocyte 
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derived macrophages with various stimuli including those associated with M1 and M2 
macrophages, cells attained multidirectional activation states as opposed to the dual M1 
and M2 based on their transcriptomic profile (Mosser and Edwards, 2008, Xue et al., 
2014). Indeed, we must begin to comprehend these activation states as a combination 
of different programs, however, as a reference of the functional diversity of these cells, 
the eight macrophage subsets which have been well characterised are described.  
Conventionally, M1 and M2 macrophages were characterised based on their reaction to 
two subsets of Th cells in mouse, Th1 and Th2, respectively (Mills et al., 2000). 
Macrophage differentiated into M1 or classically activated macrophages on exposure to 
IFNγ secreted by Th1 cells which can also be artificially induced by LPS, IFNγ and GM-
CSF. The resultant phenotype is considered to be the ‘classical’ proinflammatory 
macrophage and is characterised by the production of NO, proinflammatory cytokines 
(IL1B, IL12, IL18, and TNF) and chemoattractants (CCL9 and CXCL10) for cells like Th1 
(Arango Duque and Descoteaux, 2014). This state is governed by various transcription 
factors (STAT1, IRF5, and SOCS3) which in turn regulate pathways like IRF/STAT, 
IFN/TLR, NFKB/PI3 pathways (Raza et al., 2014) all of which result in proinflammatory 
responses and downregulation of immunosuppressive molecules like IL10. In contrast,  
M2 macrophages or ‘alternately-activated’ macrophages are considered anti-
inflammatory and secrete high levels of IL10. M2 activation states are associated with 
Th2 secretory molecules and further diversify (M2a - d) (Figure 1.3). M2a (wound healing 
macrophage) is associated with tissue repair and is induced by IL4 and IL13 (Martinez 
et al., 2008); M2b (regulatory macrophages) expresses higher levels of IL10 than M2a, 
however, they also produce various proinflammatory cytokines (TNFα, IL1β and IL6) and 
are induced by immune complexes and LPS (Wang et al., 2019a); M2c macrophages 
are referred to as deactivated macrophages as they downregulate proinflammatory 
cytokines and redirect their functions to scavenging, angiogenesis and wound healing 
(Lurier et al., 2017). These cells are induced by IL10, TGFβ and glucocorticoids; and 
M2d macrophages are induced by IL6 and adenosine, thereby secreting growth factors 
(VEGF) and anti-inflammatory cytokines to promote tissue repair, tumour progression 
and angiogenesis (Rőszer, 2015, Yao et al., 2019). Certain classifications are further 
divided giving a spectrum of activation states as previously proposed e.g. M2c is divided 




Figure 1.3. The subsets of M2 macrophage. 
Shown are the four subsets of M2 macrophages taken from (Yao et al., 2019). The figure 
highlights the molecules which induce the phenotype, the resultant receptors and cytokine 
profiles, including the function these subsets carry out. 
 
In addition to the M1 and M2 macrophages are the TAM, TCR+ and CD169+ 
macrophages. TAMs, as the name suggests, are tissue macrophages at the tumour site 
or circulating monocytes which on exposure to the tumour microenvironment differentiate 
into TAMs and have shown to express both M1 and M2 associated genes (Schmieder et 
al., 2012). Much like other macrophage subsets, TAMs can be subdivided further based 
on their cytokine profile. These cells are associated with tumour progression, e.g. they 
secrete various proteolytic enzymes such as serine proteases and metalloproteinase 
(MMP2, MMP7 and MMP9) which lead to the degradation of the extracellular matrix 
thereby promoting metastasis (Lin et al., 2019). Hence, therapeutic strategies aim to 
suppress their immune-suppressive phenotype by reducing infiltration or causing them 
to differentiate into an immune-active phenotype (Cassetta and Kitamura, 2018).  TCR+ 
macrophages have been identified in mouse and human. These cells express CD3, 
TCRαβ, and TCRγδ, thought to be unique to T cells (Chávez-Galán et al., 2015). This 
subset is elicited in early differentiating macrophages with TNFα promoting the 
phenotype with IL4 or IFNγ redirecting them towards M1 types (Beham et al., 2011). 
These macrophages also express other genes associated with lymphocytes and have 
been detected in atherosclerosis, tuberculosis and bacterial challenges (Fuchs et al., 
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2015, Fuchs et al., 2013). CD169+ macrophages are located in secondary lymphoid 
organs and migrate during immune activation. Hence, these cells are more involved in 
immunomodulation, e.g.  they can present antigen to B cells and activate CD8+ T cells, 
evident from their expression of MHCII and CD68 (Martinez-Pomares and Gordon, 
2012). Interestingly, these cells are unable to phagocytose. 
1.3.3 Dendritic cells 
DCs were first identified as phagocytic cells of the spleen which elicited an antibody 
response (Steinman and Cohn, 1973), and even now are defined by their efficacy in 
taking up antigen and present them to T cells. Current studies have revealed the 
immense diversity of these cell types, including the multiple subsets residing in peripheral 
tissues. In this section we discuss the seven subsets that have been identified in blood, 
these include conventional DC1 (cDC1), cDC2 (CD1C_A and CD1C_B), CD16+ DC, Axl 
DC (CD123+ Axl+ DC and CD11c+ Axl+ DC) and plasmacytoid DC (pDC). 
cDC1s constitute only 0.05% of peripheral blood mononuclear cells (PBMC) (Jongbloed 
et al., 2010). These cells are identifiable by markers such as CLEC9A, CADM1, CD141 
and XCR1 (Villani et al., 2017), and their development is regulated by transcription 
factors such as IRD8, BATF3 and ID2 (Murphy et al., 2016). cDC1s are efficient in 
presenting antigen and under bacterial and viral infections they prime CD8+ T cells 
(Theisen and Murphy, 2017). Furthermore, these cells can detect intracellular double 
strand (dsRNA) and DNA using TLR receptors (TLR3, TLR9 and TLR10) thereby 
triggering the production of type 1 IFNs and IL12 in an IRF3-dependent manner (Liu et 
al., 2015). In contrast to cDC1, the cDC2 subset is the most abundant DC of PBMC, with 
a higher expression of CD11c, and are regulated by a different set of transcription factors 
(IRF4, NOTCH2 and KLF4) (Murphy et al., 2016). These cells express various lectins 
(CLEC12A, CLEC4A, and CLEC10A) and TLRs (TLR2, TLR4 and TLR5) (Rhodes et al., 
2019). On TLR stimulation, they secrete chemokines (CCL3 and CCL4) and cytokines 
(TNF, IL6, and IL12) (Piccioli et al., 2007). cDC2 can be subdivided into CD1C_A and 
cDC_B. CD1C_A highly express FCGR2B, MHC class 2 genes, CD1C and CD11C. 
Relatively, CD1C_B are similar in their transcriptomic profile to classical monocytes and 
express innate inflammatory genes (Villani et al., 2017). Functionally, these subsets 
have shown to trigger different differentiation trajectories in Th cells. CD1C_A polarise 
Th cells to regulatory T cells (Treg), Th2, Th17 and Th22 phenotypes while CD1C_B 
induce Th1 (Yin et al., 2017). Villani et al. also described DC4 or CD16+ DCs, which lack 
expression of typical DC markers such as CD141 and CD1c. Furthermore, these cells 
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are considered proinflammatory, as on engaging TLR agonists they secrete 
inflammatory cytokines. However, further studies are required to understand these cells 
as they show a greater similarity to non-classical monocytes based on their 
transcriptomic profile, and majority of studies into DC apply gating strategies to remove 
this CD16+ monocyte subset. 
Unlike the cDC, the pDCs are characterised by their production of type 1 and type 3 
interferon and cannot induce a T cell response. These cells are specialised towards 
antiviral responses, detecting sense single-strand RNA (ssRNA) and dsRNA via TLR7 
and TLR9, respectively (Gilliet et al., 2008). The TLR pathway is regulated by IRF8 which 
also governs the production of chemokines (CCL3-5 and CXCL10-11) and induce the 
NFKB pathway to secrete cytokines (TNFα and IL6) (Honda and Taniguchi, 2006). 
Interestingly, pDCs were initially isolated using CD123 and BDCA2, however recent 
studies using scRNA-Seq reveal minor subpopulations of cells within them, termed as 
Axl+ DCs. Such analyses show the heterogeneity of cells and the power of approaches 
such as scRNA-Seq in deconvoluting this diversity. Clustering of these cells suggests 
they represent a continuum between pDC and cDC2 states. Further subdivisions have 
been observed in these Axl+ DCs, those that are CD123lowCD1chigh resemble cDC2s and 
CD123highCD1clow resemble pDCs. This is further supported by their expression of 
transcription factors ID2 and TCF4 required for the commitment towards cDC2s and 
pDCs, respectively. 
1.3.4 Granulocytes 
As part of the innate immune system neutrophils mediate immunoregulatory and anti-
microbial immunity, e.g. degranulation, phagocytosis and a specialised process called 
neutrophil extracellular trap (NET). In human, four subsets (CD177+, OLFM4+, 
CD49d+CXCR4+VEGFR1+ and TCRαβ+) have been described in health with further 
segregation of aged neutrophils (CXCR4highCD62Llow). Majority of circulating neutrophils 
in healthy individuals are CD177+, a glycoprotein which mediates their transmigration 
out of the vasculature via endothelial contact during inflammation (Sachs et al., 2007). 
This subset has been associated with various autoimmune diseases, e.g. systematic 
vasculitis (Deng et al., 2018) and inflammatory bowel disease (Zhou et al., 2018). 
OLFM4+ neutrophils comprise of 20-25% of circulating neutrophils. This subset of 
neutrophil presented NETs also stained for OLFM4s (Welin et al., 2013). In sepsis, an 
increase in OLFM4+ neutrophils correlated with organ failure while OLFM4-deficient 
models showed resistance to experimental sepsis (Alder et al., 2017, Liu et al., 2012). 
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CD49d+CXCR4+VEGFR1+ neutrophils are proangiogenic, have increased 
chemokinesis and their high levels of CXCR4 suggest CXCR4-mediated recruitment of 
these cells (Massena et al., 2015). The TCRαβ+ neutrophil represents 5-8% of 
circulating neutrophils. Triggering the TCR negatively regulates apoptosis and results in 
the secretion of IL8 which is observed in activated neutrophils and mediates further 
recruitment of neutrophils (Puellmann et al., 2006). The maturation of neutrophils is 
described by the conversion from young CXCR4-CD62L+ to CXCR4+CD62L- aged cells, 
the balance of which is governed by the circadian clock (Adrover et al., 2019). 
Neutrophils become CXCR4+ and CD62L- before they migrate to the bone marrow or 
spleen to be phagocytosed or undergo apoptosis. Furthermore, the abundance of the 
subset correlates with greater vascular damage as observed in a mouse model (Adrover 
et al., 2019). Similar to macrophages, neutrophils display numerous activation 
phenotypes under pathological conditions. However, a formal comparison of these states 
is still required as they are currently defined by the condition/disease. Some of these 
include anti-inflammatory neutrophils (CD11b+CD49d-IL10+), proinflammatory 
neutrophils (CD11b-CD49d+L12+) and those expressing receptors for antigen 
presentation (CD11bhighCD62LlowCXCR2low) (Silvestre-Roig et al., 2016, Hampton et al., 
2015). 
Eosinophils are granulated cells and provide immunity for parasitic infections, asthma 
and allergies through phagocytosis, degranulation and antigen presentation. These cells 
are in a small proportions in the bone marrow (6%), however, can increase in number in 
response to IL3, IL5 and GM-CSF (Ramirez et al., 2018). Subsequently, they migrate to 
inflamed tissues and contribute to the proinflammatory response by producing reactive 
oxygen species, cytokines (TNFα, TGFβ, IL1α and type 2: IL4, and IL13) and cationic 
proteins via degranulation (Hogan et al., 2008). The diversity of eosinophils has been 
described in various tissues and much like neutrophils their activation states are 
identified based on the disease, rather than a comparison across states. In a tumour 
model, eosinophils were essential in the recruitment of T cells via the production of 
CCL22, suggesting a role in metastasis (Zaynagetdinov et al., 2015). In a model of 
chronic colitis, eosinophils were crucial in promoting inflammation in a GM-CSF 
dependent manner, through various cytokine IL13, TNFα, and EPX (Griseri et al., 2015). 
Basophils are known for their role in allergies, barrier inflammation and anti-helminth 
immunity. These rare populations comprise <1% of PBMCs. Due to their similar 
morphology and function to mast cells, they were primarily analysed to understand mast 
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cell biology. However, subsequently their relevance in mediating anti-helminth immunity 
was realised (Schroeder, 2009). GATA2, STAT5, and IRF8 have shown to be key 
transcription factors in basophil and mast cell development. These cells have been 
proposed to originate from different progenitors depending on the tissue, these include 
the spleen (basophil-mast cell progenitor) and bone marrow (pre-basophil and mast cell 
progenitors) (Arinobu et al., 2005, Li et al., 2015). Studies describe two basophil subsets, 
those elicited by IL13 which have been extensively studied and the recently identified 
thymic stromal lymphopoietin (TSLP) stimulated subset (Siracusa et al., 2011). Both 
IL13-elicited basophils and TSLP-elicited basophils mediate a type 2 response producing 
cytokines like IL4 and IL13. A notable functional difference is the IgE dependent 
degranulation of IL3-elicited basophils resulting in the release of histamines. This 
response is relatively suppressed in TSLP-elicited basophils. Further differences are 
observed in terms of their receptors, cytokines and chemokines, e.g. TSLP-elicited 
basophils have higher levels of IL33, IL6, CCL3 and CCL4 relative to IL13-elicited 
basophils. Further studies are required to expand on their functional differences.  
Similar to basophils are mast cells, both in terms of their origin and function. The 
heterogeneity of mast cells has been described by the protease composition of their 
secretory granules, and these subsets are differently distributed across tissues. Three 
subsets of mast cells have been described, those containing tryptases (lung and gut); 
tryptases and carboxypeptidase (lung); and tryptases, chymase and carboxypeptidase 
(skin and peritoneum) (Dougherty et al., 2010). A recent study identifies two additional 
subsets distinguished by the expression of CD25, although these still require a 
comprehensive comparison with other subsets (Deho et al., 2014). Nonetheless, these 
relatively proliferative CD25+ mast cells expressed greater levels of certain cytokines 
(IL6 and TNFα), proteases (CTSG and PRSS34) and preferentially expressed the 
transcription factor KLF1 relative to CD25-. 
1.4 Lymphoid immune cell heterogeneity 
1.4.1 T cells 
T cells are part of the adaptive immune system and are characterised by TCR expression 
which recognises antigen-MHC complexes presented by APCs. As a result, T cells can 
respond in various ways depending on the context of engagement, their ontogeny and/or 
history. T cell development involves the selection of the TCR chain loci which can either 
generate αβ- (95% of T cell) or γδ-TCR T cells based on the respective TCR chain loci. 
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From haematopoiesis in the bone marrow, T cell progenitors migrate to the thymus 
through sequential states. These double negative CD4-CD8- thymic cells ultimately 
undergo selection where those successfully rearranging their TCR chain locus survive. 
These cells follow very different fates thereby resulting in different cell types. On 
successful TCR rearrangement immature αβ thymocytes become double positive 
CD4+Cd8+ and go through positive and negative selection based on their response to 
self-antigen in the context of MHC. Consequently, the process generates either mature 
CD4+ T cells (Th cells) that are MHC class 2 specific or CD8+ T cells (cytotoxic T cells) 
that are MHC class 1 specific (Germain, 2002), which can be further subdivided. Upon 
antigen stimulation naïve CD4+ Th cells can differentiate into various subsets depending 
on the cytokines they are exposed to (Figure 1.4). These include Th1, Th2, Th9, Th17, 
Th22, follicular Th cells, Tregs. Th1 and Th2 correspond to type 1 proinflammatory 
cytokines, e.g. IL12, IFNγ and TNF and type 2 anti-inflammatory cytokines, e.g. IL4, IL5  
 
Figure 1.4. CD4+ T cell subsets 
This figure was taken from (Sun and Zhang, 2014) which shows how Naïve CD4+ T cells can 
differentiate into various subsets based on the cytokines they are exposed to. The respective 
cytokines regulate transcription factors resulting in the production of certain cytokines and 




and IL13, respectively. Other subsets like Th9, Th17 and Th22 correspond to the 
cytokines they produce, IL9, IL17 and IL22, respectively (Golubovskaya and Wu, 2016). 
Unlike CD4+ T cells, CD8+ T cells can detect antigen bound MHC-1 and release 
cytotoxic granules which result in apoptosis of infected cells. These cytotoxic T cells 
include two subsets Tc1 and Tc2 corresponding to the type 1 and type 2 responses. As 
in macrophages and CD4+ T cells, type 1 is associated with IL2, IL6 with the ability to 
produce high amounts of IFNg, while type 2 are defined by their secretion of IL4 and IL5 
(Kemp et al., 2005). On activation these T cell subsets differentiate into effector cells 
which are short-lived, as well as long-lived memory T cells which reside either in tissues 
(effector memory T cells) or lymphoid organs (central memory T cells). The memory T 
cells engage with antigen to produce a faster response in terms of proliferation and 
cytokine production than effector cells (Rosenblum et al., 2016).  
Much like the abT cells, the gdT cells can polarize into various activation states 
depending on the stimuli. gdT cells have shown type 1 and type 2-like phenotypes on 
exposure to IL12 and IL4 respectively in the presence of isopentenyl pyrophosphate 
(Wesch et al., 2001). Other similar subsets include follicular helper gdT cells (Crotty, 
2011), IL17 gdT cells (Caccamo et al., 2011) and regulatory gdT cells. The latter has 
shown to be a stronger immunosuppressor than CD4+ abTreg in colorectal cancer (Wu 
et al., 2017). Interestingly, gdT cells can also present antigen during microbial infections 
and stimulate CD4+ and CD8+ abT cells via MHC (Brandes et al., 2005). 
1.4.2 B cells 
B cells function as part of the humoral immunity as they are the main source of 
antibodies. In addition, these cells present antigen and can secrete various cytokines on 
activation. Much like T cells, the development of B cells goes through various rounds of 
selection for the B cell receptor (BCR). In the bone marrow these cells sequentially 
differentiate through pro-B cells, pre-B cells to immature cells, through which they are 
positively and negatively selected for self-antigens (LeBien and Tedder, 2008). 
Subsequently, the immature B cells migrate to the spleen as transitional B cells, 
consisting of T1 and T2 B cells. T1 B cells refer to those migrating to the spleen. Once 
within the spleen they transition to T2 which in turn can differentiate into mature marginal 
zone (MZ) B cell or follicular B cells depending on the context of BCR signalling in T2 B 
cells. (Chung et al., 2003). Follicular B cells reside in follicles of secondary lymphoid 
tissues and during infection can differentiate into plasmablasts or germinal centre (GC) 
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B cells. Plasmablasts have a high affinity towards antigens, secrete large numbers of 
antibodies, and are proliferative, however these cells are also short-lived. GC B cells 
undergo various changes (class switching and somatic hypermutations) to convert to 
plasma cells which produce specific reactive antibodies. In contrast to plasmablasts, 
which are formed early on in infections, plasma cells are formed later on and are long-
lived (Vale et al., 2015). GC B cells also generate memory B cells which are in circulation 
and ready to respond to pre-exposed antigens to begin generating antigen-specific 
antibodies. As the name suggests, MZ B cells reside in the marginal zone of the spleen. 
These cells are more innate-like, as they readily respond to TLR stimuli during infection 
mediated by proximal APCs like marginal sinus associated macrophages. Like Tregs, 
there are also immunosuppressive regulatory B cells. These cells produce IL10 and 
TGBb to supress proinflammatory responses while promoting differentiation of Tregs 
(Rosser and Mauri, 2015). Primarily arising from foetal and neonatal progenitors are B-
1 B cells, which are further divided into CD5+ B1-a and CD5- B1-b. These cells migrate 
through the spleen homing in on the peritoneal cavity. Much like MZ B cells, B1-a cells 
are fast reacting innate-like cells involved in early protection and immediately produce 
natural antibodies (polyreactive with low affinity and are generated before antigen 
exposure). Alternately, B1-b cells produce antibodies after antigen exposure (Haas et 
al., 2005). 
1.4.3 Innate lymphocytes and NKT cells 
The nomenclature for innate lymphoid cells (ILCs) was introduced recently between 
2009 and 2010, where studies reported NK cell-like lymphoid cells (Spits et al., 2013). 
Further research is being conducted into the ontogeny of these cells which suggest a 
non-MHC mechanism within the bone marrow mediated through transcription factor ID2 
which counteracts B and T cell lymphopoiesis (Cherrier et al., 2012). The resultant 
immature ILCs are found to circulate in peripheral blood and in various tissues, where 
they can be primed based on environmental ques (Bal et al., 2020). Hence, ILC subsets 
are distributed differently across tissues (Yudanin et al., 2019). Studies have identified 
five subsets of ILCs including, IL1, ILC2, ILC3, lymphoid tissue inducer cells (LTi) and 
NK cells. ILC1, ILC2 and ILC3 bare resemblance to Th1, Th2 and Th17/Th22 cells, 
respectively. ILC1s are dependent on the transcription factor TBX21 (T-bet) and 
characterised by their production of IFNg (Spits et al., 2016). ILC2s are defined by 
GATA3 and produces IL4, IL5, and IL13. ILC3s are dependent on RORgt and produce 
IL3 and IL22 with a proportion also expressing IL17 (Cupedo et al., 2009). LTi’s are 
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required for organogenesis, including the development of lymph nodes and Peyer’s 
patch (Veiga-Fernandes et al., 2007). NK cells are part of ILCs and also possess 
immunoregulatory roles. These cells produce various cytokines and cytolytic granules 
on detecting MHC1, thus generating stress and apoptotic signals. NK cells originate from 
CD34+ HSCs via growth factors (FLT3- and ckit-ligand), which generate 
CD34+CD122+CD56− immature NK cells (iNK cells) (McKenna et al., 2000). These cells 
then mature to CD3-CD56+ NK cells by responding to IL15 via CD122. Mature NK cells 
are further divided into CD56dim and CD56bright cells. CD56dim cells are the major 
circulating cell populations which express KIRs and are highly cytotoxic relative to 
CD56bright NK cells. The latter are localised to lymphoid organs and are characterised by 
the production of pro-inflammatory cytokines like IFNg and TNFα (Pende et al., 2019).  
NKT cells are innate-like T cells that develop in the thymus and accordingly have a TCR. 
However, these cells recognise antigens in the context CD1D which is a non-polymorphic 
MHC class 2 molecule (Bendelac et al., 1995). Like T cells, NKT cells can be subdivided 
based on their TCR chain usage into type 1 (invariant) which detects the TCR-
αGalCer/CD1d complex and type 2 (diverse) which recognise the TCR-sulfatide/CD1d 
complex. Type I are further divided into NKT1, NKT2, and NKT17 cells which correspond 
to Th cell subsets (Watarai et al., 2012). Furthermore, similar to T cells they can respond 
to co-stimulatory signals from CD28 (Shissler et al., 2020) while also possessing various 
NK cells receptors and their cytotoxic capabilities (Makino et al., 1995). In contrast, type 
2 NKT cells are immunoregulatory, as they supress proinflammatory response of type 1 
NKT cells (Arrenberg et al., 2011).  
 
1.5 Tissue resident immune cell heterogeneity 
Depending on environmental cues cells can undergo changes at the transcriptional and 
epigenetic level thus developing tissue-specific homeostatic functions. Some TRICs 
include immune subsets described in the previous sections and are differently distributed 
across tissues. In the following section, the various TRIC populations are described, 
while highlighting certain aspects tissue-resident macrophages as these populations 
have been well studied, including their ontogeny, how they are sustained through life and 
the unique phenotypes that can develop relative to their tissue naïve counterparts. 
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1.5.1 The haematopoietic waves which generate tissue-resident 
macrophages 
Macrophage subsets originate from haematopoiesis, which can be subdivided 
chronologically into three waves, primitive, transient definitive and definitive 
haematopoiesis. The first wave or primitive haematopoiesis begins in the yolk sac on 
embryonic day 7.5 (E7.5) to E8.5 in mouse. The early Csf1rhigh c-Myb- erythroid-myeloid 
progenitors (EMP) originate from the posterior plate mesoderm in blood islands of the 
yolk sac (YS). In this phase, cells have a limited differentiation potential and give rise to 
primitive macrophages, erythrocytes and megakaryocytes (Palis et al., 1999, Tober et 
al., 2007). Even before infiltrating the brain, primitive macrophages have been shown to 
differentiate into microglial cells within the yolk sac (Ferrero et al., 2018). Of all the tissue-
resident immune cells, microglia remain the only cell type originating from YS-derived 
macrophages which can self-renew independent of circulating monocytes once they 
have migrated to the brain. Supported by fate-mapping studies labelling RUNX1+, YS-
derived cells are abundant in the mouse brain through to adulthood, whilst they are 
gradually replaced by unlabelled cells in other tissues (Ginhoux et al., 2010, Hoeffel et 
al., 2012).  
The second wave, termed as transient definitive haematopoiesis, from E9.5, involves 
late Csf1rlow c-Myb+ EMPs and lymphoid-myeloid progenitors (LMPs) originating from 
the hemogenic endothelium of the YS (McGrath et al., 2015). These progenitors have a 
broad differentiation potential once they migrate to the fetal liver, as late EMPs can 
further differentiate into macrophages, monocytes and granulocytes, and LMPs into 
lymphoid cell lineages (Palis et al., 1999, Adolfsson et al., 2005). Further differences are 
observed between late EMPs and early EMPs. Runx1 and Csf1r fate mapping models 
suggest that late EMPs and their derived macrophages largely replace early EMPs and 
give rise to tissue-resident macrophage populations, e.g. the lung, skin, and kidney, but 
not microglia (Hoeffel et al., 2015). However, whether these two populations are distinct, 
or part of a continuum remains to be investigated. Studies have proposed that late EMPs 
can give rise to tissue-resident macrophage subsets through two intermediate 
progenitors, fetal liver EMP-derived monocytes and pre-macrophages (Mass et al., 
2016). The recent study by Mass et al. shows pre-macrophages migrating into different 
tissues in a Cx3cr1-dependent manner and differentiating into respective tissue-resident 
macrophages based on environmental cues, e.g. Id3 is a key transcriptional factor for 
macrophage differentiation towards Kupffer cells, as indicated by Id3 deficient mice that 
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show a significant reduction in Kupffer cells while other tissue-resident macrophage 
populations are maintained. Further studies are required to identify the differences 
between late EMP monocytes and pre-macrophages, their differentiation trajectories and 
how they contribute to different tissue-resident macrophage populations.  
The final wave of definitive haematopoiesis involves HSCs from the hemogenic 
endothelium of the aorta, gonads and mesonephros region at E10.5 (Bertrand et al., 
2005). These cells have the potential to differentiate into myeloid and lymphoid lineages 
once they migrate to the fetal liver. Once the bone marrow cavity is formed around E17.5, 
definitive haematopoiesis begins to shift to the bone marrow where it continues 
throughout adulthood. HSCs are separated from EMPs by markers like Sca1 and unlike 
EMPs the development of macrophages from HSCs is strictly dependent on a monocyte 
intermediate (Oguro et al., 2013). With fetal liver monocytes arising from HSCs and 
EMPs, their respective contributions towards macrophage subsets and how that 
compares with the newly identified pre-macrophages are points which require further 
research. Interestingly, in addition to the brain, not all organs are entirely populated by 
bone marrow HSCs, these include the epidermis, liver and lung which are largely 
renewed from precursor which originate from the fetal liver and can be considered as 
“closed” systems (Figure 1.5) (Hashimoto et al., 2013, Merad et al., 2002). In certain 
tissues, macrophage contribution changes over time, e.g. through adulthood the 
contribution from bone marrow-derived monocytes increases in the gut, heart and 
pancreas (Ensan et al., 2016, Ginhoux and Guilliams, 2016, Bain et al., 2014, Epelman 
et al., 2014a). Furthermore, during inflammation even closed systems such as the brain 
are infiltrated by circulating monocytes, gaining a microglial-like phenotype (Leone et al., 
2006) with similar findings in microglial depletion studies (Ajami et al., 2011, Sere et al., 
2012, Lund et al., 2018). Hence, with the different waves of haematopoiesis the field is 
open to questions regarding the contribution of respective precursors towards the 
different tissue-resident macrophage, their differentiation pathways, the regulatory 
networks governing them and if their contribution changes over time and in inflammation.  
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1.5.2 Precursors determine tissue colonisation and maintenance of 
macrophages 
Recent studies have suggested that certain macrophage subsets are determined by their 
ontogeny. Relative to bone marrow-derived macrophages, embryonic-derived 
macrophages resist genotoxic stress giving them a survival advantage (Price et al., 
 
 
Figure 1.5. The contribution of progenitors from different compartments to 
tissue macrophages. 
Taken from (Ginhoux and Guilliams, 2016) the figure shows the contribution of yolk sac 
macrophages, fetal liver macrophage and bone marrow macrophages towards the various 
tissues (left) from embryogenesis to adults. Certain tissues are closed systems like the brain 
epidermis, lung and liver which are derived from the yolk sac and foetal populations and are 
maintained through adulthood. Conversely tissues like the heart, pancreas, gut and dermis are 
derived from different precursor populations with time as these systems are open.  Mac: 




2015). These cells also show a self-renewal capacity which is imprinted as their 
proliferation in GM-CSF continues for weeks unlike bone marrow-derived monocytes, 
irrespective of the fact that both cell types present a similar GM-CSF receptor sensitivity 
(van de Laar et al., 2016). Similar observations have been observed in a depletion study 
of alveolar macrophages, where fetal liver monocyte-derived macrophages more 
efficiently occupied the lung relative to those from the bone marrow (van de Laar et al., 
2016). Embryonic-derived macrophages also have longer life spans, e.g. the lifespan of 
intestinal and dermal bone marrow-derived macrophages is 4-6 weeks, while that of 
embryonic-derived cardiac macrophages is 8-12 weeks (Ginhoux and Guilliams, 2016). 
Interestingly, in certain cases bone marrow-derived macrophages have displayed a 
capacity to resemble embryonic-derived tissue resident macrophages as well. bone 
marrow-derived monocytes which infiltrate the lung and liver differentiate into alveolar 
and Kupffer cells, respectively, with few genes differently expressed relative to their 
corresponding embryonic-derived tissue-resident macrophages (Scott et al., 2016, 
Gibbings et al., 2015). Additionally, while bone marrow-derived monocytes are 
considered to have a poor self-renewable capacity as indicated by their progressive 
replenishment in tissues like the intestine and heart, depletion studies of Kupffer cells 
suggest the contrary, as bone marrow monocyte-derived Kupffer cells self-maintain for 
months (Scott et al., 2016). Therefore, precursors of macrophages determine their 
phenotypes through processes such as imprinting. To what extent these programs are 
transferred to bone marrow derived subsets based on conditions like cell depletion or 
inflammation, and why this differs between tissues are questions which require further 
research. 
1.5.3 Tissue-resident macrophages 
As infiltrating monocyte-derived macrophages are known to adopt tissue macrophage 
phenotypes, it is evident that the microenvironment has a strong impact in defining cell 
identity (Lavin et al., 2014b, Gosselin et al., 2014). Accordingly, macrophages are highly 
heterogeneous across tissues and adopt multifunctional roles in maintaining tissue 
homeostasis. For example, bone or osteal macrophages have a unique multinucleated 
morphology, proposed to increase bone resorption efficiency (Bar-Shavit, 2007).  In the 
brain, microglia regulate neuronal synaptic formation and signalling, through the process 
of synaptic pruning and regulation of myelin sheath formation, while also removing 
plaques implicated in neurodegenerative diseases (Perry and Holmes, 2014). Alveolar 
macrophages are involved in recycling surfactant molecules, neutralizing pathogens and 
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phagocytosing allergens and apoptotic cells (Forbes and Haczku, 2010). As this tissue 
is in frequent contact with external stimuli, a balance is required between initiating 
immune responses towards agonists and opportunistic pathogens vs. tolerating 
innocuous stimuli. Supporting such functionality, depletion experiments for alveolar 
macrophages during bacterial infection show an increase in inflammation and pathogen 
burden (Archambaud et al., 2010). Interestingly, although the gut is frequently exposed 
to external stimuli, gut macrophages are derived from circulating Ly6high monocytes and 
are short-lived relative to alveolar macrophages which are derived from foetal-
monocytes (Faria et al., 2017, Varol et al., 2015). In contrast to alveolar macrophages, 
depletion of Kupffer cells reduces hepatic inflammation and apoptosis, while their 
activation can cause hepatic damage (Traeger et al., 2010, Dixon et al., 2013). 
Furthermore, Kupffer cells are able to clear red blood cells undergone oxidative damage 
using specialized scavenger receptors and also remove haemoglobin containing 
vesicles, features specific to the liver (Willekens et al., 2005). Apart from function, these 
populations vary in turnover rate, ontogeny, the source of renewal and longevity, as 
discussed previously 
Diversity amongst tissue-resident macrophage populations has also been investigated 
through their transcriptomic and epigenetic programs. A study from the ImmGen, 
comparing mouse-derived macrophages from the liver, peritoneum, brain, splenic, and 
lung, shows great diversity in the genes expressed between macrophages from different 
regions (Gautier et al., 2012). Hundreds of genes presented a two-fold differential 
expression for macrophages specific to a given tissue, e.g. Cx3cr1 in microglia, the 
associated histone of which has shown to be exclusively acetylated (Lavin et al., 2014a). 
Alternately, certain genes were uniform across cell types, such as Cd14, Tlr7 and Ctsd. 
Research is still being conducted to describe the transcriptional networks which 
determine tissue-specificity, e.g. Spic (Spi-C) is required for differentiation towards red 
pulp macrophage found in the spleen, Gata6 is a regulator for peritoneal macrophage 
and Sall1 has been implicated in microglial development (Figure 1.6) (Kohyama et al., 
2009, Lavin et al., 2014a, Mass et al., 2016). In the case of Gata6, tissue-specific 
localization and phenotype has shown to be reversibly induced by modulating Gata6 
expression. However, this did not prove so for development, suggesting different 
mechanisms for acquiring tissue-specific cell identity in development and for maintaining 





Figure 1.6. Molecular signals determining tissue-resident macrophages 
Taken from (T'Jonck et al., 2018). The figure shows the macrophages precursor or pre-
macrophage and their defining (orange box) transcription factors. Also shown are the tissues 
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they migrate to and the molecular signals involved in their differentiation towards the respective 
tissue-resident macrophages.  
 
1.5.4 Tissue-resident dendritic cells 
DC populations are highly diverse across tissues with further studies required for 
standardising the nomenclature of these subsets. Here we describe some of the main 
tissue-resident DC populations which largely function in acquiring antigen and migrating 
to present them to T cells. DCs have been identified in non-lymphoid tissues (liver, lung, 
gut, kidney and skin) and lymphoid tissues (spleen, thymus and lymph nodes). 
Furthermore, although extremely heterogenous tissue-resident DC have been mostly 
described in the context of inflammation as oppose to their tissue homeostatic functions. 
In lymphoid organs, two key populations of cDC exist CD4+ and CD8+ DCs which 
present MHC1 and MHC2, respectively. These cells are essential in priming T cell 
populations by presenting antigen (Henri et al., 2001). Of the gut DCs, CD103+CD11b+ 
DCs are well characterised. These cells secrete IL6 and TGFb required for Th17 
differentiation, which are essential for the mucosal barrier (Denning et al., 2011, Blaschitz 
and Raffatellu, 2010). The lung has an assortment of DCs such as cDCs, pDCs and 
moDCs. Studies also differentiate cDC populations in the lung based on the CD103 
marker. CD103+ cDCs represent the dominant population in the lung which are efficient 
in cross-presenting antigens and in phagocytising dead cells to present to CD8+ T cells 
(Desch et al., 2011). The skin and associated dermis are home to several DC populations 
defined by CD207 and CD103 (Henri et al., 2010). The CD207+ DCs or Langerhans cells 
are essential in tissue injury as they are highly phagocytic and express chemokine 
receptors (CCR6 and CCR7) required to migrate to lymph nodes, eventually presenting 
antigens to T cells (Dieu et al., 1998). CD103+ CD207+ DCs are effective in cross-
presenting antigen while CD103-CD207+ induce Treg differentiation (Guilliams et al., 
2010).  
1.5.5 Tissue-resident neutrophils 
Conventionally, neutrophils have been thought to exist in the bone marrow, blood, lung 
and spleen and during inflammation they migrate to the site of inflammation as part of 
the innate immune response. However, recent studies have shown a wider distribution 
of these cells across tissues (liver, thymus, brain and kidney) as these cells actively 
invade certain tissues (Becher et al., 2014, Casanova-Acebes et al., 2018). Only few of 
the tissue-resident neutrophils have been examined for their tissue homeostatic 
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functions. For example, splenic neutrophils produce cytokines which promote B cell 
differentiation and antibody production (Puga et al., 2011). Neutrophils, especially aged 
neutrophils which express CXCR4, preferentially migrate to the lungs which has 
relatively large numbers of neutrophils. Furthermore, neutrophils migrate into the lung in 
a circadian pattern, although the function of these are unknown (Zhang et al., 2014). 
Studies have also shown the phagocytosis of neutrophils by macrophages results in 
cytokine secretion, remotely regulated the bone marrow niche (Casanova-Acebes et al., 
2018). . 
1.5.6 Tissue-resident lymphocytes 
Studies into conventional tissue resident abT cells mostly describe tissue-resident 
memory T cells derived from either CD4+ and CD8+ T cells. Of these subsets cytotoxic 
CD8+ T cells have been extensively studied mainly due to their protective role against 
tumour cells. Tissue-resident memory T cells have been identified in several tissues such 
as the brain, lung, gut, salivary glands and female reproductive tract. Much like other 
lymphocytes, effector T cells are recruited to the site of inflammation, where they can be 
identified by their expression of KLRG1 (Herndler-Brandstetter et al., 2018). Post-
pathogen clearance, a subpopulation of these cells down-regulate KLRG1, these 
represent the precursors to tissue-resident memory T cells. These cells are also 
identified by markers CD69 and CD103, as well as transcription factors such as Blimp-
1, Eomes, Hobit and T-bet required for their differentiation and tissue retention (Mackay 
et al., 2013, Mackay et al., 2016). In other tissues they may be controlled by additional 
regulators, e.g. in the CNS tissue-resident memory T cells are regulated by CD274 (B7-
H1), required for its long-term maintenance (Pavelko et al., 2017). Tissue-resident 
memory T cells provide an innate-like protective role as they are one of the first 
responders to viral infections across tissues, providing a stronger immune response to 
circulating memory T cells as is seen in the skin (Gebhardt et al., 2009). They produce 
a combination of cytokines IFNg and TNFa in a tissue-dependent manner and their 
accumulation is associated with a reduced pathology, as observed in the brain in 
Toxoplasma gondii infections (Landrith et al., 2017), viral infections of respiratory tract 
(Teijaro et al., 2011) and various cancers (Koh et al., 2017, Duhen et al., 2018). The 
longevity of tissue-resident T cells depends on the tissue, surviving in nasal tissues for 




Unconventional T cells which are nonpolymorphic, have also been found to be tissue-
resident such as invariant NKT cells (iNKT) and gdT cells. iNKT cells are found in the 
liver and adipose tissue, where in the latter they have shown to display markers of tissue-
resident memory T cells, CD69, as well as regulate Treg and macrophage population 
through IL2 and IL10 secretion (Lynch et al., 2015). Tissue-resident gdT cells are derived 
from thymic precursors which migrate to tissues such as the skin, lung and reproductive 
tract, where they are most enriched. In the skin these cells secrete IL17 and IL22, while 
also displaying tissue-resident memory cell markers like CD69 and CD103 (Jiang et al., 
2017). Tissue-resident memory gdT cells have shown to respond to infections with higher 
levels of IL17 in the lung and liver compared to naïve cells (Misiak et al., 2017, Romagnoli 
et al., 2016). 
The subsets of ILCs have been mostly described in terms of infections and are differently 
distributed across tissues, e.g. ILC2s have a type 2 response during helminth infections 
which promotes tuft cell differentiation via IL13 which is enriched in mucosal sites (von 
Moltke et al., 2016). IL22 production by ILC3 is found to be essential in defending against 
gut bacterium (Rankin et al., 2016). Tissue-resident NK cells have been identified in 
adipose tissue, kidney, liver, lung, skin and uterus, with CD49a serving as a marker 
(Sojka et al., 2014a, Sojka et al., 2014b). Interestingly in mouse, certain subsets do not 
express Eomes and are defined by transcriptional factors such as Plzf, Hobit (ZNF683) 
and T-bet. However, this analysis needs to be revisited in human as studies in human 
liver have shown the opposite, where ITGA1- (CD49A) cells are the resident liver NK 
cells and express EOMES (Aw Yeang et al., 2017). In the mouse liver these cells also 
present memory potential for hapten specific responses (Zhang et al., 2016). Certain 
populations also show self-renewal capacity, like in the uterus, of the circulating and 
tissue-resident NK cells only the tissue-resident population was able to proliferate (Sojka 
et al., 2018). 
1.6 Defining a cell types in the age of single cell multi-omics 
What is a cell type and how do we define it? Such questions have been the basis of 
several discussions into the identity of the cell, the conclusion to which have constantly 
evolved over time, largely driven by advances in technology. Preliminary descriptions of 
cells using light microscopy were based on their morphology. Subsequently, various 
staining techniques were developed to highlight certain cell types, e.g. the neuron 
doctrine of Santiago Ramón y Cajal (Jones, 1999) revealed various types of neurons 
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based on their morphology which were drawn from stainings using the Golgi silver 
staining method, with certain structures, such as Cajal bodies in neurons, still being used 
as a reference in studies today (Figure 1.7). Further development enabled staining of 
cells based on their expression of specific receptors using fluorescently tagged 
antibodies to track their localisation in living sections (Coons et al., 1941, Peel et al., 
1997). Even at this stage there was a continues revaluation e.g. earlier markers for Th 
cells were found to stain myeloid lineage cell types under different conditions (Wood et 
al., 1983). In the current age, cells may be defined through multiple dimensions spanning 
various omic technologies.   
New technologies, such as single cell omic platforms have enabled us to investigate the 
heterogeneity of cell types which can exist as discrete subsets, as well as a continuum 
of states. This has been shown for cells going through the different phases of cell cycle 
(Hsiao et al., 2020) and those going through haematopoiesis, gradually acquiring 
unipotency (Pellin et al., 2019). Certainly, integrating such technologies will help us 
gather the data needed to define cell types, e.g. a recent study in acute myeloid 
leukaemia used scRNA-Seq and genotyping to distinguish cell types and evaluate if they 
Figure 1.7. Describing the brain cytoarchitecture through the ages 
Taken from the (Figueres-Oñate et al., 2014). A horizontal section of the mouse olfactory bulb 
as described through the ages where neurons were stained for, using A) Golgi stains 
subsequently drawn by Cajal, B) biotinylated dextran amine injection specific to neuronal cells, 




were malignant (van Galen et al., 2019). Indeed, integrating such data will enable 
researchers to conduct cross study comparisons to evaluate cellular heterogeneity 
based on our current resources/databases. Projects generating datasets derived from a 
diverse set of cell types are already being initiated, like the Human Cell Atlas (Regev et 
al., 2017) and mouse cell atlases (Schaum et al., 2018, Han et al., 2018). However, 
studying cells in this high-dimensional space poses its own problems in terms of 
integrating these different omics data and standardising approaches to compare across 
studies, such that we have a common ontology to define cell types.  
Researchers have also developed high-dimensional approaches such as cytometry by 
time-of-flight mass spectrometry (CyTOF) which tags antibodies with metal isotopes to 
reduce spectral overlap, hence, enabling the measurement of 40 proteins at a time from 
individual cells using mass spectrometry (Leipold, 2015). This is further expanded upon 
by other omic technologies used to measure molecular properties at the single cell level, 
including scTRrio-seq (CNV, CpG methylation, and transcriptomics)(Hou et al., 2016), 
scCOOL-seq (CNV, chromatin accessibility and CpG methylation)(Guo et al., 2017) and 
CITE-Seq (transcriptomics and proteomics) (Stoeckius et al., 2017) (Figure 1.8). 
Together these systems can capture thousands of variables with which to characterise 
cell types and provide a vast amount of data to aid in deconvoluting cellular 
heterogeneity, however the current challenge is in interpreting all this information and 
reaching a consensus. 
With the shift in technological capabilities we must revaluate how we conceptually define 
cell types in the context of the cell features we can now quantify. Our interests and 
accordingly our knowledge of immune cell types diversity and biology have been 
determined by the prevalent cell types across diseases, e.g. as shown in previous 
sections numerous macrophages and T cells have been identified and referenced with 
one another to generate a comprehensive nomenclature, however, while such 
exhaustive studies of cell states across diseases and conditions are only beginning to 
take place for cells like neutrophils and other granulocytes (Silvestre-Roig et al., 2019). 
The latter are largely described in the context of few proteins presented or secreted, 
enzymes produced, diseases they are associated with and tissues they reside in (Gurish 
and Austen, 2012, Dwyer et al., 2016). Presently, much of how we define cell types has 
originated from making clear demarcations between them using selected markers. In 
certain cases, however we are beginning to see how this strategy masks cellular subsets, 
e.g. pDC isolated using CD123 and BDCA-2 were assumed to drive the IFN response 
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and T cell activation, however recent studies using scRNA-Seq reveal a minor 
subpopulations of cells within them termed as Axl+ DCs responsible for the potent 
activation of T cells (Villani et al., 2017). Such studies have helped revaluate our 
definition of cell types and their function.  
 
Figure 1.8. Single cell multiomics technologies 
Taken from (Hu et al., 2018). Single cell omic technologies for studying the central dogma at 
various levels including the genome, epigenome, transcriptome and proteome. Also shown are 
the multiomic technologies which examine a combination of these omics.  
 
To understand these systems based on our current resources and knowledge a few 
common themes have appeared, including:  
1. Comparing cell types across datasets to better understand the uniqueness of cell 
types vs. others e.g. comparing monocytic population in human to those of mouse 
(Ramachandran et al., 2019). 
2. Defining cells based ontology or lineage, shown for haematopoiesis (Weinreb et 
al., 2020). 
3. Identifying a functional role of novel cell types. 
4. Perturbation studies, by methods like CRISPR or exposing to different stimuli, to 
examine the stable and bounds of cellular states, i.e. how restricted are cell types 
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in differentiating to other states/cell types and what are the limits of this (Rubin et 
al., 2019). 
 
1.6.1 The then and now of bulk RNA-Seq 
Tissue or population-level transcriptomics data represents an average of signals 
determined by the diversity of cell populations, their numbers and their expression levels 
of genes/proteins. Such methodologies have helped describe differences between 
experimental conditions (disease and stimuli), developmental processes, subgrouping 
patients based on their response to disease, the functional annotation of genes and 
mechanisms underlying the central dogma (Wang et al., 2008, Graudenzi et al., 2018). 
There have been several drivers for understanding tissue-wide omics in humans, leading 
to the formation of several consortiums, databases and resources. Resultant studies 
have been crucial in explaining tissue-specific biology, including deviations in genetic 
architecture and gene regulation. Studies have included the Illumina Human Body Map 
2.0 and GTEx (https://gtexportal.org/home/) (Lonsdale et al., 2013) from which we can 
characterize tissue-specific gene expression profiles (Zhang et al., 2010, Pan et al., 
2013), the similarity between tissues in processes such as ageing (Yang et al., 2015), 
as well as functional and disease associations, as shown for Parkinson and Alzheimer’s 
towards the brain (Sonawane et al., 2017, Greene et al., 2015). Focused efforts, such 
as the ABA have helped identify the biological components of the brain in mouse and 
humans, by generating transcriptomics data derived from numerous regions (Shen et al., 
2012). Coupled with in situ hybridization (ISH) techniques they have provided a 
spatiotemporal view of the brain cytoarchitecture through spatial transcriptomics (Sunkin 
et al., 2013). Similar studies have generated a plethora of publicly available data for 
which various databases have been constructed including Gene Expression Omnibus 
(GEO) (Edgar et al., 2002) from the National Centre of Biotechnology and Information 
(NCBI) and ArrayExpress (Oezcimen et al., 2003) of the European bioinformatics 
institute (EBI). The data has also been summarised and visualized through resources 
such as BioGPS (Wu et al., 2009).  
The interpretation of such data is dependent on teasing out two biological signals, cell 
proportions and states. Often studies focus on one depending on the research question. 
Accordingly, several methods/strategies have been developed to analyse this data and 
to address both biological signals. “Interesting” genes with respect to experimental 
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conditions can be identified through differential expression and GCNs. The former 
reveals genes whose expression changes significantly across conditions while the latter 
highlights groups of genes part of a common biological process through guilt-by-
association as they share a common expression profile across samples. To infer the 
biology from these sets of genes, a supervised approach can be adopted. Numerous 
databases are now available like the gene ontology (GO) and molecular signature 
databases which describe various kinds of biology under different conditions using sets 
of genes or gene signatures (Liberzon et al., 2011, Ashburner et al., 2000). These gene 
signatures can represent cell types, cellular states, pathways, and diseases. Moreover, 
using transcriptomics data one can also find the directionality of a particular signature, 
i.e. if a process is down- or up-regulated using gene set enrichment analysis (GSEA) 
(Bolen et al., 2011, Verhaak et al., 2010, Shoemaker et al., 2012). Unfortunately, 
signatures can show enrichment for numerous terms associated with different cell types 
and biology due to the redundancy in known gene sets. Hence, any inferences should 
be made cautiously although methods are being developed to help interpret these results 
(Supek et al., 2011). With this redundancy in databases and their bias towards a limited 
number of biological processes, various resources including literature mining can aid in 
describing cell populations in bulk RNA-Seq data, especially cell type markers. Specific 
cell types may be identified using gene signatures or markers from which the relative 
proportion of cells can be found using methods such as CIBERSORT and ImSig (Chen 
et al., 2018, Nirmal et al., 2016). Such studies help describe the type of responses in 
disease, where the cell distribution changes, e.g. in systemic lupus erythematosus the 
leukocyte proportions described by transcriptomics data was shown to be associate the 
disease activity index as determined by clinical parameters (Abbas et al., 2009). 
However, a caveat of this is in segregating similar cell types. Another aspect of cell 
biology that can be investigated are cellular states. Some of these states are mentioned 
in gene set databases, e.g. activation states of immune cells in response to different 
stimuli (Abbas et al., 2005, Raza et al., 2014), while the degree of their activation can be 
explained by GSEA (Finotello and Trajanoski, 2018). Researchers have used different 
methods to separate the biological signal of cell activation from cell proportions in bulk-
RNA-Seq data (Shen-Orr and Gaujoux, 2013). This has also been shown in an 
epigenome-wide study of rheumatoid arthritis, where the effects of cell number assumed 
to be a confounding factor, was removed from the data, revealing disease associated 
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methylation signatures potentially contributing to genetic risk towards the disease (Liu et 
al., 2013).  
Methodologies developed to analyse high-dimensional bulk RNA-Seq data have laid the 
foundations for functional gene annotation. The advent of single cell technologies, has 
expanded our understanding of the complexity and heterogeneity of cells by adopting 
and building upon previous analytical methods (Di Carlo et al., 2012).  Several aspects 
of these analyses come from well-defined approaches in bulk RNA-Seq including QC of 
reads, mapping, alignment and normalization. CPM normalization is commonly used in 
scRNA-Seq (Hwang et al., 2018). However, certain features are unique to scRNA-Seq 
which require further development of current techniques e.g. taking into account the 
variability of library sizes arising from differences in cell size and transcriptional activity 
(L. Lun et al., 2016). Though bulk RNA-Seq highlights the dominant biology across 
experimental conditions, there have been several cases where cell subsets and their 
activation states have been underappreciated. Earlier omic studies of AD pointed 
towards dysregulation in protein homeostasis like Aß and tau, as well as an alternate 
activation of microglial cells (Papassotiropoulos et al., 2006, Martiskainen et al., 2015). 
However, only recently scRNA-Seq studies have revealed a subpopulation of microglia, 
referred to as disease associated microglia (DAM), contribute to AD pathology (Keren-
Shaul et al., 2017). Therefore, although bulk RNA-Seq describes key genes in the 
alternate activation of microglia, the approach would mask the subset of cells actually 
undergoing such changes. Such findings could mislead drug development which would 
assume a single population and may preferentially target homoeostatic microglia or 
those that are beneficial. Still, using both bulk- and scRNA-Seq  data together has proven 
useful, e.g. in improving the biological signals in scRNA-Seq data through imputation 
using reference tissue RNA-Seq profile (Zhu et al., 2018), and estimating cell proportions 
from bulk RNA-Seq using cell signatures/markers identified through scRNA-Seq, as 
protocols for isolating different cell types are still being improved upon (Wang et al., 
2019c). 
1.6.2 Advances in single cell transcriptomics 
Variation at the single cell level is also being studied through (ISH) or 
immunohistochemistry (IHC), fluorescence activated cell sorting (FACS) and new spatial 
transcriptomic approaches. As the initial effort in determining the transcriptomic profile  
single cells, Tang et al. were able to sequence mRNA captured from mouse oocytes and 
blastomeres (Tang et al., 2009). In less than a decade since then there has been an 
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exponential growth of single cell technologies which has spurred up different companies 
(10X genomics & Fluidigm), consortiums (Human Cell Atlas and Oxford Single Cell 
Biology Consortium), databases (Single cell portal and Single cell expression atlas) and 
resources (Mouse cell atlas and scQuery), all of which have contributed towards a wide 
range of biology at the single cell resolution (Hwang et al., 2018, Han et al., 2018, Alavi 
et al., 2018). Studies now include the analysis of up to 1 million cells, with technologies 
expanding to other omics (Svensson et al., 2018, Chappell et al., 2018). These 
technologies have enabled further exploration of the different aspects of cellular 
heterogeneity including the transitionary and transient states during development 
through pseudotime analysis, the relatively stable and discrete states (cell subsets and 
rare cell types) defined by their microenvironment, as well as the response state cells 
achieve based on external or internal stimuli (Farrell et al., 2018, Ledergor et al., 2018). 
Alternate splice forms across tissues have been well characterised, however studies 
from scRNA-Seq have also shown alternate isoform usage between cell types which 
may be a result of intercellular isoform variations as described in Drosophila, although, 
whether these are controlled or stochastic events is still to be known (Miura et al., 2013). 
Similar efforts have been made to describe the diversity in VDJ regions of B and T cell 
receptors, having up to 1018 combinations able to recognise several antigens, and 
directing selective responses, with applications in vaccine development (Jung and Alt, 
2004, De Simone et al., 2018, Stubbington et al., 2016). Genomics studies have 
identified cell types specific expression quantitative trait loci (eQTLs) (van der Wijst et 
al., 2018) and have been able to further resolve the association of GWAS traits to cell 
level process like haematopoiesis (Ulirsch et al., 2019). As scRNA-Seq captures a 
snapshot of the tissue, differentiating cell populations are captured at various “times” of 
differentiation, also referred to as pseudotime (Figure 1.9). This has been especially 
useful in determining the regulators of cell fates as shown through development and cell 
action in disease  e.g. GATA1 and CEBPA in haematopoiesis (Chen et al., 2019). More 
recently researchers have tracked the clonal expansion of cells from which they propose 
a precommitment of cells as has been shown for Gata2+ cells which preferentially 





Figure 1.9. Reducing high-dimensional data for interpretation 
Adapted from (Tritschler et al., 2019). We can conceptualise the differentiation of cells using 
Waddington's landscape where cells travel/differentiate through cellular states or valleys either 
stochastically or directed by stimuli to subsequently achieve more stable states. However, 
these paths are defined by the numerous features or dimensions that describe cells. An effort 
in single cell is to reduce this space while still retaining the structure of the data for our 
interpretation. scRNA-Seq takes a snapshot of differentiating cells which can be 
bioinformatically aligned in pseudotime. Such dimensionality reduction methods can aid in 
identifying the progenitor (root region), the branching points at which cells may diverge into 
multiple cell types and the stable states. 
 
In previous sections we have examined the influence of external cues to cell identity 
while poorly mentioning the internal stimuli which govern cell identity and its potential to 
differentiate. An example of this is transcriptional noise, shown to be cell type specific 
and provides the transcriptional variability required for cell types to preferentially 
differentiate into a certain state or the other  (Satija and Shalek, 2014). As mentioned 
previously, cellular heterogeneity is greatly influenced by the microenvironment. Such 
signals could be considered as extrinsic cues which orchestrate a feedback system with 
the gene regulatory network (Swain et al., 2002). Although gene regulatory networks 
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govern the type of cell, there is an intrinsic signal or noise which adds to the diversity in 
cells, which can be attributed to the stochastic nature of gene regulation (Swain et al., 
2002). These probabilistic events have been observed at both the protein and the mRNA 
level, and are referred to as transcriptional bursts (Raj et al., 2006, Lubeck and Cai, 
2012). The uniqueness of cell types, their stability and transiency between cellular states 
can be considered to be regulated by these two sources of signals or noise. Subtle 
differences in even clonal populations of cancer cells can result in varied drug responses 
(Cohen et al., 2008). In stem cells, where cell fate determination is found to be 
unpredictable, fluctuating between states makes cells prone to differentiate towards 
certain lineages (Imayoshi et al., 2013, Chalancon et al., 2012). Additionally, cell systems 
can minimize such effects or are made to be in sync through external cues such as cell 
to cell interaction (Rand et al., 2012).  
Although scRNA-Seq has opened various avenues of research it also has its own 
technological challenges. Apart from the severe PCR duplication (Marx, 2017), the main 
concerns are dropout events due to the small starting material 0.01-0.25 ng mRNA and 
low coverage of 50,000 read on average per cell commonly used. This low starting 
material results in false zero expression level of lowly expressed genes. Hence though 
similar issues have been addressed in bulk RNA-Seq and microarrays, the frequency of 
dropouts or the variability of the data is more severe (Faisal and Tutz, 2017, Aittokallio, 
2010). scRNA-Seq data is highly sparse where zeros account for more than ~50% of 
entries in the expression matrix. Methods have been developed to address this noise, 
such as imputation and noise models and clustering. Imputation algorithms for missing 
values in scRNA-Seq include global algorithms like SAVER (Huang et al., 2018) and 
MAGIC (van Dijk et al., 2018), or local algorithms including scImpute (Haimon et al., 
2018) and DR impute (Gong et al., 2018), e.g. local algorithms evaluate a local group of 
similar cells to impute values across cells. 
 
1.6.3 Network analysis of high-dimensional data 
Graph-based approaches have been used in portraying the complexity of biological 
systems. As a result, different forms of networks have been developed, with several tools 
to visualize and analyse them. Notable software for network analysis in biology include 
Cytoscape, weighted gene co-expression network analysis (WGCNA), Biolayout, and 
Stanford network analysis project (SNAP), the latter adapted for large scale networks 
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(Leskovec and Sosi, 2016) for more than a million nodes and billion edges, a feature 
becoming more attractive in an age of big data. To represent the complexity of biological 
systems several types of networks can be constructed each emphasising different 
characteristics of the data. Networks can be divided based on different criteria such as, 
static vs. dynamic, undirected vs. directed and weighted vs. unweighted networks, a 
combination of which can be used to describe different biological processes like, protein-
protein interactions (PPI), gene regulation, functional association and signalling. 
Undirected networks include PPI as shown for viruses (McCraith et al., 2000), bacteria 
(Wuchty and Uetz, 2014) and complex diseases (Safari-Alighiarloo et al., 2014) which 
have elucidated upon pathogenic mechanisms. Other undirected weighted networks for 
studying gene/protein associations such as coexpression, identify genes sharing the 
same or similar expression profiles across samples. The metrics for determining the 
similarity between genes (on their expression profile) can be calculated as distances 
such as Euclidean, Manhattan and hamming distance or similarities such as Pearson, 
cosine and Spearman correlation. A common metric for similarity is the Pearson 
correlation coefficient which ranges from -1 to 1. When comparing two genes based on 
their expression profile a value closer to -1 or 1 suggests that they are inversely 
correlated or share a positive relationship, respectively. Correlation values close to 0 
indicate no similarity between genes. For omics data like that generated from RNA-Seq, 
pairwise comparisons can be made between genes thereby generating a gene-to-gene 
matrix. Thereafter, different approaches can used to construct a GCN using this matrix. 
The most basic algorithm for this is weighted edge pruning (WEP) where a cut-off 
correlation is chosen, and genes correlated beyond this threshold are connected by an 
edge within the network. A similar approach can be used for comparing the similarity 
between samples, where pairwise correlations are calculated between samples instead 
of genes. Although, statistical approaches such as differential expression analysis 
identify genes significantly different between groups, they may lose out on complex 
patterns within the data. Through GCNs subtle patterns are revealed including those 
which may not follow sample classifications required by statistical approaches. 
Furthermore, the method has proven to capture the structure of the data, e.g. a 
commonly used algorithm for network analysis in biology is WGCNA (Langfelder and 
Horvath, 2008) which outperforms methods like hierarchical clustering which is unaware 
of the data’s topology thereby losing out on key information which effects its clustering. 
WGCNA overcomes this hurdle by applying transformations to the gene similarity matrix 
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to consider the topology of the data, ultimately calculating the topological overlap matrix 
(TOM). The TOM is then clustered using hierarchical clustering and has shown to 
improve clustering relative to hierarchical clustering on its own (Li et al., 2018). The 
caveat to GCNs however is that it is still qualitative, without a statistical approach to find 
significantly similar genes, thereby requiring external resources to prove their relevance, 
e.g. staining for proteins, correlating cell signature expression with cell numbers and 
including known markers genes, as have proven useful in identifying the various 
signatures in the brain (Hawrylycz et al., 2012). 
GCNs have been essential in capturing biological signatures across experimental  
conditions, diseases, tissues and cells (Brazma and Vilo, 2000, Serin et al., 2016). 
Findings from these studies have generated various gene signature databases, which in 
turn help describe the biology of other studies. To interpret signalling pathways, graphs 
need to model directed interactions. Resources for static directed networks which model 
signalling pathways include Reactome (Mundo et al., 2013), KEGG pathways (Kanehisa 
and Goto, 2000) and Pathway Commons (Gross et al., 2010). Dynamicity can be 
introduced into such graphs by knowing the rate of these reactions described through 
differential or linear equations such as flux balance analysis (Edwards et al., 2001), or a 
more stochastic approach such as Petri nets can be used which is independent of kinetic 
parameters (Fisher and Henzinger, 2007, Livigni et al., 2018). Subsequently, these 
models can be applied to simulate cell biology in silico in Cytoscape (Arora et al., 2016), 
Biolayout or in MATLAB (Downes et al., 2006). An amalgamation of different types of 
information like gene coexpression, interaction experiments, and literature, can be 
incorporated into an undirected weighted association network for inference, these 
comprise of Search Tool for the Retrieval of Interacting Genes (STRING) (Roth et al., 
2010), GeneMANIA (Warde-Farley et al., 2010) and Enrichment Map (Merico et al., 
2010). These methods can be especially useful in removing redundancies and gauging 
a global picture of the processes involved. In contrast, although GO terms (Ashburner et 
al., 2000) are highly informative, their redundancy and multiplicity can prove 
counterintuitive, and presented through Enrichment maps the redundancies are revealed 
thereby highlighting components of unique biology. The setback for correlative networks 
such as for gene coexpression is that casual interactions can exist between nodes which 
can be misleading, e.g. a serial stepwise pathway would appear as an interconnect hub 
instead as sequentially connected nodes following the pathway. Methods are also being 
developed to find causative interactions which outline biological pathways (Feizi et al., 
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2013) e.g. Bayesian networks inference, generate a directional network based on genes 
expression data, revealing the hierarchy of signalling pathways in Alzheimer’s (Zhang et 
al., 2013). 
Whilst conventional graph construction approaches like WEP have proven useful in bulk 
RNA-Seq, technical artefacts such as dropouts within scRNA-Seq result in poor 
correlation values between genes within this data. Hence, different approaches have to 
be used to construct graphs for this data. A popular graph construction algorithm which 
has proven useful in terms of clustering is the k-nearest neighbour (kNN) algorithm (Duò 
et al., 2018). By considering the strongest ‘k’ edges for each sample the approach 
disregards the actual strength of these edges assuming any differences to arise from 
noise and hence rather ranks edges for each node (sample or gene). Although this can 
make it difficult to differentiate between noise and actual cell subtypes when clustering, 
the approach has been widely adopted in the field with added variations (Levine et al., 
2015, Xu and Su, 2015, Wolf et al., 2018). In addition to noise, kNN helps reveal the 
different levels of complexity within cells, which has been a concern in WEP. Few 
techniques have been developed to assess what threshold should be applied in WEP 
(Borate et al., 2009), however due to the hierarchical nature of biology a single threshold 
cannot capture all the different resolutions e.g. neurons can be differentiated from glial 
cells, and at a higher resolution into their various subtypes. Derived edge reductions 
methods such as Phenograph further the modularity of the graph by evaluating  then 
filtering edges (Levine et al., 2015).  
The biological complexity and technical artefacts in scRNA-Seq have led to the 
development of various methods for high-dimensional data analysis. One of the 
challenges has been to capture differentiation trajectories of cells for which graph-based 
approaches have been used, such as Single-cell trajectories reconstruction, exploration 
and mapping (STREAM) (Chen et al., 2019), monocle (Trapnell et al., 2014), slingshot 
(Street et al., 2018), p-Creode (Herring et al., 2018) and Partition-based graph 
abstraction  (PAGA) to reduce the structure of the data to a hierarchical tree for ease of 
interpretation (Herring et al., 2018, Wolf et al., 2019). Such tools also provide great 
visualisation which has become a field on its own. Although methods such as Principal 
component analysis (PCA) are still being used for dimensionality reduction as well in 
visualising the dominant variations within the data. Newer machine learning methods 
such as t-distributed stochastic neighbour embedding (tSNE) (Maaten and Hinton, 2008) 
and Uniform manifold approximation and projection (UMAP) (Becht et al., 2019) have 
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also been developed to capture data topology in a specified set of dimensions, usually 
two. In addition, these methods optimise the visualisation to highlight differences 
between data-points/samples like in tSNE where discrete cell types and even 
differentiation trajectories appear as globular. This is not so in UMAPs and network 
visualisation, where the latter further retains the essence of distance between the 
network components, not captured in UMAP and tSNE plots. Another avenue for scRNA-
Seq data analysis is in determining the gene regulatory network. As mentioned 
previously there are limitations to differential expression analysis, especially in 
determining which genes are regulated together within the set of genes differentially 
expressed between conditions/states. For constructing gene regulatory networks, 
several approaches have been developed, some of which show bias towards synthetic 
data such as Single cell regularized inference using time-stamped expression profiles 
(SINCERITIES) (Papili Gao et al., 2017), while others perform better overall like GENIE 
and GRNBoost (Aibar et al., 2017). Conversely, a study has also shown the 
inconsistency in the results of such algorithms (Chen and Mar, 2018). Network 
algorithms such as WGCNA are also being used to conduct such analyses and a recent 
study shows the promise of their application (Iacono et al., 2019). A unique network-
based approach which tries to address the sparsity of the scRNA-Seq data is MetaCell. 
The method aims to retain the structure of the data while aggregating similar cells into 
MetaCells (Baran et al., 2018). This helps reduce the data sparsity by averaging reads 
from similar cells into so called MetaCells, thereby aiding in downstream analyses. Self-
assembling Manifolds (SAM) on the other hand reduces dimensions by learning a fuzzy 
representation of the data through graphs, while iteratively removing genes which 
contribute poorly to the graph’s structure. Furthermore, the number of edges for each 
node within the graph is also evaluated, thereby converging to the “original” structure of 
the data, all independent of any threshold (Tarashansky et al., 2018). In summary, 
graphs have infiltrated the various spheres of analysis in single cell approaches and are 
only moving further in their capability to handle its complexities. 
 
1.7 Aims and objectives 
In the course of my doctoral studies, I have sought to investigate different aspects of 
TRICs. Listed below are the various aims and questions of the work. 
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1.7.1 Chapter 2 
Previous studies of the group have examined the transcriptional diversity of microglia 
during aging and in response to prion infection in mice, a well characterised model of 
neurodegeneration (Vincenti et al., 2016). In this chapter the core transcriptional 
signature of human microglia is examined through GCNs, and subsequently used to 
investigate the region-dependent responses of microglia in ageing and Alzheimer 
disease. 
1. How do previously derived microglia compare, and what factors may cause them 
to show this consistency/inconsistency?  
2. What is the core human microglia signature across brain regions? 
3. How do microglial cell numbers and phenotype change in ageing and Alzheimer’s 
depending on the region?  
1.7.2 Chapter 3 
The work in chapter 2 is expended upon by examining the heterogeneity of all immune 
cell types across tissues through different forms of RNA-Seq data including those derived 
from marker-defined immune cell types and those from the unbiased approach of 
scRNA-Seq: 
1. For cell types predefined by markers, how are different immune cell types 
associated i.e. how similar/different are they to one another and what are the 
gene clusters associated with these cell types? 
2. Similarly, how are immune cells associated with one another and which gene 
clusters represent them based on scRNA-Seq derived from different tissues? 
3. How do gene clusters compare between those derived from predefined cell types 
and those identified in an unbiased way using scRNA-Seq? 
4. What known and novel biology do these gene clusters describe, especially those 
concerning TRICs? 
1.7.3 Chapter 4 
Investigate the genes associated with TRICs in human and compare these signatures 
with those previously identified in mouse. 
1. What are the TRIC associated gene signatures from different tissues in human? 
2. What is the distribution (presence/absence) of immune cell types across tissues? 
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3. What biology of TRICs do these gene signatures describe and how do they 





2. Chapter 2: A core transcriptional signature of human microglia: 
Derivation and utility in describing region-dependent alterations 
associated with Alzheimer's disease 
2.1 Introduction 
The investigation into TRICs was started by studying microglia i.e. macrophages of the 
nervous system known for their involvement in various neurodegenerative diseases. 
Investigations into microglia in different regions of the brain have shown them to exhibit 
different phenotypes as has been shown by our lab in a chronic neurodegenerative 
mouse model induced by prion inoculation (Vincenti et al., 2016). The study showed a 
region-dependent increase in microglial numbers post prion inoculation, an indication of 
microglial response towards inflammation, with those of the thalamus having the highest 
and the cerebellum with the lowest numbers of microglia (Vincenti et al., 2016). A similar 
study in mouse described the different regional profiles of microglia through ageing. 
Notably, microglia in the cerebellum were found to be immune-vigilant due to their higher 
expression of various sensory molecules, while cortical microglia highly expressed 
immunoregulatory molecules. The authors also found that through ageing the 
hippocampus began to adopt cortical microglial phenotypes (Grabert et al., 2016).  
Studies have also compared the transcriptomic profiles of microglia in mouse and human 
finding neurodegeneration disease associated genes enriched in gene modules of 
microglia and varying ageing transcriptomic profiles of microglia between species (Miller 
et al., 2010, Galatro et al., 2017). Indeed, these cells display great regional heterogeneity 
in health and disease, which also varies across species. To this end we sought to define 
a conserved set of human microglial genes in the context of the CNS using GCN analysis 
which could be used to investigate region-dependent changes of the cell in health and 
disease. Additionally, our preliminary analysis revealed great variability across previous 
studies defining microglia both in human and mouse. Hence, to account for possible 
sources of variation we considered multiple datasets for signature derivation spanning 
various brain regions, sequencing platforms and donors. On validating this core human 
microglial signatures, we could conduct qualitative (cell number) and quantitative 
(activation state) investigations into different brain regions through ageing and in 
Alzheimer’s disease. In this work I conducted all the analysis and wrote the initial draft. 
The co-authors were extremely helpful in discussing the types of analyses that could be 



































In this chapter we studied the human microglia in ageing and Alzheimer’s disease which 
was motivated by the discrepancies observed between other studies defining this cell 
signature, the regional heterogeneity of microglia and the susceptibility of human 
microglia towards diseases like Alzheimer’s. At the time, bulk tissue transcriptomics was 
the dominant source of gene expression data from post-mortem human brain samples. 
Today, four years later this resource continues to expand, however with increasing single 
cell and nuclear RNA-Seq data e.g. ABA recently generated the spatially-resolved 
transcript amplicon readout mapping (STARmap) which includes single cell spatial 
transcriptomics of the mouse brain (Wang et al., 2018). Using the selected bulk 
transcriptomics datasets, we identified core signature genes of the human microglia 
while trying to take account of technical (sequencing platforms) and biological factors 
(donors and brain regions). Another factor for future analyses would be the 
methodologies used for signature derivation as these methods have tuneable 
parameters which influence the sensitivity and size of the signature. A meta-analysis of 
current single cell and bulk RNA-Seq datasets could definitely help describe a core 
microglial signature as well as regional homeostatic signatures and activation states. 
The advantage of deriving a core signature was that it would enable the investigation 
into regional responses of microglia as shown for ageing and in Alzheimer’s disease. 
Since the study was published it has also been used in determining the microglial state 
in Huntington’s disease (Al-Dalahmah et al., 2020). Whilst, GCN analysis was ideal for 
deriving a core human microglia signature as the cell type represents the dominant 
macrophage or immune cell type within the brain, it could be challenging to derive such 
TRIC signatures in other tissues where TRICs represented a small proportion of the cell 
within the tissue and shared their biology/pathways with other resident cells. Hence, 
single cell or pooled cell derived RNA-Seq would be preferred in more complex tissues. 
A recent single nuclear RNA-Seq (snRNA-Seq) study of Alzheimer’s disease identified 
microglial states of which associated genes matched those identified here in, including 
the downregulation of homeostatic genes (CX3CR1 and P2RY12) and upregulation of 
immune related inflammatory genes (HLA-DRA and SPP1) (Mathys et al., 2019). 
However, as a note of caution a recent snRNA-Seq study has found poor capture 
efficiency of certain key genes characteristic of mouse disease associated microglia 
(Thrupp et al., 2020) which highlights the importance of high quality (coverage and 
sensitivity) sequencing data such as bulk transcriptomics. Hopefully in the future the 
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quality of data generated from single cell technologies would compare with that of bulk 
RNA-Seq.  
From a biological standpoint we have examined region-dependent microglial responses 
in ageing and Alzheimer’s. These results match those from single cell studies however 
similar region-dependent analyses are still required to describe potential microglia 
subpopulations. In terms of signature derivation, the analyses showed the potential of 
using bulk transcriptomics data. Altogether the study shows the relevance of deriving 
homeostatic signatures to understand cell type biology under physiological conditions 
and using them to understand these cells in pathology, while highlighting the possible 




























3. Chapter 3: Diversity of tissue-resident immune cells in mouse and their 
gene signatures  
3.1 Introduction 
In chapter 2, the transcriptomic profile of human microglia was investigated in health, 
ageing and Alzheimer’s disease. Like other studies our analyses revealed the region-
dependent heterogeneity of microglia. Indeed, the transcriptional signature of these cells 
has shown to be different from tissue-naïve macrophages and they have specialised 
functionality associated with CNS homeostasis, such as synaptic organization (Galatro 
et al., 2017). By understanding the biology of homeostatic microglia, their role in 
pathological conditions such as ageing, and Alzheimer’s disease could be investigated. 
Hence, an understanding of the homeostatic signature of TRICs can help describe their 
role in disease. With this in mind, the analyses in this chapter expands from microglia to 
immune cells across different tissues under homeostatic conditions. 
In addition to their protective role, TRICs are specialised towards maintaining 
homoeostasis of particular tissues. In the introduction, the role of TRICs both in health 
and disease has been described. Briefly, immune cells exposed to certain environmental 
cues from the surrounding tissue can differentiate into TRICs, which involves remodelling 
of their transcriptomic and epigenetic landscape (Yoshida et al., 2019, Lavin et al., 
2014a). As a result, these cells adapt to their environment, gaining tissue-specific 
phenotypes to maintain tissue homeostasis, metabolism, facilitate organogenesis, and 
during inflammation TRICs also display alternate activation states relative to their tissue-
naïve counterparts (Ransohoff, 2016). Furthermore, TRICs can have different 
ontogenies and be sustained through slow proliferation of local progenitors instead of 
repopulation through circulating immune cells. TRICs are not only relevant in 
physiological conditions but play a key role in disease pathology, e.g. a reduction in the 
phagocytic capacity of alveolar macrophages has been observed in COPD patients, 
making them ineffective in clearing lung infections (Jubrail et al., 2017). Appreciation of 
such functionalities and their relevance to disease has pushed forth therapeutic 
strategies which try and regulate TRIC phenotypes, e.g. an increase in microglial 
activation is associated with AD, hence various therapeutic strategies have been 
proposed to inhibit microglial activation in patients (Biber et al., 2019).  
The importance of TRICs in physiological and pathological conditions has led to an 
interest in understanding their biology. Researchers have examined various aspects of 
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these cell subtypes, including their ontogeny (Mass, 2018, Vasanthakumar et al., 2015, 
Mackay et al., 2013), renewal capacity (Hashimoto et al., 2013), homeostatic role in 
tissues (Nguyen et al., 2011, Sathi et al., 2017), how they differ from other immune cell 
subtypes (Lavin et al., 2014a, Sojka et al., 2014a) and their contribution to disease (Shaw 
et al., 2018, Bergsbaken and Bevan, 2015). Cross-tissue comparisons allow us to 
appreciate the degree of immune cell heterogeneity explained by tissues, i.e. tissue 
dependent and independent regulatory networks of the immune landscape. However, to 
date there are very few reports of cross-tissue comparisons of TRICs, and the majority 
of these reports are reviews (Fan and Rudensky, 2016, Weller and Spencer, 2017, 
Masopust and Soerens, 2019). Alternatively, studying TRIC biology in the context of a 
single tissue, cross-tissue comparisons would enable us to gauge the degree of immune 
cell heterogeneity explained by tissues i.e. tissue dependent and independent regulatory 
network of the immune landscape. In this chapter cross-tissue comparisons are 
conducted in order to describe immune cell type and TRIC diversity.  
Previous studies have investigated immune cells using predefined sets of markers 
TRICs or using an unbiased approach such as scRNA-Seq. Subsequently, cells/samples 
have been profiled using omics technologies to understand the regulatory networks 
defining these cell types. Considering a few examples where researchers have adopted 
markers to isolate cell types; Lavin et al. described the regulatory landscape (enhancers 
and transcription factors) of isolated macrophages from different tissues (lung, brain, gut, 
spleen and liver) (Lavin et al., 2014a). This is further expanded upon by the ImmGen 
consortium which analysed 86 cell populations across lineages, tissues and maturation 
states (Yoshida et al., 2019). Although cell type markers are a great resource for cell 
identification, the field has begun to appreciate the heterogeneity of cells, and hence 
recent studies have adopted single cell omics to identify novel TRICs. These analyses 
investigate different immune cell types across tissues (three to five) including T cells 
(Szabo et al., 2019), Tregs (Miragaia et al., 2019), NK cells (Sagebiel et al., 2019) and 
macrophages (Mass et al., 2016). However, with an ever increasing number of scRNA-
Seq datasets and atlases (Schaum et al., 2018) there is great scope of investigating 
TRICS across a larger set of tissues. 
The primary aims of this chapter were to:  
1) Explore how cell types are associated based on their transcriptomics profile, and how 
well does this correlate with our understanding of marker defined cell types. Thereby, 
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appreciating how one defines cell types and the extent to which they can be separated. 
For this, the similarity between marker-defined cell types from the ImmGen resources 
were studied based on their transcriptomic profile and gene modules uniquely associated 
with some but not all cell types were identified.  
2) In order to conduct an unbiased investigation of TRICs Tabula Muris scRNA-Seq 
dataset was considered, a compendium of 100,605 cells from 20 mouse tissues across 
seven adult mice (3 months), sequenced using FACS- and microfluidic-based single cell 
technologies (Schaum et al., 2018). Using such large datasets would help identify and 
characterise the hierarchy of cell ontology, ranging from cell-lineages to -subtypes, 
including TRICs.  
3) Lastly, to examine the commonality between the biased (ImmGen) and unbiased 
(Tabula Muris) approach to observe the advantages and disadvantages of each. 
 
3.2 Material and methods 
3.2.1 ImmGen RNA-Seq data pre-processing and analysis 
In order to provide a set of reference gene expression profiles for a wide range of immune 
cell populations, two RNA-Seq datasets from the ImmGen resource were identified, 
including the “System-wide RNA-Seq profiles” (GSE109125) and “OpenSource 
Mononuclear Phagocytes Project” (GSE122108) datasets. Cell populations represented 
within these datasets were of lymphoid, myeloid and mesenchymal origin, isolated from 
a range of embryonic and adult mouse tissues. Both datasets were generated from 
pooled cells isolated by FACS, each cell population being defined by a set of markers 
with some samples derived from stimulated cells. The Mononuclear Phagocyte dataset 
consisted of 412 samples and the System-wide dataset of 157 samples. With the current 
study focusing on the biology of unstimulated adult cell populations, samples derived 
from cells that were treated/stimulated and those isolated from embryos or neonates 
were excluded from this analysis. This resulted in 384 samples in total being taken 
forward with 139 samples being from the System-wide dataset and 245 samples from 
the Mononuclear Phagocyte dataset. Represented in this combined dataset were 128 
combinations of cell-markers used for FACS isolation of cells from 25 tissues, each 
assumed to describe a distinct cell type. The dataset comprised of various cell types with 
one or more subsets (number shown in parenthesis) dependent on the localisation and 
maturation state, these included B cells (18), DCs (20), endothelial cells (2), epithelial 
66 
 
cells (1), fibroblasts (1), neutrophils (2), ILCs (5), macrophages (27), mast cells (1), 
monocytes (5), NK cells (6), NK T cells (1), pericytes (1), stem cells (6) and T cell (22) 
(Table S3.1). There were 1 to 23 replicates for each cell type with majority having 2 
replicates. Datasets were individually normalized for TPM-like values using a scaling 
factor of 104. Datasets were merged based on 12,144 genes having an expression value 
greater than 0.5 TPM in at least one sample.  
To analyse the similarity between samples, a sample-to-sample correlation network was 
generated from the combined dataset using the open-source network analysis software, 
Graphia (https://graphia.app/). A pairwise Pearson correlation matrix was calculated 
between samples based on all the 12,144 genes within the dataset. A graph was then 
constructed using a Pearson similarity coefficient threshold of r ≥ 0.87, generating a 
network of 379 samples/nodes and 3,739 edges. At this threshold, similar groups of cells 
formed cliques characterised by dense interconnectivity between similar samples. The 
graph was clustered using Markov cluster algorithm (MCL) with an inflation of 2.0, 
resulting in 30 cell clusters. To analyse genes underpinning the cellular diversity a GCN 
was generated using a Pearson threshold of r ≥ 0.8. The resultant graph comprising of 
6,307 genes and 193k edges was clustered using MCL with an inflation of 2.0 (Table 
S3.2). Of the 473 gene clusters, the 175 possessing five or more genes were annotated 
based on known cell markers and manual inspection of the cell types displaying the 
highest average expression of clustered genes relative to other cell types. 
3.2.2 Tabula Muris single cell RNA-Seq data pre-processing and quality 
control 
To investigate TRIC types in mouse, scRNA-Seq data from the Tabula Muris dataset 
(Quake et al., 2017) was selected for analysis. This dataset comprised of cells 
dissociated from 20 individual mouse tissues prepared through the 10X Chromium and 
Smartseq2 platforms. For this study, only immune cells sequenced using the SmartSeq2 
platform were selected as a wider range of tissues were analysed using this platform and 
the approach also provided higher quality data in terms of the number of genes identified 
per cell (Wang et al., 2019b). In addition, cells from the bone marrow were not considered 
for this study, as the focus was on mature TRIC types, not their differentiating states from 
progenitors. In total 10,860 cells were selected, derived from 12 tissues of both male and 
female mice (n = 7). This data was then pre-processed using the Seurat pipeline (Satija 
et al., 2015) as described in the Tabula Muris study. This included filtering: 1) any gene 
expressed in less than five cells or having fewer than five reads in total; 2) any cell that 
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did not have 500 to 25k detectable genes and 50k to 2M reads. The quality-controlled 
data, which comprised of 10,792 cells and 16,091 genes was log-normalized and scaled 
to regress out the effects of library size, ribosomal content and Rn45s. Based on the 
most variable genes (standard deviation ≥ 0.5), principal components were calculated 
and tested for using the Jackstraw approach (Chung and Storey, 2015). The first 42 
significant principal components were selected (empirical P value < 0.05). These were 
then used for visualisation and subsequent quality control and clustering using Graphia.  
Pairwise correlations were calculated between each cell based on the 42 significant 
principal components to generate a cell-to-cell network. To reveal distinct cell 
populations, nodes and edges were filtered based on a correlation threshold of r ³ 0.7, 
a minimum node degree of 30 and the k-NN algorithm was applied with k = 25. The 
resultant network consisted of 6,536 cells and was clustered using the MCL algorithm at 
an inflation of 1.7, giving a total of 53 clusters. For downstream statistical analyses, a 
sufficient number of cells were ensured for each grouping. 1) At the cluster level, small 
clusters having less than 10 cells were removed (cluster 52 & 53). 2) Cells belonging to 
the same cluster and tissue, having less than 5 cells were removed. 3) The nine clusters 
identified as microglial (based on the expression of Cx3cr1, P2ry12 and Tmem119) were 
collapsed into a single cluster as they captured donor differences rather than differences 
due to brain regions. This filtering left a total of 43 clusters comprising a total of 6,355 
cells. 
3.2.3 Cluster based annotation of single cells 
Single cells from the Tabula Muris dataset were annotated by comparing their expression 
profile with FACS isolated cell types from the ImmGen data. To determine the similarity 
between cells from the Tabula Muris dataset with those of the ImmGen dataset, only the 
most variable genes (standard deviation > 0.5) identified for each dataset were 
considered amounting to 6,399 genes. A Pearson correlation was then calculated for 
each cell of the Tabula Muris dataset with samples of the ImmGen dataset. Considering 
similarity coefficients above the threshold of r ≥ 0.3, cells were provisionally annotated 
based on the most similar cell type they associated with from the ImmGen. For clusters 
where more than 50% of cells were of the same cell type annotation and found enriched 
using the Fisher exact test, all cells within that cluster were annotated as that cell type.  
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3.2.4 Approaches to construct gene coexpression networks from single 
cell RNA-Seq data and their comparison 
GCNs were constructed from the scRNA-Seq data of the Tabula Muris. Three methods 
were used to generate GCNs, these included the “Average”, “Subcell”, and “Filter-
average” method. The first approach averaged gene expression across cells of each 
cluster resulting in a cluster vs. gene expression matrix. The second approach further 
subdivided clusters into 5 subclusters or Subcells, each having a minimum of 5 cells. 
The subclustering was done by examining cells from a given cluster and iteratively 
clustering them using the Louvain clustering algorithm with each iteration clustering the 
graph with a lower k (starting from k = number of cells -1) using a kNN (lower values of 
k resulted in more clusters) until the following thresholds were crossed, that is 1) 
maximum of five subclusters to a cluster and 2) each subcluster having a minimum of 
five cells. Through each iteration the largest subcluster was subdivided first and if not a 
lower value of k was chosen for clustering. After the Subcells were constructed a similar 
averaging of gene expression was done across cells of the subcluster which gave a 
Subcell vs. gene expression matrix. The third method constructed a GCN in a similar 
way to the first, however before averaging, lower expression values were filtered. Here, 
each cell-cluster was examined one at a time and those genes were considered which 
showed 1) expression in more than 5% of cells, 2) had maximum expression beyond 0.5 
log TPM and 3) were expressed in a minimum of 3 cells. Genes which did not meet these 
criteria were given a zero-expression value for the cluster being filtered. Subsequently, 
gene expression was averaged for cells across each subcluster or Subcell. 
The three methods used to construct GCNs were compared using two approaches. First, 
the top 4,000 correlated genes from each method were examined for their correlation 
values across the three methods and if they changed from one method to the other. For 
this a single representative metric was required to estimate how correlated a gene was 
within a dataset generated from a method. For this, the kNNcorrelation of a gene was 
considered, which was the average correlation the gene had with its ten nearest 
neighbours. The metric was used to examine the distribution of correlations for the top 
4000 correlated genes in one method and how this distribution changed in other methods 
i.e. if highly correlated genes in one method were similarly correlated in the others. This 
approach was taken further by ranking the genes based on their kNNcorrelation and 
comparing them across datasets. Comparing rankings would account for the differences 
in the ranges of the Pearson correlations between methods. Second, the top 50 (by size, 
69 
 
number of genes > 10) gene clusters unique to each approach were investigated and 
examined if they were a result of technical artefacts. For this, gene clusters unique to a 
certain method were identified and studied. To estimate the uniqueness of a gene cluster 
for each method, each cluster was compared to all the top 4000 correlated genes from 
the other two methods based on their gene overlap using the Jaccard index (from 0 to 
1, with fully overlapping gene lists having a value of 1) and the two values were averaged 
to estimate the final gene cluster uniqueness. Hence, gene clusters unique to a method 
had the least overlap i.e. low average Jaccard index with the top 4,000 correlated genes 
from the other two methods. Of the top 50 clusters from each method the two most 
unique clusters (lowest Jaccard index) from a method were examined for their GO 
enrichment, estimated using clusterProfiler (Yu et al., 2012). 
 
3.3 Results 
3.3.1 Mouse immune cell gene signatures from RNA-Seq analysis of FACS 
cell populations 
The ImmGen project provides an extensive resource of transcriptomics and epigenetic 
data derived from pooled FACS cells spanning a variety of immune cell types from 
different tissues of the mouse. For this study, two RNA-Seq datasets were examined the 
“System-wide” and “Mononuclear phagocytes” collection. These datasets comprised of 
cells isolated by FACS from different mouse tissues using various markers. As the focus 
of the work was on homeostatic TRICs from adult mice, samples derived from embryonic 
stages and stimulated conditions were removed. However, a small number of non-
immune cells, endothelial cells and fibroblasts were left in to provide contrast. The 
datasets were merged totalling to 384 samples derived from FACS cells based on 128 
combinations of markers from 25 different tissues which were analysed together. To 
investigate cell groupings, a sample-to-sample network (Figure 3.1) was generated 
based on the Pearson similarity coefficient. The r threshold was set to ≥ 0.87, the highest 
value at which majority of samples were connected within the graph. The resultant 
network comprised of 379 cell samples which were connected by 3,739 edges. Upon 
clustering the graph with MCL (inflation = 2), samples grouped into 30 ImmGen cell 
cluster (ImmCC), with five singletons, i.e. unconnected cell samples which were not 
similar to any other sample at this threshold (Table S3.1).  
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All replicate samples were connected, and similar cell types tended to co-cluster or 
reside in the same vicinity of the graph, e.g. several myeloid cells (macrophages and 
DCs) were part of the same component, while cells of the lymphoid lineage formed a 
separate component. In certain cases, however, cells formed separate components, 
suggesting they had a distinct expression profile. These included, fibroblasts (ImmCC 
25), endothelial cells (ImmCC 24), certain types of macrophages (alveolar, ImmCC 13 & 
22; microglia, ImmCC 4; peritoneal, ImmCC 2 & 17; and splenic, ImmCC 30 & 29) and 
plasma cells (ImmCC 20). Certain macrophages and DC types were part of the same 
component but clustered independently into tissue-resident cell types, such as Kupffer 
cells (ImmCC 14) and aortic macrophages (ImmCC 12), as well as immature cell types 
like pre-DCs (ImmCC 10). The analysis confirmed the quality of the data, as in the 
majority of cases, graph visualisation and clustering reaffirmed the known similarities  
 
Figure 3.1. Sample-to-sample correlation network of ImmGen data 
A sample-to-sample correlation network was constructed from the 384 ImmGen samples 
selected for this study based on the similarity between their gene expression profile. Samples 
correlated at r ≥ 0.87 are connected by a weighted non-directional edge. The resulting 
network was clustered into 30 groups using MCL (inflation = 2). Cell samples clustered 
together were given the same colour and labelled with the cluster number (in parenthesis) 
and cell types within it (as described by the authors). Distinct components can be observed 
for lymphoid cells (bottom right), certain macrophages and DCs (bottom centre), while several 




between immune cell types. To study subtle associations/differences between cell types, 
the GCN was studied. 
With few biological replicates included in the ImmGen data it is difficult to conduct 
statistical analyses across cell types as is common practice in differential expression 
analyses. Therefore, GCN analysis was  adopted to reveal genes that shared a common 
expression profile across cell populations, a methodology known to capture 
coexpressing genes associated with a given biology (Xue et al., 2014, Nirmal et al., 2018, 
Patir et al., 2019, Patir et al., 2020). Similar to the network generated for samples, a 
gene-to-gene network was constructed based on the Pearson correlation coefficient, 
using a threshold of r ≥ 0.8 and subsequently clustered using MCL (inflation = 2). The 
resultant graph comprised of more than 193k edges that connected 6,307 genes 
(nodes), which clustered into 608 gene clusters (Figure 3.2). The 175 largest clusters (n 
> 5 genes) were manually annotated based on the average expression profile of genes 
within the cluster. ImmGen gene clusters (ImmGC) were annotated for a certain cell type 
if the average expression of its genes were highly expressed in that cell population 
(Table S3.2). Additionally, gene clusters were annotated based on the cell type(s) they 
were associated with and to what degree/specificity. Gene clusters were annotated as 
“General” towards a certain cell type if they showed a high average expression of 
clustered genes relative to other samples and “Specific” if other cells showed negligible 
expression these genes. Where multiple cell types showed a comparable average 
expression, the gene cluster was annotated for cell types from the highest to lowest 
average expression. For example, cluster 1 was annotated as “General [Lymphoid 
progenitors = Stem cells], because the clustered genes were expressed in several cell 
populations, with the highest expression in lymphoid progenitors and stem cells which 
had similar average expression levels. In this case, the cluster was associated with the 
cell cycle, as its genes had a high expression in proliferative cells and included many 
well-known cell cycle gene families such as cyclins (Ccnf, h & e1), Cdk (Cdk1, 2, 4 & 7) 
and Cdc (Cdc6, 7 & 45). Annotating the gene clusters revealed various aspects of TRIC 
biology including cell lineages (myeloid - ImmGC 52 & lymphoid ImmGC 110), cell types 
(T cell - ImmGC 24, Treg ImmGC 205, NK cells – ImmGC 14 & ILC – ImmGC 60), 
developmental stages (preDC ImmGC 25/169, lymphoid progenitors ImmGC 9/84/92 & 
mature lymphocytes ImmGC 42), and TRIC types. Gene clusters representative of cell 
types included known transcriptional regulators, e.g. Eomes for NK cells (Zhang et al., 
2018b) and Rora for ILCs (Walker et al., 2019). Of the clusters representing TRIC  
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signatures, most numerous were those for macrophages which contained well 
established transcriptional regulators, e.g. Gata6, Pparg, Sall1 and Spic for peritoneal, 
alveolar, microglial and splenic macrophages, respectively (Mass, 2018, T'Jonck et al., 
2018, Davies et al., 2013). Other TRIC associated genes included Mybl1 a marker for 
germinal centre B cells (Ding et al., 2015) and Tnfrsf9, expressed in non-lymphoid tissue 
Tregs (Miragaia et al., 2019). Interestingly, Ctla4 which was present in the gene cluster 
associated with colonic Tregs has been shown to increase Treg cell numbers in the colon 
and not in other tissues during Foxp3 induction (Barnes et al., 2013). In addition to the 
supplementary tables for gene coexpression clusters the cell annotations from the top 
 
Figure 3.2. ImmGen gene correlation network.  
GCN constructed based on the similarity of expression profiles across samples from the 
ImmGen data (r ≥ 0.8). The GCN was clustered into 608 clusters using MCL. The graph is 
broadly segmented into myeloid-specific clusters (top right) and lymphoid-specific clusters 





50 gene clusters (based on size) have been summarised, which is an indicator of cellular 
heterogeneity across the different cell types and as expected dominant in macrophages 
(Table 3.1) Overall, the GCN analysis revealed known TRIC associated genes, as well 







Figure 3.3 The average expression profile of gene coexpression clusters 
identified in ImmGen. 
Each panel within the layout represents the average expression profile (z-score) of a gene 
cluster identified from the GCN shown in Figure 3.2. The panels are titled with the cluster 
number, number of genes in the cluster (shown in parenthesis) and the cell type(s) they are 
highly expressed in. The x axis constitutes of samples which are arranged and coloured 
based on the bottom legend. The y axis shows the average expression profile (z-score) of 
all the genes within that cluster. In addition, for certain cell type-associated gene clusters 
the expression profile (z-score) of marker genes is also shown (black line). The panels are 
layered out such that the gene cluster associated with a cell type (in bold) is displayed first, 
after which related TRIC associated gene clusters are shown. 
 
 
Table 3.1 Summary of immune cell type associated coexpression clusters (top 
50) 
Lineage Cell ontology 
Cell ontology 








Cell type multiple  Cluster 36 
Macrophage TRIC 
 Brain Cluster 6 
 Peritoneal Cluster 12 
 Lung Cluster 23 
 Spleen Cluster 28 
 multiple Cluster 34 
 Lung Cluster 37 
 Brain Cluster 39 
 Liver Cluster 43 
 Liver Cluster 44 
 Spleen Cluster 45 
 Lung Cluster 48 
Dendritic cell 
Cell type multiple  Cluster 35 
Cell subtype multiple  Cluster 8 
Cell subtype 
and TRIC multiple 
 Cluster 25 
Neutrophil Cell type   Cluster 18 





Cell type multiple 
 Cluster 30 
 Cluster 24 
B cell Cell type 
  Cluster 20 





centre Cluster 38 
 Spleen Cluster 49 
Plasma cell Cell type   Cluster 10 
Thymocyte Cell subtype 
Double +ve  Cluster 22 
Double +ve  Cluster 46 
T cell 
Cell type   Cluster 42 
Cell subtype Naïve  Cluster 31 
Treg TRIC  Colon Cluster 50 
NK cell Cell type   Cluster 14 
ILC Cell subtype 
ILC3  Cluster 16 
ILC2   Cluster 26 
      
 
 
3.3.2 Clustering and classification of single cells 
In order to identify TRICs unbiased by  predefined cell type, scRNA-Seq from the Tabula 
Muris dataset (Quake et al., 2017) was examined. The dataset is derived from cells 
isolated from 20 different mouse tissues. To investigate the immune component, immune 
cells (as annotated by the authors) spanning 12 tissues were selected. Furthermore, 
given the focus on the biology of TRICs, not haematopoiesis, all cells from the bone 
marrow were excluded. The selected cells were pre-processed using the Tabula Muris 
pipeline and quality controlled for through a graph-based approach which identified 
outliers based on their lack of similarity to neighbouring cells (Table S3.3). To calculate 
the similarity between cells, the most variable genes across these cells were identified 
and through PCA the 42 most significant (P value < 0.05) PCs were calculated for each 
cell. Subsequently, a Pearson correlation matrix was calculated to define the similarity 
between cells based on their PCA profile. The matrix was used to construct a sample-
to-sample graph at a threshold of r ≥ 0.7, applying the kNN algorithm with the k = 25. 
Within this network, outliers were poorly connected to neighbouring cells and those 
connected to less than 30 cells were excluded from the network. The remaining graph 
of 6,536 cells was then clustered using MCL (inflation = 1.7). Although microglial cells 
formed five clusters, this division represented donor variation rather than regional 
variation. Hence, the microglial clusters were aggregated into a single cluster. For 
reliable statistical analysis, small groups based on clustering and tissue of origin were 
filtered for those having less than five cells. The remaining cells totalled to 6,355 cells 
spanning 12 tissues (Table S3.4, Figure 3.4) and formed 43 Tabula Muris cell clusters 




Figure 3.4 Tissue of origin and original annotation of Tabula Muris immune cells. 
Visualisation of the final quality controlled 6,355 immune cells from Tabula Muris, where 
similar cells are proximal to one another. This cell layout is constructed only for visualisation 
using a kNN graph with k = 20, followed by the Fruchterman-Reingold force directed algorithm 
to layout the network in two dimensions (edges not displayed). In the left panel cells are 
coloured according to the 12 tissues from which they were isolated. The right panel displays 
the 12 original cell annotations defined by the authors. Broadly, the larger cell populations 
which segregate out include the different myeloid populations (top component), B cells 
(bottom, centre), T cells (left) and microglia (right). The shortcomings of the cell annotation 
can be observed in the interspersed myeloid cell types, especially the monocyte and 
neutrophil populations (top). 
 
On inspecting the cell annotaions provided by the authors there were two main issues 
(for downstream analysis in this chapter), 1) many cells were broadly classified into 
leukocytes and myeloid cells; 2) myeloid cell types like monocytes and neutrophils were 
difficult to differentiate as they did not form separate clusters and instead aggregated 
together. To improve upon the cell annotation, cells were reannotated using the ImmGen 
resource as a reference, since the resource includes transcriptomics data of a wide 
variety of predefined immune cell types.  Each cell from the processed Tabula Muris data 
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was compared with samples from the ImmGen dataset using the most variable genes 
across each dataset. Cells were temporarily annotated for the cell types they were most  
 similar to from the ImmGen.  Where this similarity was poor r < 0.3 cells were annotated 
as “low confidence”. Finally, TMCCs enriched in cells of a certain cell type’s annotation 
were annotated as such. This resulted in TMCCs being grouped into 20 broad cell types 
(Table S3.4, Figure 3.5). Relative to the original annotation there was a greater 
granularity and distinction of myeloid and lymphoid populations. In addition to the correct 
cell type annotation certain TMCCs were correctly annotated for their tissue of origin. For 
example, TMCC 24 and 26 comprised of cells isolated from the heart and were annotated 
as aortic macrophage from the ImmGen data. Such cases also included splenic B cells, 







Figure 3.5 ImmGen-based annotation of Tabula Muris scRNA-Seq data.  
The figure shows the different steps involved in the broad annotation of the Tabula Muris 
immune cell populations based on the known cell classifications from ImmGen. This was 
done in three steps: 1) Tabula Muris cells were clustered into 43 groups (top panel); 2) Each 
cell was then annotated for the most similar cell type from ImmGen, based on their 
transcriptomic profile. This is shown in the middle panel where cells from the Tabula Muris 
are coloured based on their Pearson correlation coefficient, with the most similar sample 
from ImmGen; 3) Lastly, cell clusters enriched in cells of a given annotation were then 
annotated as such resulting in the final cluster level annotation (bottom panel). 
  
3.3.3 Constructing gene coexpression networks from scRNA-Seq data 
After broadly classifying each cell from the Tabula Muris immune subset, genes that 
gene associated with them were identified. Due to the strong influence of technical and 
biological factors associated with scRNA-Seq, including dropout effects and the apparent 
transcriptional heterogeneity within cell types, it is a challenge to capture the complexity 
of gene expression patterns which underlie the biology within this data. Although 
differential expression analysis helps identify genes highly expressed in a cell type, how 
specific the genes are, and the genes shared across different cell types may go unseen. 
To overcome this, I looked at aggregating reads from cells within a cluster. This would 
reduce the variation within the data attributed by dropouts or variation within cell types, 
and would focus on the variation between clusters, ideally representing the differences 
between cell types or cell states, e.g. activation or differentiation. The approach would 
help improve modelling gene expression patterns like those captured by gene 
coexpression analysis. To test this theory, three approaches were explored (Figure 3.6). 
For the first approach (Average method), the log normalized counts for each gene across 
cells within a cluster were averaged, thereby generating a cluster vs. gene expression 
matrix. In the second method (Subcell method) each cluster was divided into 
‘subclusters’ or ‘Subcells’ using the Louvain clustering algorithm (Blondel et al., 2008) 
and in a similar way gene expression values were averaged across cells of the  
subclusters thus generating a Subcell vs. gene expression matrix. The approach was 




Figure 3.6 Depiction of the three approaches used for sample reduction of 
scRNA-Seq data 
The three approaches used to stabilise signals within scRNA-Seq data to construct a GCN. 
All approaches require the pre-processed expression matrix with samples clustered. The 
approaches include 1) averaging normalised reads of each gene across samples of a given 
cluster. 2) Subclustering the data by further clustering samples from each cluster and 
averaging within these subclusters. 3) Applying different low-end expression filters for each 
cluster and subsequently averaging gene expression across each cluster. 
 
 method), it was hypothesized that some of the averaged signals from the above 
approaches might be unduly influenced by noise or spikes in expression contributed by 
a few cells. These signals would thereby serve to falsely represent the pattern of 
coexpression of the cluster. Hence, similar to the first approach, the third method used 
the average signal of genes within clusters; however, before averaging each gene from 
the original cell expression matrix, lowly expressed genes with spikes in expression were 
replaced with zero expression values. The thresholds were applied on clusters 
individually for each gene. These thresholds included: 1) genes expressed a minimum 
of 5% of cells within the cluster; 2) at least one cell with an expression above 0.5 log 
TPM and; 3) a minimum of 3 cells expressing a gene. Additionally, to exclude spikes 
observed in RNA-Seq data, the expression values of cells within a cluster were capped 
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at 95% confidence interval for each gene. The approach would potentially highlight 
strong biological signals while removing low level signals, the majority of which are likely 
due to technical factors. Using the expression matrices generated from each method, 
GCNs were constructed at different Pearson correlation thresholds optimised to include 
~4,000 genes within each network (Table S3.5). First, the overlap between these top 
4,000 correlated genes from each network was compared (Figure 3.7A & B). The 
overlap in gene content between networks was 2,307 genes (37%), with approximately 
a third of the total number of genes (found in each network) unique to each method. 
Next, I wanted to know if highly correlated genes (the top ~4,000 correlated genes) from 
one dataset were differently correlated in another dataset, e.g. from one method certain 
genes could be highly correlated to one another, however on using a different method 
they may be poorly correlated. This comparison does not comment on the performance 
of methods but reveals how similar methods are. For this comparison, a metric to 
measure whether a gene was highly/poorly correlated within a dataset was required. 
This was measured for individual genes from each dataset by taking the average 
correlation of the gene with its ten nearest neighbours, referred to as “kNNcorrelation”. 
Resultantly, each gene had a single kNNcorrelation value, a measure of its correlation 
within the dataset. Looking at the top correlated genes from the Average method (~4,000 
genes from the Average method network), the kNNcorrelation of genes showed a similar 
distribution to the Filter-average method, while the Subcell method had a long tail. This 
indicated that highly correlated genes in method 1 and 3 were poorly correlated in the 
Subcell method, likely due to the replicates (Subcells) for each cell cluster unique to the 
approach. As a secondary measure, genes were ranked within a dataset based on the 
kNNcorrelation, such that highly correlated genes had higher rank values and the least 
correlated gene had a rank of 1 (Figure 3.7C). On examining the ranks of the top 4,000 
genes from each method, the Average and Subcell method showed similar distributions. 
This suggested that both methods identified similar genes to be highly correlated. 
Strikingly, the distribution of Filter-average gene ranks differed from both the Average 
and Subcell method, where top genes from the Filter-average approach had lower ranks 
in the Average and Subcell method, signified by their tailed distribution. The inverse was 
also observed as highly correlated genes in the other two methods presented lower ranks 
in the Filter-average approach. Overall the analysis revealed the similarity and 
differences between the three approaches, in that: 1) genes from the Subcell method 




Figure 3.7. Comparison of gene coexpression networks from signal stabilising 
approaches. 
A) Comparison of gene coexpression networks generated from three approaches used to 
transform scRNA-Seq data prior to GCN construction. Each network comprises of close to 
4,000 genes connected by the highest correlations between them. B) Overlap between the 
network genes produced by the three methods. C)  Metrics to compare the distribution of 
gene-to-gene correlations based on the different gene summary algorithms. Each plot 
represents a comparison of the gene networks produced from each method, e.g. the top left 
panel shows the proportion of network genes from the “Average” method based on their 
mean correlation with their ten closest members calculated for each the three datasets 
(coloured). The right panel ranks genes based on the above metric and makes a similar 




 representing each cluster in contrast to the other methods which had a single sample 
representing a cell cluster; 2) the Filter-average method identified certain genes as highly 
correlated which were poorly correlated genes in the other two methods and vice versa. 
As one of the most pronounced differences between methods were the genes unique to 
each, they examined for their association with any known biology rather than technical 
artefacts. By analysing gene clusters unique to a given approach one could determine 
which methods were influenced by technical artefacts as they would not be enriched in 
any known biology. First, the top 50 (based on size) clusters were considered from each 
method as these represented large gene clusters which were likely to be enriched for a 
known biological function (GO terms). Next, those clusters were examined which were 
conserved across methods and which of those were unique. To quantify the uniqueness 
of gene clusters to a given method its overlap as measured by the Jaccard index was 
calculated for each cluster with the top 4,000 correlated gene from the other two methods 
(Table S3.6). The Jaccard index is calculated by taking the number of genes in the 
cluster that overlap with the top 4,000 network genes generated from the other method, 
divided by the total number of genes in that cluster. I measured the combined overlap 
for each cluster with other methods by averaging the Jaccard indices. This measure was 
then used to rank individual clusters thereby highlighting poorly overlapping clusters. 
Clusters having a lower value were more unique to the method, and those whose genes 
are highly conserved had higher values. For comparison, two of the most unique clusters 
(lowest average Jaccard Index) from each method were analysed. From the Average 
approach, clusters 31 and 40 (Figure 3.8) were underrepresented in the other methods. 
It was assumed that the unique signals captured by the “better” method would represent 
a biological signal rather than a technical artefact, such as a spike in expression. On 
analysing the two clusters from the average approach GO enrichment analysis showed 
no significant enrichment for GO terms (Table 3.2). This was also observed for cluster 
48 and 49 from the Subcell method (Figure 3.9). On investigating the expression pattern 
of genes from these gene clusters, for the Average method, they displayed high 
expression in only one of the samples (representing a cell cluster) and similarly a high 
expression in a single Subcell from the Subcell approach. Hence, these genes 
coexpressed due to the relatively high expression in a single Subcell. It was argued that 
if this signal described real biology it would be highly expressed by the majority of cells 
representing that cell cluster (in the Average approach) or Subcell. In both cases, it was 
found that only a few cells (mostly one cell) showed a high expression in the cell grouping 
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(cell cluster or Subcell), and therefore this signal likely represented a random spike in 
expression due to technical factors. In contrast, the Filter-average method gene cluster 
15 and 44 (Figure 3.10) were enriched in processes associated with RNA processing 
including “Mitochondrial translation” (adj. P value 9.7x10-4) and “rRNA processing” (adj. 
P value 4.6x10-4). Consistent with GO terms for gene-clusters examined in the Filter-
average method, the clusters were proximal to the cell cycle gene-cluster 1. Unlike the 
other methods, genes from these clusters were expressed in several samples (cell-
clusters). These results indicated that the Average and Subcell method were prone to 
capturing false signals introduced by technical noise, while these signals are removed in 
the Filter-average approach.  
 
 
Figure 3.8. Gene clusters from Average method. 
Shown are the expression profiles for two gene clusters, cluster 31 (upper panel) and 40 (lower 
panel) from the Average method. These clusters had the least overlap of genes with networks 
from the other two methods. Each panel has three expression profiles, the first, being the 
average expression (y axis) profile of genes from that gene cluster as observed in each of the 
different cell clusters (x axis). The second shows the expression profile of the genes with the 
highest average expression in that gene cluster for each cell (dots) across the different cell 
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clusters. The third shows the average expression profile of the same genes by the average 
method. The networks on the right shows the location of these clusters within the network. 
 
 
Figure 3.9 Gene clusters from Subcell method. 
Shown are the expression profiles for two gene clusters, cluster 48 (upper panel) and 49 
(lower panel) from the Subcell method. These clusters were found to have the least overlap 
with networks from the other two methods. Each panel has three expression profiles, the first, 
being the average expression (y axis) profile of genes from that gene-cluster as observed in 
each of the Subcells (dots) of the different cell-clusters (x axis). The second shows the 
expression profile of the genes with the highest counts in that gene cluster for each cell (dots) 
within the different cell clusters. The third, shows the average expression profile of the same 
genes by the Subcell method. Here, the gene expression of Subcells are shown as boxplots, 
as multiple Subcells are part of a cell-cluster, unlike the Average and Filter-average approach 
where there is a single sample/bin for a cell-cluster, hence displayed with histograms. The 




Figure 3.10. Gene clusters from Filter-average method. 
Shown are the expression profiles for two gene clusters, 15 and 44 from the Filter-average 
method. These clusters had the least overlap with networks from the other two methods. 
Each panel has three expression profiles, the first, being the average expression (y axis) 
profile of genes from that gene-cluster as observed in each of the different cell-clusters (x 
axis). The second shows the expression profile of the genes with the highest counts in that 
gene cluster for each cell (dots) within the different cell clusters. The third, shows the average 
expression profile of the same genes by the average method. The networks on the right 




Table 3.2. GO enrichment of gene clusters compared between methods 




GO:0060215 Primitive hemopoiesis 8.98E-02 1 
GO:0018342 Protein prenylation 8.98E-02 1 
GO:0097354 Prenylation 8.98E-02 1 
GO:0007183 SMAD protein complex assembly 8.98E-02 1 
GO:0007351 Tripartite regional subdivision 8.98E-02 1 
Cluster 
31 
GO:0071712 ER-associated misfolded protein catabolic process 4.81E-02 2 
GO:0071218 Cellular response to misfolded protein 6.32E-02 2 
GO:0051788 Response to misfolded protein 6.32E-02 2 
GO:0006515 
Protein quality control for 
misfolded or incompletely 
synthesized proteins 
6.32E-02 2 





Epithelial cell proliferation 
involved in lung 
morphogenesis 
6.22E-02 1 
GO:0090494 Dopamine uptake 6.22E-02 1 
GO:0061140 Lung secretory cell differentiation 6.22E-02 1 
GO:0071679 Commissural neuron axon guidance 6.22E-02 1 
GO:0090493 Catecholamine uptake 6.22E-02 1 
Cluster 
48 
GO:0098739 Import across plasma membrane 5.55E-02 2 
GO:0098656 Anion transmembrane transport 5.55E-02 2 
GO:0015893 Drug transport 5.55E-02 2 
GO:0015809 Arginine transport 5.55E-02 1 





GO:0032543 Mitochondrial translation 9.69E-04 3 
GO:0140053 Mitochondrial gene expression 1.26E-03 3 
GO:0051028 mRNA transport 4.78E-02 2 
GO:0034660 ncRNA metabolic process 4.78E-02 3 
GO:0050657 Nucleic acid transport 4.78E-02 2 





GO:0022613 Ribonucleoprotein complex biogenesis 7.12E-05 9 
GO:0034660 ncRNA metabolic process 7.98E-05 9 
GO:0006364 rRNA processing 4.65E-04 6 
GO:0034470 ncRNA processing 7.25E-04 7 
 
 
3.3.4 Gene coexpression network from tissue-resident immune cells 
To identify gene coexpression clusters associated with TRICs from Tabula Muris, the 
GCN constructed from Filter-average approach in the previous section was used. 
Relative to the other two methods for constructing GCNs, the Filter-average approach 
had few false positive gene clusters i.e. Tabula. Muris Gene Clusters (TMGC) 
represented known biology rather than technical artefacts e.g. spikes in expression. The 
GCN constructed from the previous section was used, which composed of 4,006 genes. 
Individual TMGCs, where possible, were given a functional annotation based on 
literature mining and enrichment analysis using the ImmGC annotation and GO terms 
(Table S3.7, Figure 3.11). 195 TMGCs were found to be enriched in ImmGCs. This 
included TMGCs representative of pathway biology, cell lineages, cell types and TRICs. 
The pathway signatures identified included cell cycle (TMGC 1), ribosomal (TMGC 5), 
and class 2 antigen presentation (TMGC 35). Cell cycle genes from TMGC 1 (including 
Cdk1, Cdk2, and Mcm gene family) were highly expressed in single and double positive 
thymocytes (TMCC 3, TMCC 28 and TMCC 30) which are known to be highly 
proliferative during thymopoiesis. Ribosomal genes were highly expressed across cell 
types, excluding neutrophils which have relatively little transcriptional activity to other 
immune cells during homeostasis (Monaco et al., 2019). As expected, class 2 antigen-
presentation genes (H2-Aa, H2-Ab1 and H2-Eb1) were highly expressed in B cells, 
macrophages and DC populations. Lineage associated signatures were identified for 
myeloid (TMGC 2, 281 genes and TMGC 11, 66 genes) and lymphoid (TMGC 45, 15 
genes) lineages. Lymphoid associated genes included Ets1 and Ptprcap, known 
regulators of lymphoid differentiation and activation. While, the myeloid signature 
comprised of known regulators (Sfpi1, Cebpa and Cebpb), certain genes within these 
TMGCs were highly expressed in specific cell types, e.g. the complement family (C1qa, 
C1qb and C1qc) were highly expressed only in macrophages. Such cases where TMGC 
include gene with multiple expression patterns highlights the influence of clustering and 








A) The gene coexpression network constructed from the Filter-average method (generated 
and studied in the previous section). Briefly, the GCN was constructed from the expression 
matrix calculated from the Filter-average approach. Here, a correlation threshold was chosen 
such that ~4,000 genes were connected within the graph. For each of the clusters shown in 
A), there are also B) the average expression profiles across Tabula Muris cell-clusters (x 
axis). Each panel represents gene signatures for either immune cell lineages, cell types or 
TRICs. The samples of each plot are ordered and coloured based on the bottom legend. 
Headings in bold represent the major cell types after which follow the expression profiles of 
related subtypes. mac: macrophage 
 
 Cell type-associated gene signatures were identified for macrophages (TMGC 26), 
monocytes (TMGC 37), neutrophils (TMGC 3), DCs (TMGC 20), B cells (TMGC 13), T 
cells (TMGC 20), Tregs (TMGC 27), NK cells (TMGC 12) and ILCs (TMGC 7 & 16). 
Except for NKT cells, all aforementioned gene signatures had a comparable ImmGC 
(enrichment adj. P value < 0.05). Genes associated with NKT cell were split across 
TMGCs, much like gating strategies adopted for flow-cytometry which require a series of 
markers to specify cell types, e.g. NKT cells showed a high expression of signature 
genes from both T cells (TMGC 18, 46 genes) and NK cells (TMGC 12, 65 genes). For 
similar reasons, TMGCs were identified for some cell subtypes including some TRICs, 
but not all the cell subsets.  
TMGCs were associated with ten macrophage subsets. Well-studied macrophage 
subtypes associated with relatively large TMGCs (indicative of their unique biology) were 
Kupffer cells (TMGC 4, 95 genes) and microglia (TMGC 10, 71 genes). Kupffer cells 
showed a high expression of known markers, e.g. Clec4f, Alb and Nr1h3, while microglia 
clusters included Cx3cr1, P2ry12, Tyrobp and key regulator Sall1. TMGC, 23 (36 genes) 
and 38 (18 genes) corresponded to the aortic macrophage TMCC 31 and a combination 
of TMCC 24 and 26, respectively. TMGC 23 contained aorta-associated genes including 
Fktn (highly expressed in the heart and mutations in which cause Fukuyama muscular 
dystrophy) (Ujihara et al., 2019), Hrh1 (G protein mediating muscle contraction and 
capillary permeability) (Bhuiyan et al., 2011), and Pppp2r5b (involved in myocyte 
function)(Lubbers and Mohler, 2016). TMGC 38 comprised of important myocyte 
homeostatic genes such as Nppa (required for myocyte growth and differentiation) (Kny 
et al., 2019) and Actc1 (cardiomyocyte survival) (Forte et al., 2018). TMGC 17 and 28 
showed a high average expression in tracheal macrophages of TMCC 6 and 27. TMGC 
17 comprised of various lung and endothelium associated homeostatic genes like Aqp1 
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(lung fluid transport) (Gao et al., 2013), Bpifa1 (upper airway immunity) (Tsou et al., 
2018), Eng, Egfr (Brechbuhl et al., 2014), and Cav1 (Krasteva et al., 2006). Certain 
genes within this TMGC were also linked with lung diseases, such as Kank2 (Zhang et 
al., 2018a), Prmt1 (Avasarala et al., 2015) and Cul4 (Wang et al., 2015) were associated 
with non-small cell lung cancer, and Tns1 with COPD (Soler Artigas et al., 2011). TMGC 
28 was enriched in the ImmGC 37 (adj. P value < 2.8x10-3) and found to have high 
expression in alveolar macrophages. The TMGC comprised of several chemokines 
(Ccl3, Ccl4 and Ccl12) supported by enrichment of “Leukocyte migration” GO term (adj. 
P value < 4.4x10-11). Macrophage TMCC 36 comprised of cells derived from various 
muscle-containing tissues, i.e. diaphragm, trachea and skeletal muscle. The group of 
cells showed high expression of genes from TMGC 22, which was enriched in muscle-
associated (adj. P value < 1.2x10-2) GO terms. Cell types spanning different tissues were 
also identified, like ILCs of TMCC 35 and 38. Corresponding to these TMCCs were the 
TMGC 16 and 7, respectively. In the Tabula Muris these cells originated from adipose 
and trachea, suggesting these TMCCs represented ILC subtypes, rather than tissue-
resident populations. TMGC 16 included Il17a known to be expressed in ILC3 and Il5 
associated with ILC2 was present in TMGC 7. Whilst, not all TMCCs or TRICs identified 
from the sample-to-sample network had a corresponding gene coexpression module, 
some were identified and are presented in Table 3.3. 
Table 3.3. Cell-clusters and associated gene coexpression clusters. 






Myeloid Cell lineage 
  2 
  11 
Monocyte Cell subtype 
7  37 
14  14 
TRICS 42 Fat 33 
Macrophage 
Cell type   26 
TRICS 
36 multiple 22 
1 Brain 10 
1 Brain 47 
6 Trachea 17 
9 Fat 55 
29 Kidney 64 
29 Trachea 28 
31 Heart 23 
39 Liver 4 
39 Liver 60 
multiple Aortic 38 
multiple Fat 21 
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Neutrophil Cell type   3 
Dendritic cell 
Cell type 
  20 
  51 
  56 
Cell subtype 
15  50 
20  8 
15, 33  40 
TRICS 
15 Lung 49 
33 Trachea 29 
2 Fat 6 
Dendritic cell, 
Monocyte Cell type 
  48 
  58 
Lymphoid Cell lineage   45 
B cell 
Cell type   13 
TRICS 
2 Liver 46 
2 Lung 54 
23 Lung 31 
43 Spleen 19 
multiple Spleen 30 
T cell 
populations Cell type 
  18 
  39 
CD4+ T cell TRICS 27 Lung 59 
CD8+ T cell Cell subtype 17,34 
 62 
TRICS 17 Lung 67 
Treg Cell subtype 41 
 27 
TRICS 41 Fat 57 
NK cell Cell type   12 
NK and NKT cell Cell type   32 
NKT cell TRICS 16 Liver 36 16 Fat 43 
ILC Cell subtype 
38  7 
35  16 
38  41 
 
3.4 Discussion 
The protective role of the immune system against infection is well understood, with many 
studies characterising their responses to activation in disease, injury and to artificial 
stimuli. In the past decade, efforts have also been made to understand tissue-specific 
roles of the immune system. TRICs maintain tissue homeostasis by acquiring various 
functions specific to the needs of the host tissue, e.g. phagocytosing surrounding 
debris/necrotic cells, or facilitating organogenesis during early development (Caputa et 
al., 2019, Munro and Hughes, 2017). These adaptations occur at the transcriptomic and 
epigenetic level and influence the cell’s response to inflammation which differs from their 
tissue naïve cells of the same cell type. The importance of these TRICs has been shown 
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in various diseases, e.g. microglia in neurodegenerative diseases as well as tumour-
associated ILCs and memory T cells (Dadi and Li, 2017, Djenidi et al., 2015, Colonna 
and Butovsky, 2017). Consequently, several studies are being conducted to further our 
understanding of their role in these tissues in health and disease. Recent efforts have 
investigated the cellular heterogeneity of a specific cell types across tissues (Mass, 2018, 
Sagebiel et al., 2019, Miragaia et al., 2019, Szabo et al., 2019), while others have 
compared immune cell populations (Lavin et al., 2014a, Yoshida et al., 2019). Such 
studies have generally only examined a few tissues, and while some focus on a single 
immune cell type, others investigate specific cell types using predefined markers. In this 
study, I utilise the growing public resources available from bulk and scRNA-Seq data 
derived from various tissues to compare immune cell populations. Through this analysis 
I also explore the contribution of tissues to immune cell heterogeneity. In the past, 
classification of immune cell subtypes has largely focused on their response to stimuli, 
and whilst some have been named based on their tissue of origin, e.g. Kupffer cells, 
microglia, little attention has been given to their tissue-specific function under 
physiological conditions.  This also raises the question of how we define cell types, for 
which in this chapter differences between cell types were examined, as identified by 
markers and those through unbiased clustering of single cells based on their 
transcriptomic profiles. Furthermore, through these analyses I developed techniques to 
identify cells based on their transcriptomes and construct GCNs to find coexpressing 
gene clusters associated to the cell classifications. 
To understand how well cell markers differentiate cell types two ImmGen datasets  were 
studied, the “Mononuclear phagocyte” dataset (the ImmGen and Benoist, 2016) which 
has only very recently been examined for the metabolic diversity of mononuclear 
phagocytes (Gainullina et al., 2020), and the “System wide” dataset used to define cis-
regulatory elements of the mouse immune system (Yoshida et al., 2019). On analysing 
the sample-to-sample network the observed grouping of samples was influenced by the 
cell type, tissue of origin and developmental state, as might be expected. Distinct groups 
were observed for certain macrophages such as alveolar, microglial, splenic and 
peritoneal macrophages. Furthermore, peritoneal macrophages were found to be 
proximal to monocytes. In contrast, Kupffer cells and aortic macrophages were closely 
related to one another. These associations could hint at the ontogeny of cell types, e.g. 
both liver and heart macrophage have a significant contribution from yolk-sac-derived 
macrophages of E8.5 (Epelman et al., 2014b) while peritoneal macrophages are 
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maintained through circulating monocytes in adults (Cassado Ados et al., 2015). Unlike 
myeloid cell types, all those from the lymphoid lineage were connected as part of a single 
component and clustered together based on cell types. 156 gene modules were found 
associated with different cell biology which ranged from cell lineages to cell subtypes 
such as TRICs. Such an analysis to identify TRICs signatures has not been conducted 
using these datasets and provide gene signatures for several known TRICs as defined 
by markers. These gene signatures highlighted TRIC associated homeostatic genes 
including transcription factors e.g. Sall1 (microglia), Gata6 (peritoneal macrophage), 
Spic (splenic macrophage) and Pparg (alveolar macrophage) (Mass, 2018). 
Interestingly, only a few gene clusters were specific to cell types as defined by markers, 
e.g. a subset of splenic macrophages. Hence, instead of defining cell types from cell-cell 
clustering based on their entire transcriptome, a better way to define cell types/clusters 
may be to use gene coexpression patterns, especially for those cell types with few genes 
differing in expression from other cell types. The gene cluster corresponding to Kupffer 
cells (cluster 43), did not contain the newly identified transcriptional regulator Id3 (Mass 
et al., 2016), as the gene displayed expression in some lymphoid cells as well. Indicative 
of a multifunctional role of transcriptional factors that are maybe required in combination 
to prompt a unique cell identity. 
The above analysis showed that cell types defined by markers did not always separate 
well when considering the whole transcriptome. This could suggest: 1) that certain 
markers may not be specific and instead encompass several cell types e.g. F4/80 was 
used to isolate microglia (Lawson et al., 1990) in the CNS under the assumption of a 
lack of other CNS macrophages (Greter et al., 2015). Therefore current markers to 
isolate microglia are more specific like Cx3cr1 and Tmem119 (Bennett et al., 2016). The 
use of scRNA-Seq to identify cell types in an unbiased way should help mitigate such 
misconceptions. 2) Using the entire transcriptome may not be sufficient/appropriate in 
differentiating cell types, especially for those cell types distinguished by a few marker 
genes, especially in the case of closely connected cell types observed in the ImmGen 
sample-to-sample network, including DC subtypes and lymphoid cells, which in GCNs 
show specific gene coexpression clusters. Furthermore, classifying cell types may 
require other omics and functional studies.  
As an unbiased approach, immune cells from the Tabula Muris dataset were also 
studied. The dataset comprises of scRNA-Seq data derived from 20 different tissues. 
Here, immune cells were selected for analysis based on the author's original cell 
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annotation. However, examination of these cells using a cell-to-cell similarity network, 
suggested the original annotation could be improved upon, e.g. different myeloid cells 
like monocytes and neutrophils could not be differentiated within the network, and the 
annotation included broad groupings such as leukocytes and myeloid cells. Here, I 
developed a novel method which utilized gene expression profiles of known cell types to 
help annotate unknown cells based on their transcriptomic profile. Unlike other 
methodologies, the approach annotated entire cell clusters to reduce the influence of 
misannotated cells, i.e. only when the majority of cells within a cluster were of the same 
annotation was the cluster annotated as such. The approach added significant detail to 
the original annotation, and in certain cases revealed TRICs, such as aortic 
macrophages and splenic B cells. Further granularity was added to this by clustering the 
data. However, much like our conclusion from ImmGen, transcriptome wide comparisons 
of cell types could be limited to broad cell type annotations, hence further investigations 
were made for cell subtypes like TRICs by examining gene coexpression modules.  
The field of scRNA-Seq has brought forth several methodologies to account for the noise 
and heterogeneity within the data, involving clustering (Lin et al., 2017), imputation 
(Eraslan et al., 2019), dimensionality reduction (Sun et al., 2019) and trajectory analysis 
(Wolf et al., 2019). However, few studies have analysed coexpressing genes (Chen and 
Mar, 2018, Pratapa et al., 2020) and rather rely on differential expression analysis to 
define cell types. Here, three approaches to construct GCNs from scRNA-Seq data were 
developed and evaluated to help identify gene coexpression modules supporting the cell 
classifications from Tabula Muris. The methods extended from the idea of MetaCells 
(Baran et al., 2018), which aggregates reads across near identical groups of cells to 
improve the signal within scRNA-Seq data. Here, similar approach was adopted to 
reduce the noise and variation within the data to help construct GCNs with a higher 
distribution of correlation values relative to that generated from the entire dataset of cells. 
By aggregating gene expression values over clusters one can capture the variation 
across cell types rather than cells. Since, each cell type is defined by one bin/sample the 
correlation space is balanced giving equal weightage to each cell type, especially in 
cases where there is a large discrepancy in the number of cells between cell types. 
Although the approach is yet to be compared with other methodologies, it addresses two 
issues, the need for analysing inter-cell type variation rather than intra-cell type variation 
and having a balanced correlation space. To construct GCNs from Tabula Muris by 
aggregating data across cell types/clusters two factors were additionally considered, 
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filtering expression outlier (including spikes and dropouts) and introducing “replicates” or 
Subcells by subclustering cells within a cluster. These two ideas addressed key issues 
in defining correlations between samples from RNA-Seq data, the noise (spikes and 
dropouts) and variation (intra-cell types variation). Accordingly, three approaches were 
employed 1) simple aggregation/averaging read across cells in clusters, 2) averaging of 
reads within subclusters and 3) filtering the expression before averaging within clusters. 
Preliminary analysis for the distribution of correlations found similarities between the 
average and Subcell approach while also revealing lower correlation values for the 
Subcell method. This was understandable as the method involved a greater number of 
bins/Subcells to represent a cluster relative to the other two approaches. A simple 
averaging within clusters and subclusters revealed a great number of gene modules 
associated with spikes in expression of few cells. This effect was more pronounced in 
clusters with a small number of cells as each cell’s contribution was higher relative to 
larger clusters having hundreds of cells. Some of these gene clusters were further shown 
to be absent of any known biology based on GO annotations. In contrast, filtering and 
then averaging within clusters resulted in fewer gene modules associated with technical 
artefacts. The factors discussed herein could influence other GCN construction 
approaches which may be biased by dominant (cell numbers) cell types within the 
dataset and to technical artefacts. However, this would require a formal comparison. The 
Filter-average approach was taken forward to examine the coexpressing genes and 
biology of TRICs from the Tabula Muris. 
To support the cell classifications, gene coexpression clusters were annotated based on 
their expression profile and validated using the results from the ImmGen analysis and 
GO annotations. 44 gene clusters showed high expression for either certain cell linages, 
cell types, cell clusters or TRICs. Several of these signatures were found to overlap with 
the ImmGen gene clusters for the same cell type. In line with our current knowledge of 
TRICs the most diverse population was of macrophages having 11 gene clusters, 
including associated with the brain, trachea, fat, kidney, liver and aorta.  Second, were 
DCs with 7 gene clusters (lung, trachea and fat) and third B cells with 6 gene clusters 
(liver, lung and spleen). Through literature mining several homeostatic genes were 
identified supporting gene clusters associated with eight of the tissue-resident 
macrophage populations. Furthermore, signatures were found for cell types dependent 
and independent of tissue, e.g. DC clusters from the lung and trachea shared a common 
biological gene signature while also having signatures unique to their tissue. While few 
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such cases were observed cell types largely segregated on tissue, signifying this to be 
the dominant factor for cell type variation. Although a further comparison is required with 
cell types identified in literature this study covers a wide range of cell types across tissues 
and supports them with relevant coexpressing gene clusters.  
In summary, this chapter has used both biased and unbiased approaches to examine 
the tissue dependence of immune cell diversity based on their transcriptomic profile. The 
unbiased Tabula Muris analysis revealed 44 gene clusters associated with the hierarchy 
of immune cell types from lineages to cell subtypes, with the most numerous being those 
associated with TRICs, indicative of their unique biology. Furthermore, these 
observations aligned with well characterised marker-defined cell types from the ImmGen. 
Indeed, similar analyses on larger datasets will help us appreciate the full spectrum of 




4. Chapter 4: Human tissue-resident immune cell signatures from bulk 
tissue RNA-Seq data 
4.1 Introduction 
In previous chapters TRIC signatures were derived using data generated from various 
transcriptomic platforms and across species. The utility of these signatures was also 
demonstrated. For instance, it was in shown in chapter 2 that by deriving the homeostatic 
signature of human microglia, one could then examine the cell’s profile and proportion 
across different brain regions and conditions in health and disease. Accordingly, in 
chapter 3 the analysis was extended to derive homeostatic TRIC signatures across 
different mouse tissues at the cellular level. This resolution helped determine the biology 
of these immune cell types across tissues and the contribution of tissue-dependent 
variation towards cellular heterogeneity. Together these analyses in mouse and human 
pointed towards the potential to deconvolute TRIC signatures from bulk RNA-Seq data 
for human tissues. 
Similar to studies in mouse, researchers have investigated the heterogeneity of human 
derived TRICs. These studies span several cell types including tissue-resident memory 
T cells (Kumar et al., 2017), regulatory T cells (Niedzielska et al., 2018), ILCs (Ricardo-
Gonzalez et al., 2018), NK cells (Crinier et al., 2018), macrophages (De Schepper et al., 
2018), B cells (Zhao et al., 2020) and DCs (Alcántara-Hernández et al., 2017), derived 
from the lung, liver, spleen, gut, skin, adipose, blood, bone marrow, brain and thymus. 
Different methodologies have been adopted to study the transcriptomic, proteomic and 
epigenetic profiles of these cells, e.g. bulk-RNA-Seq, scRNA-Seq, CyTOF and ATAC-
Seq. The experimental design of these studies can be generalised into one of two 
approaches; the investigation of multiple or all cell types within a tissue, and the 
examination of a single cell type across multiple tissues. The first provides information 
on the biology of individual tissue cell types and accordingly helps understand the tissue 
as a whole. For example, analysis of each cell type from the liver (hepatocytes, liver 
endothelial cells, cholangiocytes, stellate cells, Kupffer cells, monocytes, T cells, NK-like 
cells and B cells) using scRNA-Seq provided a description of their function, thereby 
informing us of the different biology within the tissue (MacParland et al., 2018). However, 
in this chapter the focus was on studying the variability across TRIC types across tissues. 
The aforementioned studies which analysed a single cell type across tissues tended to 
describe the cell’s core signature and its tissue specific functions, as have been 
described for tissue-resident Tregs in non-lymphoid tissues (Miragaia et al., 2019). As a 
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reference for tissue-resident populations, many studies follow a common procedure of 
comparing TRICs with the corresponding cell types in blood or lymphatic tissues (for 
lymphocytes). Such studies have highlighted tissue specific properties such as genes 
associated with cell migration which are required to establish tissue residency (Miragaia 
et al., 2019). In contrast to such exploratory analyses, certain studies have focussed on 
the relevance of TRICs in pathological conditions (Savas et al., 2018) or their response 
to stimuli (Woodward Davis et al., 2019). Finally, TRICs have also been compared across 
species to reveal evolutionary changes in cellular heterogeneity and their functions. A 
notable example being the comprehensive examination of microglia across eight species 
(human, macaque, marmoset, sheep, mouse, hamster, chicken, and zebrafish) to 
examine the changes within microglial populations through evolution (Geirsdottir et al., 
2019). In summation, these studies inform us of TRICs with respect to their core 
signature, tissue specific functions, tissue-dependent subsets, their abundance, and 
their conservation across species. This study addresses similar research questions by 
utilising GTEx, a human tissue expression atlas. 
Similar to our analysis of human microglia in chapter 2, a thorough examination of human 
TRIC expression signatures was conducted in this chapter by utilizing the GTEx resource 
(Lonsdale et al., 2013). The resource comprises of bulk RNA-Seq data derived from 33 
tissues across 52 regions and is the most comprehensive human tissue transcriptomic 
resource currently available. Using this dataset, the following questions were 
investigated: 1) the distribution immune cell types across tissues; 2) genes unique to cell 
types and those that are shared amongst them across tissues; and 3) how they compare 
to mouse TRIC signatures. To do so, a set of reference immune signatures (RIS) which 
represent core genes for cell types (macrophage, B cell, T cell, NK cell, neutrophils and 
plasma cell) were first defined. These gene sets guided the derivation of TRIC signatures 
within individual tissues, which was performed using GCNs. Subsequently, these 
signatures were compared with one another and with TRIC signatures previously derived 
from the mouse RNA-Seq data in chapter 3.  
 
4.2 Material and methods 
4.2.1 Data preprocessing 
Human tissue transcriptomics data was downloaded from the GTEx portal 
(https://www.gtexportal.org/) (Lonsdale et al., 2013). The dataset (version 7) is a 
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comprehensive collection of RNA-Seq data from various human tissues. It includes 
samples from 33 tissues which are further sub-divided into 52 regions. For these 
analyses, tissues with a minimum of 20 samples were considered, thus excluding 
samples from the bladder (n = 11), cervix (n = 11) and fallopian tube (n = 7). Furthermore, 
samples derived from Epstein-Barr virus transformed lymphocytes were excluded as 
they were not considered relevant to this work. The filtered dataset was derived from 28 
tissues (n = 11,529, across 48 regions), where the number of samples per tissue varied 
from 45 to 564. Due to the large number of brain regions, samples from similar regions 
were merged into a single dataset, e.g. all cortex-related regions were treated as one. 
This was done for the cerebellum, basal ganglia and cortex, producing a single 
expression matrix for each. Two rounds of quality control were conducted for each of the 
tissues. First, a sample-to-sample network was generated at a Pearson correlation 
coefficient threshold of r ≥ 0.9 for each tissue region, with lowly expressed genes 
(maximum expression <1 TPM) filtered from the input gene expression matrix. In each 
case the majority of samples were connected as a single network component. Outlier 
samples that were singlets i.e. unconnected to other samples were filtered out. Second, 
samples from each tissue region were filtered on the basis of their expression of ImSig 
gene signatures (Macrophages, Monocytes, Neutrophils, B cells, Plasma cells, NK cells, 
T cells, and Interferon). Samples were removed if they had an average expression for 
any of the signatures greater than 3 standard deviations away from the linear or the 
geometric mean. Resultantly an expression matrix was produced for each of the 28 
tissues which included 10,461 samples. 
4.2.2 Deriving the reference immune signature 
To generate RISs a GCN was generated from a dataset comprising of a subset of 
samples from each tissue of the GTEx. To balance the contribution of each tissue to this 
combined dataset an equal distribution of 100 samples per tissue type (where available) 
were selected. In tissues where fewer than 100 samples were available, all the samples 
from these tissues were considered. Additionally, where a tissue was represented by 
more than one region, equal number of samples from each tissue region were selected 
such that the samples from the tissue totalled hundred. For example, 100 samples were 
selected from the colon where 50 samples were taken from each of the regions, the 
“Sigmoid” and “Traverse” region. To decide which samples should be selected for the 
combined dataset, samples from each tissue region were first ranked based on their 
average expression of the individual ImSig signatures. As a result, each sample had nine 
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rankings corresponding to the individual ImSig signatures and samples showing the 
highest variation in their ranking across signatures were preferred. For instance, samples 
with a high average expression of T cell signature genes and a low expression of those 
for B cells would be preferentially selected over samples with a high expression of both 
cell types. Theoretically, such an approach would include samples across which the 
proportions of immune cell types varied the most. Therefore, this would be ideal for gene 
coexpression analysis which is driven by the variation of biological signals/gene 
expression across samples. The resultant combined dataset amounted to 2,719 
samples. 
To identify genes associated with potential cell subtypes, coexpressed genes went 
through two rounds of clustering (Table S4.1 & 4.2). First, genes associated with the 
immune system were identified i.e. clusters enriched in ImSig genes. For this a GCN was 
generated from the combined dataset at a Pearson correlation threshold of r ≥ 0.83 in 
order to accommodate close to 15,000 genes. The resultant GCN was clustered using 
MCL (Dongen, 2000) with an inflation of 1.7  Each cluster was tested for an enrichment 
in ImSig gene signatures using the Fischer’s exact test. The majority of enriched (adj. P 
value < 0.05) clusters formed a subnetwork which were separate from other components 
of the graph. These clusters comprised of 1,090 genes and were considered as the 
immune component of the network. Using this subset of genes from the combined 
dataset a GCN was reconstructed using the kNN algorithm (k = 5) and a correlation 
threshold of r ≥ 0.82. The graph was clustered into 64 clusters using an inflation of 1.7. 
These clusters were annotated for a given cell type depending on the ImSig cell 
signatures in which they were enriched (adj. P value < 0.05) , and marker genes e.g. for 
B cells (CD19 and BLK), endothelial cells (ICAM2), macrophages (complement family, 
CSF1R and AIF1), NK cells (KLRK and GZM family), neutrophils (CSF3R and FCGR3B), 
plasma cells (IGH family) and T cells (CD3 chains). Gene clusters associated with certain 
cell types of the myeloid lineage, including macrophages, monocytes and DCs could not 
be differentiated and were hence classified as ““Mac-Mono-Den”. The genes with the 
“Mac-Mono-Den” annotation were divided into two groups as some of these clusters 
were segregated i.e. not directly connected with one another in the graph. A similar case 
was observed for “T cells”. Clusters which included genes from multiple ImSig signatures 
were annotated as “Immune”. Cluster 18 which comprised of mitochondrial and 
ribosomal genes was not considered for downstream analyses.  
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4.2.3 Derivation of human tissue-resident immune signatures 
To derive TRIC signatures a GCN was constructed for each of the 21 tissues individually. 
Here, the quality-controlled data without down-sampling was considered. A GCN was 
constructed for each tissue at a Pearson correlation threshold at which ~15,000 genes 
were present in the graph (Table S4.3). For the artery, liver, pancreas, pituitary, small 
intestine, spleen and stomach, genes representing multiple RIS clustered together, 
hence, GCNs were reconstructed at a higher Pearson correlation threshold to include 
~10,000 genes within the graph. Clustering was carried out for each tissue using MCL 
with an inflation of 1.7. The annotation of gene clusters for a given cell type was carried 
out in three steps. Broadly, the strategy first identified which immune cell types were 
present in the tissue i.e. a confident set of core clusters representative of a specific 
immune cell type, followed by the aggregation of neighbouring clusters which likely 
consisted of immune genes. The three steps involved, 1) constructing the GCN and 
clustering it, as mentioned above. 2) Identifying gene clusters that confidently 
represented immune cell types i.e. clusters having a significant enrichment in a particular 
RIS cell type (adj. P value <10-10) and included cell type associated markers. In majority 
of tissues NK cell and T cell markers clustered together these were annotated as “T cell 
– NK cell”. 3) Those clusters neighbouring the core were annotated for that cell type if 
they were enriched in RIS or if they were not connected to any other cluster. In cases 
where the clusters were neighbouring core clusters associated with multiple immune cell 
types, they were left unannotated.  
 
4.3 Results 
4.3.1 Reference immune signatures for human tissues 
TRIC signatures were derived using GCNs from human bulk tissue transcriptomics data 
drawn from the GTEx project (v7). The dataset was subsetted by including tissues which 
had more than 20 samples, while excluding samples derived from EBV-transformed 
lymphocytes, thus leaving 11,529 samples from 28 tissues (43 tissue regions). Quality 
control was performed on each of the tissue regions by removing outlier samples which 
poorly correlated with other samples from that region. Additionally, we sought to remove 
samples with elevated levels of inflammation, as their presence in the dataset would 
drive inflammation associated immune signatures and potentially obscure homeostatic 
TRIC signatures. To identify such signatures, we used ImSig, a collection of cell/pathway 
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signature gene lists representative of different immune cells derived from samples under 
pathological conditions. The average expression of each signature was calculated for 
individual samples and those beyond 3 standard deviations of the geometric and linear 
mean for a given tissue were removed. The quality-controlled data comprised of 
expression matrices for each of the tissues amounting to 10,461 samples (Table 4.1).  
Table 4.1 Sample distribution after quality control and in the combined dataset. 





Adipose  Subcutaneous 442 400 50 Visceral (Omentum) 355 310 50 
Adrenal Gland Adrenal Gland 190 170 100 
Artery   
Aorta 299 267 33 
Coronary 173 153 33 
Tibial 441 403 33 
Brain   
Amygdala 100 94 12 
Caudate (basal ganglia) 160 148 6 
Nucleus accumbens (basal 
ganglia) 147 134 4 
Putamen (basal ganglia) 124 118 2 
Cerebellar Hemisphere 136 123 6 
Cerebellum 173 167 6 
Anterior cingulate cortex 
(BA24) 121 111 4 
Cortex 158 146 3 
Frontal Cortex (BA9) 129 122 5 
Hippocampus 123 117 12 
Hypothalamus 121 112 12 
Spinal cord (cervical c-1) 91 86 12 
Substantia nigra 88 81 12 
Breast  Mammary Tissue 290 266 100 
Colon  Sigmoid 233 212 50 Transverse 274 248 50 
Esophagus   
Gastroesophageal Junction 244 223 33 
Mucosa 407 377 33 
Muscularis 370 342 33 
Fibroblast Transformed fibroblasts 343 306 100 
Heart  Atrial Appendage 297 273 50 Left Ventricle 303 277 50 
Kidney  Cortex 45 39 39 
Liver Liver 175 161 100 
Lung Lung 427 376 100 
Minor Salivary 
Gland Minor Salivary Gland 97 86 86 
Muscle  Skeletal 564 501 100 
Nerve  Tibial 414 373 100 
Ovary Ovary 133 116 100 
Pancreas Pancreas 248 230 100 
Pituitary Pituitary 183 165 100 




Not Sun Exposed 
(Suprapubic) 387 356 50 
Sun Exposed (Lower leg) 473 426 50 
Small 
Intestine  Terminal Ileum 137 121 100 
Spleen Spleen 162 139 100 
Stomach Stomach 262 235 100 
Testis Testis 259 234 100 
Thyroid Thyroid 446 406 100 
Uterus Uterus 111 100 100 
Vagina Vagina 115 106 100 
Whole Blood Whole Blood 407 368 100 
Bladder Bladder 11 NA NA 
Cells  Cells - EBV-transformed lymphocytes 130 NA NA 
Cervix  Ectocervix 6 NA NA Endocervix 5 NA NA 
Fallopian 
Tube Fallopian Tube 7 NA NA 
 
Total number of samples downloaded from the GTEx (v7) portal (33 tissues, 52 regions). Those 
tissues which have not been considered for the study were not QC’d and accordingly are marked 
as “NA”. Downstream GCN analysis for deriving TRIC signature was conducted for individual 
tissues highlighted in green. The data was also downsampled to produce the combined dataset 
used to identify the RIS downstream. 
 
To guide the derivation of immune cell signatures for each tissue, we required a set of 
markers genes or signatures for these cell types. Although, the ImSig signatures 
characterised these cell types, they were derived from samples under pathological 
conditions. Therefore, a new immune cell signatures were derived from a combined 
dataset of the different GTEx tissues using GCN analysis, ergo these would represent 
homeostatic RIS. To have an equal contribution from each tissue to maintain a balanced 
correlation space the data was down sampled to 100 samples per tissue (where 
possible) and equally sampling regions for that tissue where more than one was defined. 
Each tissue was downsampled independently, first, for a given ImSig signature all 
samples were ranked, and this was done for each of the seven ImSig cell signatures 
thus generating seven ranks for each sample. Subsequently, samples with the most 
variation between their rankings were given priority. Such an approach would select 
samples across which the expression of immune signatures varied the most i.e. the 
proportion (cell abundance) of different cell types varied the most across these samples. 
This procedure of downsampling would be ideal for GCN analysis, as it would balance 




Figure 4.1. Derivation of a human reference immune signature.  
Procedure for identifying homeostatic immune cell signatures from a subset of GTEx samples 
from each tissue. A combined dataset was produced by down-sampling to 100 samples from 
each of 28 human tissues.  First (top left), a GCN of the top ~15,000 correlated genes was 
constructed (~8.6M edges) using r ≥ 0.83 and clustered using MCL (inflation = 1.7). A distinct 
region of the network (highlighted in green) was enriched in ImSig genes. These 1,090 genes 
were reanalysed (centre panel) by constructing a GCN (4,156 edges) using a kNN (k = 5), r ≥ 
0.82 and clustered using MCL (inflation = 2.2). Highlighted, are the subsequent annotations for 
gene clusters of the network for immune cell types/subtypes. 
 
From the combined dataset, RIS were derived in two stages (Figure 4.1). First, a GCN 
was constructed from the combined tissue dataset using an r threshold value of ≥ 0.83. 
The 15,573 gene network connected by 8,648,165 edges was clustered using MCL with 
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an inflation of 1.7.  Interestingly, the majority of clusters enriched (adj. P value < 0.05) in 
ImSig signatures localised to a distinct area of the graph (Table S4.1). This “immune 
segment" which comprised of 1,090 genes was re-examined for potential cell subtype 
signatures using a GCN. Using this gene-set a kNN graph was constructed at a 
correlation threshold of r ≥ 0.82 and k = 5. The graph consisted of all the genes from the 
immune segment which were connected through 4,156 edges and clustered using MCL 
with an inflation of 2.2. Each of the resulting 64 clusters were annotated as being 
associated with a given cell type based on their enrichment in ImSig signatures and 
immune marker genes (Table S4.2). Genes were annotated for one of the 12 classes 
including nine immune cell types, MHC class 2, mitochondrial (cluster 18) and “immune” 
clusters. These “immune” clusters were annotated as such because they consisted of 
genes from multiple ImSig signatures, hence making it difficult to provide a single cell 
type annotation for these genes. As signatures of the different myeloid cell types 
(monocyte, macrophage and DC) were difficult to differentiate in the GCN, they were 
classified under a single annotation of macrophage-monocytes-dendritic cells (Mac-
Mono-Den). For the majority of cell types, their associated gene clusters were 
concentrated within a region of the network. However, clusters for certain cell types were 
segregated, i.e. disconnected within the graph, suggesting that they could represent 
different cell subtypes. This was observed for Mac-Mono-Den and T cells where each 
had two groups of gene clusters spatially separated within the network. This distinction 
was considered for annotating signatures, e.g. T cells were identified by two signatures 
“T cell 1” and “T cell 2”. Such granularity in defining cell signatures could aid in 
distinguishing cell subtypes in downstream analyses by increasing the statistical power 
of enrichment analyses where an immune cell subtype maybe represented by only a few 
genes. The final RIS included 1,073 genes annotated for 11 signatures, as the 
mitochondrial gene cluster was excluded (Table S4.2).  
 
4.3.2 Deriving tissues-resident immune cell signatures from human tissue 
transcriptomics 
To derive TRIC signatures a GCN was constructed for each of the 21 tissues and genes 
were annotated based on the following criteria. For every tissue a GCN was constructed 
using a specific Pearson correlation threshold (Table S4.3) to produce networks with 
approximately 15,000 genes, which were subsequently clustered using MCL with an 
inflation of 1.7. For certain tissues immune signatures were difficult to segregate from 
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the GCN (artery, liver, pancreas, pituitary, small intestine, spleen and stomach) i.e. 
known markers of different cell types clustered together within the GCN such as T cell 
(CD3E and CD3D) and Mac-Mono-Den (AIF1 and CSF1R). To help segregate such 
clusters into clusters associated with distinct cell types, GCNs were reconstructed at 
higher thresholds to include approximately 10,000 genes. The parameters for each 
network are described in Table S4.3. Gene clusters were annotated for immune cell 
types in three steps. As shown for the liver (Figure 4.2), first GCNs were constructed, 
clustered and clusters enriched for RIS were identified (adj. P values < 0.05). Second, 
as different tissues have distinct combinations of immune cell types present within them 
it was first necessary to determine which immune cell types were present in the tissue 
by identifying core gene clusters for each immune cell type. A core cluster associated to 
a certain cell type was identified based on its enrichment (adj. P value < 10-10) of that 
RIS and known marker genes for that cell type. Third, clusters neighbouring core gene 
clusters were annotated for the associated cell type provided they were enriched in RIS 
or were only connected to the clusters considered from step 2. However, in cases where 
a cluster was neighbouring core clusters of multiple cell types they were left unannotated. 
Thus, TRIC signatures were derived from each of the 21 tissues by constructing a GCN 




Figure 4.2. Derivation strategy of tissue-resident immune cell signatures from 
individual human tissues shown for liver. 
The three steps used to identify immune cell signatures for a given tissue. 1) A GCN was 
constructed for each tissue with correlation threshold set to keep ~15,000 genes within the 
network. In certain tissues, where signatures of different immune cell types could not be easily 
discerned, GCNs with ~10,000 genes were constructed.  All graphs were clustered (inflation = 
1.7) and clusters examined for their enrichment of RIS. Gene clusters annotated for a certain 
biology have all genes coloured based on the bottom right panel. 2) To identify which immune 
cells were present in the tissue a set of confident core clusters were selected for each cell type 
based on their enrichment and cell type marker genes. 3) The final annotation included clusters 










Figure 4.3. Immune cell signatures from human tissues. 
TRIC signatures are highlighted across GCNs constructed for each of the 21 tissues from 
GTEx. Each panel consists of a GCN constructed from gene expression data of the respective 
tissue. Networks were constructed using a correlation threshold such that the resultant network 
included 15,000 genes, while for certain tissues (artery, liver, pancreas, pituitary, small 
intestine, spleen and stomach) as clusters associated with different cell types were not easily 
differentiated a higher correlation threshold was used to accommodate 10,000 genes in the 
network. Within the network of genes (grey) the derived immune cell signature genes are 
highlighted (coloured) and annotated. B: B cell, NK: natural killer cell, N: neutrophil, TN: T cell 





After the analysis, 91 signatures were identified across 21 tissues describing 7 TRIC 
annotations (Mac-Mono-Den, neutrophil, plasma cell, B cell, T cell, NK cell and T cell-
NK cell). In majority of tissues, marker genes for T cells and NK cells co-clustered and 
were instead annotated as “T cell-NK cell”. Signature sizes varied from 4 genes including 
the B cell signature from the heart (CD19, BLK, FCRL2 and MS4A1) to Mac-Mono-Den 
signature from the minor salivary gland containing 437 genes. Not all immune cell type 
signatures were identified across tissues. The Mac-Mono-Den and T cell-NK cell 
associated signatures were identified in all 21 tissues, followed by plasma cells (20 
tissues), neutrophils (14 tissues) and B cells (11 tissues) (Figure 4.4). Certain tissues 
including colon, lung and spleen, contained all the six types of immune cell signatures (6 
signatures). The least number of TRIC signatures were identified for the brain, this 
included two signatures, the Mac-Mono-Den and T cells-NK cells. 
 
Figure 4.4. Immune cell signature sizes across tissues 
The number of genes (size and colour) annotated for a given immune cell type (y axis) across 
the 21 tissues of the GTEx (x axis) (Lonsdale et al., 2013). 
 
The overlapping biology between T and NK cells was also observed when comparing 
the number of genes overlapping between immune cell signatures across tissues 
(Figure 4.5). Signatures associated with T cell, NK cell and T cell–NK cell showed 
preferential overlap relative to other cell types as they had higher values (close to 1) of 
Jaccard index. Based on the same index Mac-Mono-Den largely shared signature genes 
with neutrophils and T cell-NK cells while B cell signatures overlapped most with those 
of T cell-NK cells. The number of genes unique to a certain cell classification varied from 
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30 genes identified for NK cells to 1,012 genes for Mac-Mono-Den. Across tissues 
plasma cell signature genes overlapped the least with any of the other signatures (93 
overlapping genes), while Mac-Mono-Den signatures genes (393 genes) overlapped the 
most with other cell classifications. 
 
Figure 4.5. Gene overlap across tissue resident immune cell signatures. 
The number of genes annotated for each of the seven immune cell signatures across 21 tissue 
transcriptomics datasets from the GTEx. The matrix shows the number of common genes 
between the different immune cell type signatures. Additionally, the colour of the cells 
represents a metric of comparing inter-signature overlap, that is the Jaccard index where a 
value of 1 (red) signifies perfect overlap between gene lists and that of 0 (purple) represents 
no overlap. 
 
Next, we examined the genes associated with the different immune cell types and how 
strong this association was based on the number of times they associated with an 
immune cell signatures across the various tissues. This analysis revealed high confident 
core genes for cell types while also highlighting genes uniquely associated with an 
immune cell type from a certain tissue (Table 4.2). For example, four genes (C1QA, 
C1QB, C1QC, and MS4A6A) were found associated with Mac-Mono-Den in all 21 
tissues, again highlighting the ubiquitous distribution of these cell types relative to others. 
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Other cell types had fewer signatures derived across the same tissues, indicative of their 
presence in limited number of tissues as was observed in Figure 4.5B. High confident 
genes or core genes of an immune cell types were considered as those which were 
associated with the cell types in more than half the number of tissues the cell type 
signature was derived in e.g. Mac-Mono-Den signatures were identified in all 21 tissues 
and accordingly the 124 genes associated with Mac-Mono-Den in 11 tissues or more 
were considered as high confidence. Interestingly, for a given cell type only a few core 
genes were identified across all the tissues. In contrast, several genes were associated 
with a cell type in a single tissue e.g. 142 genes were associated with NK cell signatures 
only in single tissues while 828 genes were associated with Mac-Mono-Den. Further 
examination of high confidence genes revealed known markers and gene families 
associated with the respective immune cell type (Table 4.3). High confidence genes for 
Mac-Mono-Den included those from gene families such as Fc fragment of IgG receptors 
(FCER1G, FCGR1A, FCGR1B, FCGR2A and FCGR3A), scavenger receptors 
(CLEC7A, CD163, CD68, MSR1 and STAB1) and the complement system (C1QA, 
C1QB, C1QC, C3AR1 and C5AR1) (Hirayama et al., 2017). The majority of genes 
associated with plasma cells were of the Immunoglobulin family while those for B cells 
included known markers (CD19, CD79A and BLK) and members of the Fc Receptor-Like 
(FCRL1, FCRL2, and FCRLA) (Capone et al., 2016). T cells were associated with CD3 
molecules (CD3D, CD3E and CD3G) and associated proteins (CD8A, ITK, ICOS, and 
LCK) (Smith-Garvin et al., 2009). NK cell high confident genes included EOMES, which 
is a known transcription factor for the cell type (Simonetta et al., 2016). Additionally, 
genes included killer cell lectin like receptors (KLRB1, KLRC2, KLRC3, KLRC4, KLRD1, 
KLRF1, KLRG1 and KLRK1) and granzymes (GZMA, GZMH and GZMM) associated 
with NK cells development and cytotoxic activity, respectively (Abel et al., 2018). A 
combination of high confident genes for T cells and NK cells was observed for the T cell-
NK cell classification, suggesting that the classification did capture signatures of both 
cell types where it was difficult to separate them. Genes associated with neutrophils 
included chemotactic receptors like formyl peptide receptors and C-X-C motif chemokine 
receptor (Leoni et al., 2015) and L-selectin required for neutrophil migration towards sites 
of inflammation (Sheshachalam et al., 2014). Thus, the GCN approach was able to 
capture core immune cell type signatures from the 21 different tissues. In contrast, 
identifying TRIC associated genes was more challenging as it was difficult to segregate 
true TRIC associated genes from false positive and false negatives based on the GCN 
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analysis alone. Although, on examining certain known TRIC genes such as microglial 
genes, CX3CR1 and P2RY12 were observed in Mac-Mono-Den signatures of the brain.   
 












21 4 0 0 0 0 0 0 
20 5 8 0 0 0 0 0 
19 13 12 0 0 0 0 0 
18 5 8 0 0 0 0 0 
17 13 10 0 0 0 0 0 
16 17 15 0 0 0 0 0 
15 13 6 0 0 0 0 0 
14 12 12 0 0 0 0 0 
13 16 5 0 0 0 4 0 
12 13 10 0 0 0 3 0 
11 13 14 2 0 0 9 2 
10 18 13 2 0 0 9 1 
9 25 9 2 0 0 11 1 
8 25 19 4 1 0 13 3 
7 21 12 1 3 0 10 3 
6 24 21 8 2 0 20 11 
5 33 28 6 6 0 15 7 
4 48 20 4 17 0 29 6 
3 97 39 17 19 6 29 19 
2 162 60 33 56 26 53 46 
1 828 418 257 181 142 247 413 
 
The table shows the number of genes which are associated with a certain immune signature 
(column 2 to 7) and over how many tissues (column 1: number of tissues). The colours represent 
the number of genes from green to red representing low to high counts. 
 
Table 4.3 High confidence immune cell associated genes 
Cell type Genes 
Mac-
Mono-Den 
ADAP2, AIF1, ALOX5AP, AOAH, APOBR, ARHGAP30, ARHGAP4, ARRB2, 
BIN2, BTK, C1orf162, C1QA, C1QB, C1QC, C3AR1, C5AR1, CCR1, CD163, 
CD180, CD300A, CD300C, CD33, CD37, CD4, CD53, CD68, CD84, CD86, 
CLEC7A, CORO1A, CSF1R, CTSS, CYBB, CYTH4, DOCK2, DOK2, DOK3, 
EBI3, ENSG00000268802.1, EVI2A, EVI2B, F13A1, FCER1G, FCGR1A, 
FCGR1B, FCGR2A, FCGR3A, FERMT3, FGD2, FOLR2, FPR3, GPR34, 
GPSM3, HAVCR2, HCK, HCLS1, HCST, HK3, IFI30, IGSF6, IL10RA, IRF5, 
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ITGAM, ITGB2, LAIR1, LAPTM5, LAT2, LCP1, LILRA2, LILRA6, LILRB4, 
LINC01272, LRRC25, LST1, LY86, MNDA, MPEG1, MS4A4A, MS4A6A, 
MS4A7, MSR1, MYO1F, NCF2, NCF4, NCKAP1L, NFAM1, OSCAR, 
PARVG, PCED1B-AS1, PIK3R5, PLCB2, PLEK, PTAFR, RAC2, RASGRP4, 
RNASE6, RP11-1334A24.6, RP11-750H9.5, SASH3, SCIMP, SELPLG, 
SIGLEC1, SIGLEC7, SIGLEC9, SIRPB2, SLA, SLC11A1, SLC7A7, SLCO2B1, 
SNX20, SPI1, STAB1, TBXAS1, TFEC, THEMIS2, TLR2, TLR8, TMIGD3, 
TNFAIP8L2, TYROBP, VAV1, VSIG4, WAS, WDFY4 
Plasma 
cells 
ENSG00000211671.2, ENSG00000211936.2, ENSG00000211940.2, 
ENSG00000211953.2, ENSG00000231486.3, ENSG00000235896.2, 
ENSG00000253705.1, FCRL5, IGHA1, IGHA2, IGHG1, IGHG2, IGHG3, 
IGHGP, IGHJ1, IGHJ2, IGHJ3, IGHJ4, IGHJ5, IGHJ6, IGHM, IGHV1-14, 
IGHV1-18, IGHV1-2, IGHV1-24, IGHV1-3, IGHV1-46, IGHV1-67, IGHV1-
69, IGHV2-26, IGHV2-5, IGHV2-70, IGHV3-11, IGHV3-13, IGHV3-15, 
IGHV3-21, IGHV3-23, IGHV3-33, IGHV3-43, IGHV3-48, IGHV3-49, 
IGHV3-53, IGHV3-6, IGHV3-60, IGHV3-66, IGHV3-7, IGHV3-71, IGHV3-
72, IGHV3-74, IGHV3OR16-8, IGHV3OR16-9, IGHV4-28, IGHV4-31, 
IGHV4-34, IGHV4-39, IGHV4-55, IGHV4-59, IGHV4-61, IGHV5-51, 
IGHV6-1, IGKJ3, IGKJ4, IGKJ5, IGKV1-12, IGKV1-16, IGKV1-17, IGKV1-
27, IGKV1-33, IGKV1-39, IGKV1-5, IGKV1-6, IGKV1-9, IGKV1D-33, 
IGKV1D-39, IGKV2-28, IGKV2-30, IGKV2D-28, IGKV3-11, IGKV3-15, 
IGKV3-20, IGKV3-7, IGKV3D-11, IGKV3D-15, IGKV3D-20, IGKV3D-7, 
IGKV4-1, IGKV7-3, IGLC2, IGLC3, IGLC6, IGLC7, IGLJ1, IGLJ2, IGLJ3, 
IGLL5, IGLV1-40, IGLV1-44, IGLV1-47, IGLV1-51, IGLV2-11, IGLV2-14, 
IGLV2-23, IGLV3-1, IGLV3-10, IGLV3-16, IGLV3-19, IGLV3-21, IGLV3-25, 
IGLV4-69, IGLV6-57, JCHAIN, MZB1, POU2AF1 
B cells BLK, CD19, CD79A, CLEC17A, CNR2, ENSG00000260655.1, FAM129C, 
FCRL1, FCRL2, FCRLA, MS4A1, P2RX5, PAX5, RP11-148O21.2, RP11-
148O21.4, TBC1D27, TLR10, TNFRSF13B, TNFRSF13C 
T cells ACAP1, CARD11, CARMIL2, CD2, CD3D, CD3E, CD3G, CD40LG, CD6, 
CD8A, CD96, ENSG00000229164.5, GPR171, ICOS, ITGAL, ITK, LCK, 
MAP4K1, NLRC3, PCED1B-AS1, RASAL3, SH2D1A, SIRPG, SIT1, THEMIS, 
TIGIT, TMC8, TRAT1, TRBC2 
NK cells CD160, CD247, ENSG00000161570.4, EOMES, FASLG, FCRL6, GZMA, 
GZMH, GZMM, IL2RB, KLRB1, KLRC2, KLRC3, KLRC4, KLRD1, KLRF1, 
KLRG1, KLRK1, LINC00861, NKG7, PRF1, PTGDR, PYHIN1, S1PR5, 
SAMD3, SH2D1A, SH2D2A, SLA2, STAT4, TBX21, TRDC, ZAP70 
T cell-NK 
cell 
ACAP1, CARD11, CARMIL2, CD2, CD247, CD3D, CD3E, CD3G, CD48, 
CD5, CD6, CD69, CD8A, CD8B, CD96, CTSW, ENSG00000161570.4, 
ENSG00000264198.1, EOMES, GFI1, GPR171, GPR174, GZMA, GZMH, 
GZMK, GZMM, IL2RB, IL2RG, IL7R, ITGAL, ITK, KLRB1, KLRK1, LCK, 
LINC00861, LY9, MAP4K1, NKG7, P2RY10, PYHIN1, RASAL3, RUNX3, 
SCML4, SH2D1A, SIRPG, SIT1, SLA2, SLAMF6, SYTL1, TBC1D10C, TBX21, 
THEMIS, TIGIT, TMC8, TRAF3IP3, TRAT1, TRBC2, UBASH3A, ZAP70 
117 
 
Neutrophils AC007278.3, ADGRG3, AQP9, BCL2A1, CLEC4D, CSF3R, CTB-61M7.2, 
CXCR1, CXCR2, FCAR, FCGR3B, FPR1, FPR2, IL18RAP, LILRA5, MCEMP1, 
MEFV, NFE2, S100A12, SELL, VNN2 
 
Each of the rows represent immune cell annotations for which gene signatures were derived from 
21 human tissues. For each annotation column 2 shows all the high confident genes which were 
repeatedly associated with the corresponding cell type in more than 50% of the tissues the cell 
type was identified in. 
 
4.3.3 Comparing tissue-resident immune cells from mouse and human 
To try and help identify potential TRIC signatures and compare them with mouse, TRIC 
signatures from human (GTEx) were compared with the corresponding TRIC signatures 
from mouse (ImmGen and Tabula Muris) (Table S4.4). For each GTEx gene cluster 
(GTExGC) we obtained overlapping gene clusters from mouse (ImmGen and Tabula 
Muris) (Table 4.4). Three main observations were made from these analyses. First, 39 
GTExGCs matched gene clusters from mouse with respect to their cell type and tissue. 
These clusters were associated with twelve TRICs classifications in the GTEx including 
six gene clusters associated with Mac-Mono-Den, four for T cell-NK cell and two for B 
cells. Second, unlike the TRIC annotation from the mouse datasets, those from the 
human were much broader and majority of the GTEx gene clusters annotated as Mac-
Mono-Den overlapped with tissue-resident macrophage signatures from mouse, and 
those annotated as T cell-NK cells or T cells overlapped with mouse tissue-resident 
regulatory T cell signatures. Third, on closer investigation of the genes, we identified both 
known marker genes for B cells (SPIB) and Tregs (CCR4, CTLA4, GATA3 and TIGIT). 
In addition, seven of the TRICs had some of their signature genes supported by literature 
in representing those TRICs e.g. CX3CR1, P2RY12 and TREM2 for microglia. Other 
examples of tissue-specific genes included, BLVRA, BLVRB, HMOX1, SCL48A1 and 
VCAM1 for splenic macrophages, which help in regulating the cell’s inflammatory 
phenotype (Wegiel and Otterbein, 2012), function in maintaining iron homeostasis 
(Sukhbaatar and Weichhart, 2018) and migration (Dutta et al., 2015). The literature also 
supported the role of CR2 and DTX1 for splenic B cells (Descatoire et al., 2014); C5AR1 
(Wiese et al., 2017) and FOLR2 (Schyns et al., 2019) for oesophageal macrophages; 
MCOLN1 (associated with adipose tissue) (Wiklund et al., 2016) and CLEC10A (Hill et 
al., 2014) for adipose macrophages; CCR4 (aids in Treg migration and establishment in 
the tissue)(Guo et al., 2008) for colonic Tregs. A GTEx gene cluster annotated for Kupffer 
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cells (cluster 28) was enriched in ImmGen gene cluster 44 defined by a high expression 
in Kupffer cells.  
Table 4.4 Overlap between human and mouse tissue-resident immune cells. 
GTEx Datasets 
P value Gene ID Clus
ter Tissue Annotation Dataset Dataset: (Cluster Annotation) 
14 Adipose Monocyte/Macrophage ImmGen 
154_General [Macrophage: 
Mesenteric sheet == 
Macrophage: Alveolar CD45+ 
CD11blo CD64+ CD11c+ 
SiglecF+ >> Macrophage Fat] 
0.106 MCOLN1 
14 Adipose Monocyte/Macrophage ImmGen 
34_Specific [Macrophage: 
Aortic == Macrophage: Fat >> 
Macrophage: Alveolar Cd11b+ 
Cd64+ Ly6c- CD206+ MHCII+] 
0.086 CLEC10A/FCGRT 
17 Adipose T cells_NK cells TM 
41_Innate lymphocyte (type 
LP): C38, Fat 0.050 SYTL1 
17 Adipose T cells_NK cells TM 43_NK T cell: C16, Fat 0.043 TMC8 
17 Adipose T cells_NK cells TM 57_Treg: C41, Fat 0.033 TIGIT 
169 Brain Monocyte/Macrophage TM 10_Microglia 0.007 
P2RY12/P2RY1
3 




7 Brain Monocyte/Macrophage ImmGen 
119_Specific [Macrophage: 
Microglia >> Macrophage: 
Peritoneal] 
0.126 PLXDC2 
169 Brain Monocyte/Macrophage TM 47_Microglia 0.024 CX3CR1 
7 Brain Monocyte/Macrophage TM 47_Microglia 0.032 
LPCAT2/PLXD
C2 














8 Colon T cells_NK cells ImmGen 
113_Specific [Treg: Colon == 
Innate lymphocyte: Colon] >> 
General [Innate lymphocyte == 
Treg == Epithelial cell] 
0.060 CCR4 
8 Colon T cells_NK cells ImmGen 
26_Specific [Innate 
lymphocyte: Small intestine >> 
Treg: Colon] >> General 
[Innate lymphocyte] 
0.433 GATA3 
8 Colon T cells_NK cells ImmGen 
50_Specific [Treg: Colon] >> 
General [Treg == NK cell == 
Types of Dendritic cells] 
0.001 CTLA4/TIGIT/TNFRSF4 





Aorta >> Macrophage: Lung 
CD11b+  CD64+  Ly6C-  






Lung CD27+ SiglecF+ >> 
Macrophage: Spleen == 
Macrophage: Kupffer cell] >> 
General [Monocyte == 












Alveolar Cd11c+ SiglecF+] 0.626 RNASE2 
16 Esophagus 
Monocyte/Mac





Aortic == Macrophage: Fat >> 
Macrophage: Alveolar Cd11b+ 
Cd64+ Ly6c- CD206+ MHCII+] 
0.013 C5AR1/CLEC10A/STAB1 
398 Kidney Monocyte/Macrophage TM 64_Macrophage: C29, Kidney 0.000 LILRA6/LILRB3 
5 Kidney Monocyte/Macrophage TM 64_Macrophage: C29, Kidney 0.007 
LILRA2/LILRB4/
LILRB5 
6 Liver Monocyte/Macrophage ImmGen 
25_Specific [Dendritic cell: 
Liver preDC >> Dendritic cell: 
Plasmacytoid] >> General 
[Dendritic cell: Bone Marrow, 
Dendritic cell: Spleen] 
0.373 CD300C/TMEM229B 
28 Liver Monocyte/Macrophage ImmGen 
44_Specific [Macrophage: liver 
>> Endothelial cell: CD45- 
CD31+ PDPN+] >> General 






1 Small intestine T cells ImmGen 
50_Specific [Treg: Colon] >> 
General [Treg == NK cell == 
Types of Dendritic cells] 
0.054 TIGIT 
256 Spleen B cells TM 19_B cell: C43: Spleen 0.030 POLR1E 
8 Spleen B cells TM 30_B cell Spleen 0.001 ARHGAP24/CR2/DTX1 
8 Spleen B cells ImmGen 38_Specific [B cell: Germinal centre] 0.218 MBD4 
110 Spleen B cells ImmGen 
97_Specific [B cell: Fr E. >> B 
cell: Splenic memory == B cell: 
Splenic T1] >> General [B cell 
== Dendritic cell: PreDC == 
Dendritic cell: Plasmacytoid] 
0.007 SPIB 
400 Spleen Monocyte/Macrophage ImmGen 
108_Specific [Macrophage: 
Mesenteric == Macrophage: 
Spleen] 
0.011 BLVRB 
105 Spleen Monocyte/Macrophage ImmGen 
129_Specific [Macrophage: 
Spleen >> Macrophage: 
Thymus 64+ == Macrophage: 
Lung CD27+ SiglecF+ >> 
Macrophage: Fat] 
0.018 PLD3 
105 Spleen Monocyte/Macrophage ImmGen 
161_Specific [Macrophage: 
Lung CD27+ SiglecF+ >> 
Macrophage: Spleen == 
Macrophage: Kupffer cell] >> 
General [Monocyte == 
Macrophage == Fibroblast == 
Endothelial cell] 
0.015 BLVRA 





125 Spleen Monocyte/Macrophage ImmGen 
28_Specific [Macrophage: 
Spleen] 0.029 CREG1 
139 Spleen Monocyte/Macrophage ImmGen 
28_Specific [Macrophage: 
Spleen] 0.084 VCAM1 
118 Spleen T cells TM 27_Tregs: C41, Spleen >> Tregs: C41, Fat 0.015 CTLA4 
59 Spleen T cells TM 27_Tregs: C41, Spleen >> Tregs: C41, Fat 0.015 MATK 
 
Shown are the 39 GTExGCs which overlap with gene clusters from mouse (Tabula Muris and 
ImmGen dataset) and are also associated with the same cell types and tissues from those derived 
from mouse. The first three columns refer to the GTExGC, their cluster number, the tissue they 
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were derived from and the cell type they represent. The remaining columns refer to gene clusters 
from mouse and which were also enriched for certain GTExGCs. Included are the mouse gene 




To understand the functions of TRICs in maintaining tissue homeostasis in health and 
death, in chapter 3 TRIC signatures were derived from two data sources derived from 
mouse tissue, the ImmGen (bulk RNA-Seq of known FACS isolated cell types) and 
Tabula Muris (scRNA-seq data of cells from different tissues). In this chapter, we sought 
to extend these efforts to human tissues by utilising the extensive GTEx resource. GCN 
analysis was used to derive TRIC signature from each of the 21 tissues considered, and 
subsequently they were compared with those derived from mouse (in chapter 3), for 
validation and to estimate the conservation of TRIC signatures across species. 
To derive TRIC signatures each tissue was examined for coexpressing genes using 
GCNs, however for this a reference immune signature was required to determine which 
gene clusters were representative of immune cell types. A recent publication showed the 
importance of deriving immune signatures directly from tissues so as to identify immune 
cell types (Nirmal et al., 2018). This set of signatures, called ImSig, was in contrast to 
blood-derived immune signatures for deconvoluting immune cell types from tissues, e.g. 
CIBERSORT (Chen et al., 2018). Although, ImSig was a great resource for immune cell 
derivation from human tissue, the approach was directed towards identifying immune 
cell signatures under pathological conditions especially focussing on different types of 
cancers. Therefore, in order to define TRIC signatures from homeostatic tissues, a set 
of RIS were derived from human tissue samples having no known pathology. For this 
analysis the GTEx resource was used, a comprehensive human tissue atlas of gene 
expression data. This extensive dataset was first downsampled to attain an equal 
number of samples from different regions, thus balancing the correlation space for GCN 
analysis. Such an approach would give equal weightage to tissues for the correlations 
calculated between genes. After downsampling the dataset, RISs were derived using 
GCN analysis where gene clusters were annotated for a given cell type based on their 
enrichment for ImSig signatures. The RIS signatures defined broad immune cell 
classifications, including neutrophils, B cells, plasma cells, T cells, NK cell and in the 
case of macrophages, monocyte and DCs where no cell type specific clusters could be 
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identified, associated gene clusters were classified as ‘Mac-Mono-Den’. Altogether, the 
RIS represented the core signatures of these broadly defined cell classifications that are 
conserved across the 28 tissues of GTEx.  
Using the RIS, TRIC signatures were defined for each of the 21 selected tissues of the 
GTEx. The RIS were used to annotate gene clusters generated from the GCNs for each 
tissue. For constructing GCNs an appropriate threshold was applied to retain 15,000 
genes to make GCNs and gene clusters comparable across tissue. Alternatively, 
disparities in GCN sizes could lead to numerous small clusters in GCNs with few genes 
due to the sparsity of the network while bigger but fewer clusters would be present in 
larger GCNs. To annotate tissue derived gene clusters for immune cell types, first, core 
gene clusters were identified based on the enrichment of RIS and cell types makers. 
Assuming that not all immune cell types are present in every tissue, the core clusters 
revealed the presence or absence of cell types within each tissue. This step was followed 
by incorporating neighbouring gene clusters enriched in RIS genes, with that of core 
clusters. In majority of tissues distinct signatures were obtained for each cell type. 
However, similar to how ImSig genes associated with macrophages, monocytes and 
DCs co-clustered while deriving RIS, on deriving TRIC signatures from individual tissues, 
certain tissues had markers genes associated with T cells and NK cells co-cluster. 
Hence, in certain cases it was difficult to identify gene signatures uniquely defining a 
single cell type. This is likely due to the amalgamation of biological signals in bulk RNA-
Seq data, also touched upon in chapter 2. Signals in tissue transcriptomics data are 
dependent on the sample’s cell composition, and their expression levels of genes. An 
ideal GCN analysis to identify cell signatures would have cell types vary in different 
proportions across samples with a high expression of marker genes, likely the case for 
the colon, lung and spleen where all cell types (those considered in the RIS) are identified 
with distinct signatures. In contrast, there are two possibilities where marker genes for 
different cell types may co-cluster when deriving cell signature from bulk RNA-Seq data 
using GCN analysis. First, if different cell type associated genes would coexpress with 
one another (as a function of cell type proportion and expression level of their signature 
genes) across samples, they would appear to represent a single biology when using 
GCN analysis. Second, if the signal of a certain cell type is low relative to other cell types 
within the tissue sample, associated genes of the cell type may co-cluster with genes 
associated with similar cell types. These reasons possibly contribute to the combined 
signatures observed for “T cell-NK cell” and “Mac-Mono-Den”. In certain cases where 
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genes have similar coexpression patterns but are associated with different cell types, 
one can adjust the correlation threshold to construct GCNs to help segregate these 
genes into separate clusters. This was observed in certain tissues where genes for Mac-
Mono-Den co-clustered with those of neutrophils and T cells. In such cases, a higher 
correlation threshold was used to construct the GCN for a tissue thus segregating 
immune cell types signatures. Therefore, even though the number of genes was kept 
consistent for each tissue GCN, the degree to which TRIC associated coexpression 
patterns differed from one another varied across tissues. This variation is likely a function 
of the cellular composition of the tissue. Thus, constructing GCNs based on known 
biology would be appropriate as genes from each tissue would have different 
distributions of correlation values dependent on the cellular composition of the tissue. 
Altogether, the aforementioned procedure with the use of RIS could be used to identify 
immune cell signatures across other bulk RNA-Seq datasets derived from healthy human 
tissues. 
The derived signatures were then studied for their distribution across tissues. From the 
brain T cell-NK cells and microglial signatures were derived. This observation was 
supported by the fact that majority of immune cells in the brain are microglia (80% of 
immune cell types), second to which are various types of T cells (Korin et al., 2017). 
Although other immune cell types have been found in the brain through FACS, due to 
their lower cell abundance, and accordingly fewer reads relative to other brain cell types, 
their signatures would not be captured using GCN analysis. In other tissues all 6 immune 
cell types were derived, and for these tissues mass cytometry studies have shown their 
respective cell numbers to represent approximately more than 10% of cells within the 
tissues, this includes the colon (van Unen et al., 2016), lung (Hanidziar et al., 2020) and 
spleen (Goltsev et al., 2018). Hence, the analysis is able to capture the 
presence/absence of immune cells across tissues, although differentiating amongst 
certain signatures was challenging, e.g. for myeloid cell types as well as T cells and NK 
cells. The TRIC signatures were compared with those in mouse (ImmGen and Tabula 
Muris TRIC signatures derived in chapter 3) using enrichment analysis. The mouse 
signatures provided a higher resolution of cell classifications many of which were 
supported through predefined markers from the ImmGen. 39 gene clusters overlapped 
across similar TRICs signatures from mouse to human which described 12 TRIC 
populations in human. Interestingly, for broad cell classifications such as Mac-Mono-
Den, associated gene clusters mainly overlapped with macrophage signatures from the 
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mouse, rather than monocytes or DCs. A similar observation was seen in the T cell-NK 
cell classification in human which pointed to Treg gene signatures in mouse. This could 
suggest that these cell types were abundant, highly expressed marker genes, or 
expressed a unique set of genes in the context of the tissue. There has been an 
increased appreciation for tissue-resident Tregs in maintaining tissue homeostasis and 
as a therapeutic target (Lu et al., 2015, Sharma and Rudra, 2018, Zhou et al., 2015). 
Through literature mining supporting genes were found for seven of the TRIC 
populations, including macrophages (brain, liver, spleen, oesophagus and adipose), B 
cells (splenic) and Tregs (colonic). Thus, the analysis revealed TRIC associated genes 
conserved across species, however few TRIC signatures from human were enriched for 
those from mouse. One reason could be the lack of conservation of TRICs across 
species. A more likely scenario is that TRICs would likely share genes with other tissue-
resident cells to maintain tissue homeostasis and GCN analysis would capture 
associated gene modules, however, be unable to differentiate between the cell types 
utilising the pathways. Hence, GCN analysis enables the derivation of different immune 
cell signatures across tissues, revealing core genes associated with these cell types. In 
contrast, identifying and supporting genes associated with tissue homeostasis was more 
challenging, because such genes would need to be uniquely expressed by the cell type 
or be abundantly expressed (a combination of higher cell abundance or expression of 
the gene) to be captured by GCN analysis. Furthermore, whilst certain signature genes 
were supported by literature, an indication of true positive TRIC associated genes, further 
experimental validation would be required to separate them from the false positive 
genes. In such cases where we study functional gene modules shared across cell types 
their derivation from scRNA-Seq may be more informative as it would describe which 
cells utilise those modules and how highly they are expressed within them.  
In summary, human TRIC signatures have been characterised across 21 tissues of the 
GTEx resource and have compared them with those from the mouse. In the process 1) 
gene signatures associated with 6 immune cell types were derived under physiological 
conditions, referred to as RIS. 2) Furthermore, with the methodologies adopted here in 
these RIS were further used to derive TRIC signatures from bulk RNA-Seq data derived 
from individual tissues of the GTEx. Using the RIS, 91 TRIC signatures were derived 
from the 21 tissues through GCN analysis. 3) These signatures comprised of known 
markers which were conserved across tissues for the respective cell type. 4) Immune 
cell signatures overlapped across similar cell types e.g. lymphoid immune cell signatures 
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shared several genes. 5) Not all immune cell types had signatures in all tissues, and 
their presence/absence across tissues. 6) 39 signatures mapped between common 
TRICs across mouse (ImmGen and Tabula Muris) and human. 7) Of these, seven 
signatures included genes supported by literature in representing the respective cell 
type. In future studies one would hope to conduct similar analyses for deriving TRIC 




5. Chapter 5: Conclusions 
In this thesis TRIC gene signatures from mouse and human were investigated using 
transcriptomic data from different sources and platform. Through these signatures the 
biology of TRICs and their diversity was investigated. In the process, the advantages 
and disadvantages of using different transcriptomic technologies for cell signature 
derivation were discussed, while also developing novel approaches to analyse single cell 
transcriptomics data. Sequentially, through the chapters various aspects of TRIC biology 
are studied at different resolutions (tissue or cell) and species.  
This work began with the investigation of microglia, following on from the work of the 
Freeman and McColl labs (Grabert et al., 2016, Vincenti et al., 2016) and their relevance 
in to mouse models of mimicking the pathology of Alzheimer’s disease. This work 
showed the complexity of neurodegenerative models where microglia displayed regional 
heterogeneity in their numbers and activation state. The following questions on microglia 
were examined in chapter 2: 
1. Can we define an expression signature for microglia in the context of human brain 
tissue?  
2. Does this signature show any quantitative or qualitative differences based on the 
of brain? 
3. How can the signature be used in studying microglia behaviour (cell abundance 
and activation state) in the context of aging and neurodegenerative disease? 
Initially, existing microglial expression signatures were examined, however, little 
consistency was observed between these signatures both in mouse and human. It was 
argued that this could be due to the different transcriptomic platforms used, donor 
differences, sample types (tissues and cells), brain regions sampled across studies or 
the methods used to derive them. The reality is that it is probably a combination of all 
factors. To see if we could do better, nine transcriptomic datasets were used spanning 
different platforms (microarray and RNA-Seq), 427 brain regions, 220 donors and 
sample types (pooled cells and brain tissue). GCN analysis of each dataset produced 
microglial signatures for each from which a core human microglia signature was 
generated with the 298 genes which overlapped across more than two of the dataset 
derived signatures. Signature genes were validated through various public resources, 
examining staining of their encoded proteins across brain regions (from the HPA), higher 
average expression in myeloid cell types relative to other immune and CNS cell types 
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(primary cell atlas) (Mabbott et al., 2013), and the correlation between their average 
expression with microglial density across regions (Lawson et al., 1990). The signature 
was then used to determine microglial response in different brain regions during ageing 
and in Alzheimer’s disease. In relation to ageing, the proportion of microglia as 
determined by the average expression of signature genes correlated with the distribution 
of microglial inflammation and neuronal loss across the brain regions examined, while 
for Alzheimer’s it correlated with neuroinflammation, tau burden, and neuronal loss. 
Furthermore, the analysis of the microglial transcriptomic profile in Alzheimer disease 
revealed the downregulation of homeostatic genes and upregulation of 
neuroinflammatory genes as well as genes from the TYROBP-TREM2 pathway 
implicated in the disease. A similar phenotype was observed in a recent snRNA-Seq 
study that examined brain cells from 48 donors balanced for donors with no 
neuropathology and those with Alzheimer’s disease (Mathys et al., 2019). However, this 
study also revealed that human microglia are not entirely similar to mouse disease 
associated microglia and instead present an ageing like profile. An example of this is 
TREM2 which is upregulated in mouse neurodegenerative models while remaining 
unchanged in human Alzheimer’s disease (Keren-Shaul et al., 2017). We too observed 
a similar profile for TREM2, however further analyses are required to confirm these 
findings as several studies have also shown how current single cell technologies may 
still lack the sensitivity of detecting certain genes (Thrupp et al., 2020). In the Alzheimer’s 
study, Mathys et al. also voiced concerns for the small number of cells examined in their 
study. Hence, even though an ideal experiment for chapter 2 would be to analyse 
snRNA-Seq data derived from cells of different brain regions under physiological and 
neurodegenerative conditions, from a technical standpoint the current technologies still 
require further improvements in their sensitivity to capturing and quantifying reads, as 
well as their throughput as having more cells aids downstream analyses. This will 
become possible in the future with the continuous development of single cell omics, e.g. 
SmartSeq3 (Hagemann-Jensen et al., 2020). In certain cases, bulk RNA-Seq data may 
be a better choice over (more cost effective and sensitivity towards reads) scRNA-Seq 
when deriving a core signature as has been conducted for microglia which have a distinct 
transcriptional program relative to other CNS cells across brain regions. The core human 
microglial signature derived by this work has already been utilised in characterising the 
microglial response in Huntington’s disease (Al-Dalahmah et al., 2020). Where scRNA-
Seq takes the upper hand is in tracking the various subpopulations for that cell type, 
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which in bulk RNA-Seq would amalgamate into a single signature, i.e. appear as single 
cell type if they are not sufficiently different based on their transcriptome. The field of 
microglial biology continues to expand, studying the many phenotypes of microglia. For 
example, the use of CyTOF to describe homeostatic microglia across five brain regions 
(Böttcher et al., 2019). Alternatively, to study the activation states of microglia 
researchers have been generating and exploring neurodegenerative mouse models 
(Masuda et al., 2020) while others have compared these states across species 
(Geirsdottir et al., 2019). As we expand on the number of scRNA-Seq datasets derived 
from a combination of different models, stimuli, species and diseases we would 
essentially possess a host of cell perturbations from which to deconstruct their gene 
regulatory network ultimately enabling in silico perturbations to the regulatory network as 
has been proposed (Lotfollahi et al., 2018). Whilst, studying the brain transcriptome, one 
other gene module caught my interest and this led to recent publication of a signature 
for motile cilia, as seen in the brain associated with ependymal cells (Patir et al., 2020). 
The microglial signature from chapter 2 highlighted the potential use of gene signatures 
and the importance of studying homeostatic TRIC signatures. This work was expanded 
upon in chapter 3 where several immune cell types including various TRIC types were 
examined based on their transcriptomic profile. In this chapter the following questions 
were addressed:  
1. How similar are immune cell types with respect to their lineage and tissue of 
residence? 
2. To what extent does tissue determine the diversity of cell types? 
3. What are the signatures associated with different TRICs? 
4. How well do the signatures between marker defined cell types compare with cell 
types defined through scRNA-Seq? 
Three datasets aided in addressing these questions. Two of the datasets were from the 
ImmGen resource where samples were derived from pooled cells of FACS isolated 
immune cells. Here, cell types were predefined based on markers. In contrast the third 
dataset, the Tabula Muris comprised of scRNA-Seq data derived from different mouse 
tissues, from which immune cell types, as annotated by the authors, were considered. 
Generated by what might be considered a ‘biased’ approach, the ImmGen datasets 
revealed lymphoid cell types to be largely similar to one another while for the myeloid 
system cell types were more heterogeneous including the different types of tissue-
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resident macrophages (alveolar, microglial, splenic and peritoneal). Hence, at least in 
this dataset, the sample-to-sample network suggested that cell types within a lineage 
are very similar (interconnected within a single graph component) and that tissue-
resident populations, mostly with respect to macrophages are more distinct. One would 
assume that based on markers, replicates for the same cell type would form separate 
clusters. In contrast, a continuity was observed from one cell type to the other. This lack 
of distinction between certain cell types was also observed in the Tabula Muris, where 
different cell types were part of a continuum of states, e.g. aortic macrophages clustered 
together however they were still part of the macrophage component with no obvious 
boundaries distinguishing them from other tissue-resident macrophages, hence 
requiring approaches such as graph-based clustering to distinguish them. 156 
coexpressing gene modules were found associated with a cell type or groups of cell 
types, ranging from cell lineages to TRICs. Several signatures associated with TRICs 
contained known markers and transcription factors. For the unbiased analysis the 
SmartSeq2 derived scRNA-Seq data from Tabula Muris was used as it is known to have 
a better-read coverage of genes with fewer dropouts than the 10x Chromium system, 
thereby improving downstream analyses. Furthermore, there is also the issue of the non-
uniformity in isolating cells and the susceptibility of certain cells which likely explain the 
absence of certain obvious cell types, e.g. splenic macrophages in Tabula Muris.  
Improving such protocols would make single cell omics data more closely resemble the 
tissue composition and improve read capture sensitivity. Analysis of scRNA-Seq data 
from Tabula Muris found the similarity/differences between cell types matching those 
observed from the marker-based ImmGen analysis, i.e. lymphoid cell types showed 
great similarity in comparison to the more heterogenous myeloid cell types, especially 
macrophages. These observations suggest an agreement between cell types identified 
by unbiased approaches such as scRNA-Seq and biased approaches like those defined 
by markers, highlighting how far the field has come in defining cell types. However, a 
more refined evaluation of marker-based cell types would involve the investigation of the 
marker-defined cell types using scRNA-Seq as has been recently examined for DCs and 
monocytes (Villani et al., 2017).  
Forty-four gene clusters were identified associated with different cell classifications, 
several of which mapped to ImmGen gene clusters for the same cell type. For both 
ImmGen and Tabula Muris, the majority of the cell types were defined by their tissue of 
origin, as opposed to a cell subtype (a cell type present in several tissues), e.g. the 
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different ILC subsets. Furthermore, both datasets showed macrophages to be the most 
heterogeneous, for which associated signature genes found were supported by literature 
for similar TRICs. This would suggest that these gene signatures closely represent the 
TRICs identified here in, however, a further evaluation based on known cell types would 
help support the analysis, especially for the other TRICs which have not been as 
thoroughly examined as tissue-resident macrophages. The annotations of cell types and 
their corresponding gene clusters are a crucial part of omic analyses, as has been 
conducted for the Tabula Muris dataset using the immune cell signatures derived from 
ImmGen. The use of the ImmGen signatures in annotating Tabula Muris gene clusters 
highlights the importance of the context in which the reference signatures are derived to 
annotate either the gene or cell clusters of the query dataset. For example, the ImmGen 
signatures were a perfect reference for annotating the Tabula Muris gene clusters as 
both datasets shared similar homeostatic immune cell types and were derived in the 
context of other immune cell types. In contrast, if either of the datasets also included 
non-immune cell types, the resultant immune cell signatures (derived in the context of 
immune and non-immune cell types) would represent biological differences between 
immune and non-immune cells rather than TRIC biology. Current signature databases 
define cell type signatures across various tissues and conditions; however, they do not 
account for the variation in signatures due to the context they are derived from, i.e. the 
types of cells/tissues they are derived from. Hence, a flexibility is needed in such 
databases to define the context of the signature which is especially important in studies 
where cell types are enriched for.  
Researchers are continuing to generate cell type signatures to better understand the 
biology of cells and for annotating unknown cells by aggregating markers from the 
various stages of development and across human tissues (Zhang et al., 2018c). 
Unfortunately, even with these numerous variables, the current nomenclature or 
definition of cell types has still been restricted to a few markers as is evident from the 
ImmGen resource. Even single cell studies which describe cell biology at the highest 
resolution using tens of thousands of variables still name cell types based on 2-3 markers 
(Villani et al., 2017). Due to a lack of a comprehensive nomenclature, characterising 
novel cell types is done through manual scanning of literature of markers/signatures, 
enrichment of signatures from databases and comparison with omic profiles of previously 
identified cell types. This was especially an issue in chapter 3 as one of the future 
analyses for the Tabula Muris dataset would be to compare cells based on known cell 
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types. A structured nomenclature would certainly facilitate cell annotations through 
comparisons across studies. Such a naming system would have to be flexible, able to 
accommodate several variables, potentially include even those variables which are to 
come through future technologies. Such a cell ontology would help annotate novel cell 
types and place them within the context of existing cell types simply based on the naming 
scheme. A potential answer to this could be the use of QR codes which can potentially 
accommodate more than 30,000 modules of information. 
Through chapter 3 two methods were also developed. The first being, annotation of 
single cells based on their transcriptomic profile through comparison with the 
transcriptomic profiles of known cell types. Unlike other available approaches this 
process was done at the cell-cluster level so as to annotate groups of cells which reduced 
the chances of incorrect annotations of cells due to the influence of technical artefacts. 
2) The second method looked at constructing GCNs from scRNA-Seq data, where reads 
across cells from the same cell cluster were averaged thereby constructing a balanced 
GCN where each cell type/cluster would have an equal weight for the correlation 
calculated between genes. For constructing GCNs, two factors were evaluated which 
could potentially influence the GCN, lowly expressed genes and the number of cells. 
These factors were considered by examining three approaches (Average, Subcell and 
Filter-Average). Whilst, all methods captured similar biology (gene clusters), the Filter-
average approach comprised of fewer false positives as gene clusters unique to the 
approach were enriched for GO terms unlike the other methods. The approach involved 
averaging of reads across cells of a given cell type and filtering genes based on potential 
technical artefacts, e.g. dropouts and spikes in expression. Hence, removal of certain 
signals in gene expression helped reduce gene clusters due to technical factors and 
helped reduce the variation within the data, enabling the GCN to focus on inter-cell 
cluster variation. Although, several methods have been developed to capture regulatory 
networks in the single cell omics space such factors have not yet been considered. 
Whilst, methodologies are being developed using various benchmarks (Pratapa et al., 
2020) the field is still lacking statistical approaches for such an analysis. Certain methods 
have tried to address this, although unpublished the Seurat package in R enables 
hierarchical clustering on which differential expression analysis can be done for grouping 
at the different levels of the dendrogram, comparing two branches/groupings at a time. 
Such an analysis would greatly help in differentiating differences due to the different 
levels of cell hierarchy, from cell lineage to cell subsets. Another way of imagining such 
131 
 
a hierarchy of cell types is as a mixture of cellular states, e.g. studies are also finding 
immune like phenotypes in structural tissue cells (Krausgruber et al., 2020). This area, 
however, requires further investigation to determine conserved state associated gene 
modules across cell types. Apart from the need to develop methods to determine gene 
regulatory networks, another factor is the experimental design. Currently we rely on 
disease models to study the breath of immune cell diversity, however, this also limits us 
to the states that are attained in these diseases. Therefore, to better describe all potential 
states a cell can attain, and the pathways used to generate them, perturbation studies 
such as scRNA-Seq in combination with CRISPR would prove immensely useful (Duan 
et al., 2019). This would allow researchers to perturb the gene regulatory network of a 
certain cell type which in combination with probabilistic models could help deconstruct 
causative networks.  
In chapter 3, a comprehensive set of immune cell types were examined at the resolution 
of single cells, however, only in mouse. Hence, in chapter 4 this effort was extended to 
human. For this the GTEx dataset was considered as it is the largest and most diverse 
resource of human tissue transcriptomics data. In chapter 4, the following questions were 
investigated: 
1. Can bulk transcriptomics data be used to capture immune cell signatures across 
tissues using GCN analysis? If so, to what resolution (lineage, cell types, 
subtypes or TRICs)? 
2. What is the distribution (presence or absence) of immune cell types across 
tissues? 
3. How do TRIC signatures compare across tissues, i.e. which cell types are more 
similar to one another based on their signature genes? 
4. What are the genes that define human TRICs, i.e. the core set of genes which 
are conserved across the class of immune cell types and those genes which are 
specific to TRIC from a certain tissue? 
5. How do the TRIC signatures from human (GTEx) compare with that of mouse 
(ImmGen and Tabula Muris)? 
To derive TRIC signature from each of the 21 tissues considered, first a set of RISs were 
derived from a combination of downsampled data from all tissues. The RISs described 
six broad classifications of immune cell types of both lymphoid (B cells, plasma cells, T 
cells and NK cells) and myeloid (Mac-Mono-Den and neutrophils) lineages. These RIS 
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genes were then used to capture TRIC signatures from each tissue based on a pipeline 
developed herein using GCNs. The method accounted for the fact that not all immune 
cell types are present in every tissue. Approaches such as the use of RIS are necessary 
as the context in which we derive markers or signatures determines how we can use 
them, e.g. if we used signatures derived from a single tissue such as blood to annotate 
gene clusters in other tissues, some of the genes from blood immune cell signatures 
could represent a different biology in other tissues. The RIS helped identify the presence 
and absence of immune cell types across tissues thereby capturing 91 TRIC signatures, 
with Mac-Mono-Den clusters being present in all tissues. The analysis also described 
the distribution of immune cell types across tissues, the most evident example being for 
the brain which comprises dominantly of microglia and secondly T cells as also captured 
by the analysis. For the majority of cell types their gene signatures did not overlap, i.e. 
marker genes for different cell types did not co-cluster, however, for T cells and NK cells 
this was sometimes the case likely due to similarity between cell types. For certain 
tissues gene signatures for particular cell types like those of the myeloid lineage were 
not separable within the GCN. Therefore, higher thresholds were required to distinguish 
cell type gene signatures. This is likely due to the overlapping gene usage or biology 
across cell types and their comparable compositions within the tissue. The analysis also 
underscored the unique biology of each tissue which could be seen in the distinct 
topology of each GCN. The topology of GCNs from each tissue is likely a function of cell 
heterogeneity, cell proportions and the levels of genes they express, however, it is 
challenging to account for these factors and determine the “correct” threshold for GCN 
construction. Methods are being developed to determine a relevant threshold (Gobbi and 
Jurman, 2015). On examining the gene content of immune cell classifications across 
tissues, genes which were repeatedly associated with a certain immune cell 
classification included known marker genes for that cell type. Hence, the TRIC signatures 
derived for each of the 21 tissues did represent the broad classifications of immune cell 
types. For those genes which were unique to TRIC from a specific tissue, their validation 
was more challenging. The signatures were compared with the TRIC gene signatures 
obtained from the analysis of the ImmGen and Tabula Muris datasets in chapter 3. 39 
gene clusters mapped across human (GTEx) and mouse (ImmGen and Tabula Muris) 
for the same TRIC. These clusters were associated with 12 TRICs of which literature 
was found supporting genes for seven from their associated gene clusters. Although, 
these low confidence genes (associated with few TRICs) likely comprised of a number 
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of false positives, the aforementioned comparison between mouse and human helped 
validate certain TRIC signatures. The number of gene clusters that mapped from mouse 
to human were still few relative to the total number of gene clusters identified, the likely 
reason being the resolution of bulk transcriptomics rather than interspecies differences. 
Unlike the microglia signature which have genes specific to it which describe their 
homeostatic functions in the brain, other tissues may comprise of several cell types which 
share such genes that are responsible for tissue homeostatic functions. Assuming that 
the TRICs studied here express such genes, they may not coexpress with the immune 
cell signatures as the expression of these genes is also a function of other cell types 
(their portions and the levels at which they express these genes). Hence, although it is 
easier to identify the core signatures for immune cell types within bulk transcriptomics 
while finding TRIC associated genes is still more challenging. 
Building on initiatives such as GTEx and ImmGen, are the Human Cell Atlas (Regev et 
al., 2017) and human cell landscape (Han et al., 2020), the latter consisting of more than 
half a million cells generated from 60 tissues. This would be a great resource for the final 
analysis between mouse and human TRICs in this thesis which was otherwise limited by 
the resolution of bulk tissue transcriptomic data.  To address some of the issues in 
deriving cell signatures from bulk transcriptomics data, recent studies have moved 
towards scRNA-Seq which enables the examination of cell proportions and cell types 
independently. Now, bulk transcriptomics is instead being used to estimate cell 
proportions based on signatures or markers identified from single cell omics,  as single 
cell isolation protocols may not capture different cell types with the same efficacy (Jew 
et al., 2020, Wang et al., 2019c, Dong et al., 2020, Kang et al., 2019). However, even 
with the development of such methodologies it will be interesting to see whether the error 
rate of estimating cell types and their proportions in bulk RNA-Seq data vary across 
tissues. Nevertheless, the approach is important in treatments, e.g. in determining the 
tumour cell profiles for prognosis (Racle et al., 2017). In addition to tissue-derived bulk 
transcriptomics there is also transcriptomics data derived from pooled cells such as the 
ImmGen data examined in chapter 3. Whilst, the signal from this data was less affected 
by technical artefacts specific to scRNA-Seq such as dropouts, the approach still relied 
on FACS which is reliant on a limited number of markers for defined cell populations. 
Hence, single cell based approaches would still likely be preferred especially with future 
improvements in isolation protocols and technologies such as the Smart-Seq3 which 
improves upon the read coverage, sensitivity of read detection and library cost per cell 
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relative to previous single cell long-read technologies (Hagemann-Jensen et al., 2020). 
Recent studies have also used bulk RNA-Seq data as a reference to help impute values 
in scRNA-Seq data thereby improving downstream analyses including the detection of 
distinct cell types (Hou et al., 2020). As of now bulk RNA-Seq still holds a significant 
place in the field due to the quality of signal and its relatively low cost. 
With the diversity and development of transcriptomic technologies as described herein, 
the field of cell biology continues to develop single cell omic technologies which our 
furthers our understanding of their heterogeneity. As a result of this complexity we are 
delving deeper into the fundamental and conceptual questions of what a cell type is. My 
outlook of this discussion, also shared by Michael Elowits and his colleagues (2017), is 
to consider cells as human beings who through life make various decisions thereby 
determining their final personality and position in the world. Furthermore, these decisions 
are dependent on those made previously while also relying on the environment or 
situations they live through. For example, in  a  study of the spleen and kidney, 
macrophage-derived from embryonic progenitors could be discerned from adult 
monocyte-derived macrophages (Epelman et al., 2014a). Accordingly several methods 
are now being developed for tracking cell phenotypes (Wagner and Klein, 2020) thereby 
determining what is involved in the decisions cells make that ultimately defines their 
identity. In addition to the gene regulatory networks of cell types described in most 
studies included in this thesis, recent methodologies for capturing cell-to-cell interaction 
networks hold great potential in understanding the complex dynamics of cells within 
tissues. Apart from the cocktail of ligands which make up environmental queues that are 
required for cell development, to adopt tissue resident phenotypes and activations 
states, cell-to-cell interactions are also important signals to study. For example, 
activation of T cells is dependent on the context of TCR engagement with MHC (Kim and 
Williams, 2010). Now, using bioinformatic techniques on non-enriched samples one can 
determine the potential interactors from scRNA-Seq with tools such as CellPhoneDB 
(Efremova et al., 2020). Only recently have methods been developed to capture these 
instances of cell-to-cell interaction (Giladi et al., 2020). The approach labels distinct cell 
types which are then FACS sorted into singlets as well as interacting cells which are then 
analysed. Examining the omics of interacting cells would help identify which cells interact 
more often and what responses are induced. In addition to the network of pathways that 
define cell types, such experiments would provide the network of cell-to-cell interactions 
which determine the immune response. Hence, cell interaction networks may reveal 
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subtle or transient events between cell types relevant in disease pathology which would 
open various therapeutic avenues. 
In summary, this thesis identifies various novel immune cell signatures. In the case of 
human microglia, the signature was thoroughly validated and used to determine region 
dependent alterations in ageing vs. Alzheimer’s. Such immune cell signatures were also 
derived across tissues thereby dissecting lineage and tissue dependence. Furthermore, 
TRIC signatures were derived using various transcriptomic platforms finally comparing 
across species and RNA-Seq technologies. These analyses emphasised the limited 
resolution of bulk transcriptomics data and the complexities of single cell transcriptomics 
for which techniques for cell annotation and GCN analysis were developed. The thesis 
discusses the complexities of cellular heterogeneity and how we might better understand 
them in terms of their definition/nomenclature and the importance of databases to 
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